IP Verse

Arbutus Biopharma vs. Moderna - UPC_CFI_191/2025

The UPC Case UPC_CFI_191/2025 was filed on 03 Mar, 2025 by the plaintiff Arbutus Biopharma, Genevant Sciences against the defendant Moderna.

Case Details

    Case Number:

    UPC_CFI_191/2025

    Patent Number:

    EP2279254

    Filing Date:

    03 Mar, 2025

    Proceeding Type:

    Infringement

    Case Phase:

    Written Phase

    Plaintiffs:

    • Arbutus Biopharma
    • Genevant Sciences

    Plaintiff Representatives:

    • Mark VAN GARDINGEN

    Defendants:

    • Moderna Netherlands

    Defendant Representatives:

    • Ruben LADDÉ

    Judges:

    • Edger Brinkman
    • Margot Kokke
    • Samuel Granata
    • Xavier Dorland-Galliot

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

DateTitleLink
Oct 3, 2025Receipt-
Oct 3, 2025Exhibit-
Oct 3, 2025Cover Sheet-
Oct 3, 2025Application-
Sep 24, 2025Statement Of Reply-
Sep 24, 2025Receipt-
Sep 24, 2025Exhibit-
Sep 24, 2025Cover Sheet-
Sep 14, 2025Rejoinder On Request To Produce Evidence-
Sep 12, 2025Uploaded For Technical Reasons Only To Close Workflow
Sep 12, 2025Upc Genevant Arbutus Reply R 190 Request Signed-
Sep 12, 2025Outcome Of The Order-
Sep 12, 2025Opportunity To Comment-
Sep 2, 2025Receipt-
Sep 2, 2025Moderna R.9 Rop In Response To R.190 Rop Application-
Aug 28, 2025Receipt-
Aug 27, 202525 08 27 Ep 254 Further Comment On Request To Produce Evidence Moderna Vs Genevant-
Aug 26, 2025Reply Re R190 Request-
Aug 26, 2025Exhibit G126-
Aug 18, 2025Panel Appointment-
Aug 18, 2025Opportunity To Comment-
Aug 15, 2025R.37.2 Order
Aug 14, 2025Response To Request To Produce Evidence (Rule 190 Rop)-
Aug 14, 2025Exhibit Fs18 DI 457 Letter May-
Aug 14, 2025Exhibit Fs17 Protective Order-
Aug 13, 2025Joint Statement Regarding Bifurcation-
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop-
Aug 8, 2025Response To Deadline Extension Request-
Aug 6, 2025R.37-
Aug 6, 2025R
Aug 6, 2025Hearing Dates-
Aug 5, 2025Redacted Final Order Re R.262A Applications-
Aug 4, 2025R.262A Order-
Aug 4, 2025Outcome Of The Order-
Aug 4, 2025Opportunity To Comment-
Aug 1, 2025Request For Extension Of Deadlines-
Aug 1, 2025Receipt-
Aug 1, 2025Exhibit G125-
Aug 1, 2025Exhibit G124-
Aug 1, 2025Exhibit G123-
Aug 1, 2025Application For An Order To Produce Evidence-
Jul 28, 2025R.262A Reply-
Jul 28, 2025Exhibit G122-
Jul 25, 2025Receipt-
Jul 24, 2025R.262A Reply-
Jul 24, 2025Exhibit G122-
Jul 23, 2025Reference To Response Of Genevant-
Jul 23, 2025R.262.2 Application-
Jul 23, 2025Exhibit G121 Confidential-
Jul 23, 2025Exhibit G120-
Jul 23, 2025Exhibit G119-
Jul 23, 2025Confidential Response To Security-
Jul 11, 2025Formal Checks Notification Of Positive Outcome-
Jul 11, 2025Acknowledgement Of Lodging-
Jul 10, 2025Set Of Exhibits Fbd T 09 Confidential-
Jul 10, 2025Set Of Exhibits Fbd 11-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 5 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 4 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 3 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 2 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 1 Of 5-
Jul 10, 2025Opportunity To Comment-
Jul 10, 2025Formal Checks Request For Correction-
Jul 10, 2025Exhibit Fbd T 19-
Jul 10, 2025Exhibit Fbd T 18-
Jul 10, 2025Exhibit Fbd T 17-
Jul 10, 2025Exhibit Fbd T 16-
Jul 10, 2025Exhibit Fbd T 15-
Jul 10, 2025Exhibit Fbd T 14-
Jul 10, 2025Exhibit Fbd T 13-
Jul 10, 2025Exhibit Fbd T 12-
Jul 10, 2025Exhibit Fbd T 11-
Jul 10, 2025Exhibit Fbd T 10-
Jul 10, 2025Exhibit Fbd T 09A Confidential-
Jul 10, 2025Exhibit Fbd T 08-
Jul 10, 2025Exhibit Fbd T 07-
Jul 10, 2025Exhibit Fbd T 06-
Jul 10, 2025Exhibit Fbd T 05-
Jul 10, 2025Exhibit Fbd T 04-
Jul 10, 2025Exhibit Fbd T 03A-
Jul 10, 2025Exhibit Fbd T 03-
Jul 10, 2025Exhibit Fbd T 02-
Jul 10, 2025Exhibit Fbd T 01-
Jul 10, 2025Exhibit Fbd 16-
Jul 10, 2025Exhibit Fbd 15-
Jul 10, 2025Exhibit Fbd 14-
Jul 10, 2025Exhibit Fbd 13-
Jul 10, 2025Exhibit Fbd 12 Confidential-
Jul 10, 2025Exhibit Fbd 11A-
Jul 10, 2025Exhibit Fbd 09-
Jul 10, 2025Exhibit Fbd 08-
Jul 10, 2025Exhibit Fbd 07-
Jul 10, 2025Exhibit Fbd 06-
Jul 10, 2025Annex 7 To Exhibit Fbd T 4-
Jul 10, 2025Annex 6 To Exhibit Fbd T 4-
Jul 10, 2025Annex 5 To Exhibit Fbd T 4-
Jul 10, 2025Annex 4 To Exhibit Fbd T 4-
Jul 10, 2025Annex 3 To Exhibit Fbd T 4-
Jul 10, 2025Annex 2 To Exhibit Fbd T 4-
Jul 10, 2025Annex 1 To Exhibit Fbd T 4-
Jul 10, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025 V2-
Jul 9, 2025Set Of Exhibits Fbd T 09 Confidential-
Jul 9, 2025Set Of Exhibits Fbd 11-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 5 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 4 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 3 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 2 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 1 Of 5-
Jul 9, 2025Receipt-
Jul 9, 2025Opportunity To Comment-
Jul 9, 2025Exhibit Fbd T 19-
Jul 9, 2025Exhibit Fbd T 18-
Jul 9, 2025Exhibit Fbd T 17-
Jul 9, 2025Exhibit Fbd T 16-
Jul 9, 2025Exhibit Fbd T 15-
Jul 9, 2025Exhibit Fbd T 14-
Jul 9, 2025Exhibit Fbd T 13-
Jul 9, 2025Exhibit Fbd T 12-
Jul 9, 2025Exhibit Fbd T 11-
Jul 9, 2025Exhibit Fbd T 10-
Jul 9, 2025Exhibit Fbd T 09A Confidential-
Jul 9, 2025Exhibit Fbd T 08-
Jul 9, 2025Exhibit Fbd T 07-
Jul 9, 2025Exhibit Fbd T 06-
Jul 9, 2025Exhibit Fbd T 05-
Jul 9, 2025Exhibit Fbd T 04-
Jul 9, 2025Exhibit Fbd T 03A-
Jul 9, 2025Exhibit Fbd T 03-
Jul 9, 2025Exhibit Fbd T 02-
Jul 9, 2025Exhibit Fbd T 01-
Jul 9, 2025Exhibit Fbd 16-
Jul 9, 2025Exhibit Fbd 15-
Jul 9, 2025Exhibit Fbd 14-
Jul 9, 2025Exhibit Fbd 13-
Jul 9, 2025Exhibit Fbd 12 Confidential-
Jul 9, 2025Exhibit Fbd 11A-
Jul 9, 2025Exhibit Fbd 09-
Jul 9, 2025Exhibit Fbd 08-
Jul 9, 2025Exhibit Fbd 07-
Jul 9, 2025Exhibit Fbd 06-
Jul 9, 2025EP254 Moderna Reference To Statement Of Defence And Counterclaim For Revocation-
Jul 9, 2025Annex 7 To Exhibit Fbd T 4-
Jul 9, 2025Annex 6 To Exhibit Fbd T 4-
Jul 9, 2025Annex 5 To Exhibit Fbd T 4-
Jul 9, 2025Annex 4 To Exhibit Fbd T 4-
Jul 9, 2025Annex 3 To Exhibit Fbd T 4-
Jul 9, 2025Annex 2 To Exhibit Fbd T 4-
Jul 9, 2025Annex 1 To Exhibit Fbd T 4-
Jul 9, 2025Acknowledgement Of Lodging-
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Request Security Pursuant To R158 No 32591 2025-
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Confidentiality Request-
Jul 9, 202507 08 Upc1 EP254 Reference To Statement Of Defence For Other Defendants(307430487.1)-
Jul 9, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025-
Jun 19, 2025Response To Request For Review-
Jun 12, 2025Outcome Of The Order-
Jun 12, 2025Opportunity To Comment
Jun 11, 2025Acknowledgement Of Lodging-
Jun 6, 2025Exhibit Fbd 5-
Jun 6, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 27016 2025-
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order-
Jun 4, 2025Headnote And Keywords-
Jun 2, 2025Response To Request For Rectification-
May 28, 2025Opportunity To Comment-
May 27, 2025Receipt-
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025-
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome-
May 7, 2025Exhibit G118 Notice European Tender-
May 7, 2025Exhibit G117 Certificate Amalgamation-
May 7, 2025Exhibit G116 Opt Out Confirmation-
May 7, 2025Exhibit G115 Opt Out-
May 7, 2025Comment On Preliminary Objection-
May 7, 2025Comment On Preliminary Objection-
May 6, 2025Notification Of Service-
May 6, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Norway As-
May 5, 2025Acknowledgement Of Access To Case-
May 1, 2025Notification Of Service-
May 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Switzerland Gmbh-
Apr 25, 2025Preliminary Objection-
Apr 25, 2025Notification Of Service-
Apr 25, 2025Exhibit Fbd 4 Moderna Pl-
Apr 25, 2025Exhibit Fbd 3 Dutch Patent Register-
Apr 25, 2025Exhibit Fbd 2 National Registers-
Apr 25, 2025Act 10280 Upc Cfi 191 Confirmation Of Service-
Apr 25, 202525 04 24 EP254 Preliminary Objection Moderna VS Genevant Signed-
Apr 23, 2025Preliminary Objection-
Apr 22, 2025Preliminary Objection Moderna Uk Moderna VS Genevant (EP254) Signed-
Apr 22, 2025Notification Of Service-
Apr 22, 2025Exhibit Fbd 3 Dutch Patent Register-
Apr 22, 2025Exhibit Fbd 2 National Registers-
Apr 22, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Inc.-
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order-
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Response To Letter Brinkhof D.D17 April-
Apr 17, 2025Receipt-
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc-
Apr 17, 2025Outcome Of The Order-
Apr 17, 2025Headnote And Keywords-
Apr 17, 2025Exhibit G114 Letter Re Representation Mll Of Moderna Inc Modernatx Inc-
Apr 15, 2025Receipt-
Apr 15, 2025Notification Of Service-
Apr 15, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Sweden Ab-
Apr 15, 202525 04 15 EP254 Response Re Deadline Extension-
Apr 14, 2025Receipt-
Apr 14, 2025R 9 Aplication Reply To R 9 Request-
Apr 10, 2025Template Order-
Apr 10, 2025Opportunity To Comment-
Apr 9, 2025Receipt-
Apr 9, 2025Opportunity To Comment-
Apr 9, 2025Exhibit Fbd 1-
Apr 9, 202525 04 09 EP254 Request For Deadline Extension Moderna VS Genevant Arbutus Cfi 191 2025 Act 10280 2025-
Apr 1, 2025Notification Of Service-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Netherlands B.V.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Italy S.R.L.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Germany Gmbh-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna France Sasu-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Denmark Aps-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Uk Limited-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Spain Sl-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Belgium S.R.L.-
Mar 31, 2025Acknowledgement Of Access To Case-
Mar 28, 2025Acknowledgement Of Access To Case-
Mar 24, 2025Acknowledgement Of Access To Case-
Mar 17, 2025Panel Appointment-
Mar 13, 2025Letter For Service-
Mar 11, 2025Document From Epo-
Mar 6, 2025Receipt-
Mar 6, 2025Panel Appointment-
Mar 6, 2025Formal Checks Notification Of Positive Outcome-
Mar 6, 2025Epo Request For Case Pending-
Mar 5, 2025Statement Of Claim EP254 Signed-
Mar 5, 2025Statement Of Claim EP254Da-
Mar 5, 2025Raw Data Uv-
Mar 5, 2025Raw Data Lc Cad Sample C3-
Mar 5, 2025Raw Data Lc Cad Sample C2-
Mar 5, 2025Raw Data Lc Cad Sample C1-
Mar 5, 2025Raw Data Dls-
Mar 5, 2025Exhibit M.04 United States Pharmacopeia-
Mar 5, 2025Exhibit M.03 Semple-
Mar 5, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture-
Mar 5, 2025Exhibit M.01 Samaridou-
Mar 5, 2025Exhibit G113 Moderna Inc Annual Report Selection-
Mar 5, 2025Exhibit G112 Moderna Annual Report P. 119-
Mar 5, 2025Exhibit G111 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit G110 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit G109 Moderna Rovi Press Release-
Mar 5, 2025Exhibit G108 Moderna Rovi Press Release-
Mar 5, 2025Exhibit G107 Lonza Press Release-
Mar 5, 2025Exhibit G106 Moderna Press Release Lonza Nl-
Mar 5, 2025Exhibit G105 Moderna Ch Service Agreement Tr-
Mar 5, 2025Exhibit G104 Moderna Lonza Press Release-
Mar 5, 2025Exhibit G103 Moderna Portugal Trade Register-
Mar 5, 2025Exhibit G102 Moderna Norway Trade Register-
Mar 5, 2025Exhibit G101 Moderna Sweden Trade Register-
Mar 5, 2025Exhibit G100 Moderna Denmark Trade Register-
Mar 5, 2025Exhibit G099 Moderna Belgium Trade Register-
Mar 5, 2025Exhibit G098 Moderna Italy Trade Register-
Mar 5, 2025Exhibit G097 Moderna France Trade Register-
Mar 5, 2025Exhibit G096 Moderna Germany Trade Register-
Mar 5, 2025Exhibit G095 Moderna Uk Annual Report-
Mar 5, 2025Exhibit G094 Moderna Uk Trade Register-
Mar 5, 2025Exhibit G093 Moderna Poland Trade Register-
Mar 5, 2025Exhibit G092 Moderna Netherlands Madrid-
Mar 5, 2025Exhibit G091 Moderna Es Trade Register-
Mar 5, 2025Exhibit G090 Mresvia Lauer Taxe Germany-
Mar 5, 2025Exhibit G089 Spikevax Lauer Taxe Germany-
Mar 5, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl-
Mar 5, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl-
Mar 5, 2025Exhibit G086 Moderna Nl Hungary Contract-
Mar 5, 2025Exhibit G085 Moderna Nl Hungary Contract Hun-
Mar 5, 2025Exhibit G084 Moderna Nl Annual Report-
Mar 5, 2025Exhibit G083 Moderna Nl Trade Register-
Mar 5, 2025Exhibit G082 Ec Draft Framework Contract-
Mar 5, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 5, 2025Exhibit G080 Moderna Press Release Tender-
Mar 5, 2025Exhibit G079 Ec Press Release Tender-
Mar 5, 2025Exhibit G078 Ex Pa Ec Moderna Ch-
Mar 5, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61-
Mar 5, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60-
Mar 5, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53-
Mar 5, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44-
Mar 5, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35-
Mar 5, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26-
Mar 5, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17-
Mar 5, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8-
Mar 5, 2025Exhibit G076 Moderna Switzerland Trade Register-
Mar 5, 2025Exhibit G075 Modernacovid19Global Website-
Mar 5, 2025Exhibit G074 Modernatx Website-
Mar 5, 2025Exhibit G073 Domain Registrations Moderna-
Mar 5, 2025Exhibit G072 Modernatx Trade Register Excerpt-
Mar 5, 2025Exhibit G071 Moderna Inc Press Release-
Mar 5, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1-
Mar 5, 2025Exhibit G069 Moderna Inc Trade Register Excerpt-
Mar 5, 2025Exhibit G068 Coriolis Report-
Mar 5, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection-
Mar 5, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92-
Mar 5, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 5, 2025Exhibit G064 Ema Assesment Report Mresvia-
Mar 5, 2025Exhibit G063 Moderna Press Release 23 August-
Mar 5, 2025Exhibit G062 Mresvia Smpc-
Mar 5, 2025Exhibit G061 Mitchell Report Table Of Content-
Mar 5, 2025Exhibit G060 Coriolis Report Table Of Content-
Mar 5, 2025Exhibit G059 WO2022197624A1-
Mar 5, 2025Exhibit G058 WO2021222304A1-
Mar 5, 2025Exhibit G057 WO2021159130A2-
Mar 5, 2025Exhibit G056 Richner-
Mar 5, 2025Exhibit G055 Bahl-
Mar 5, 2025Exhibit G054 Espeseth-
Mar 5, 2025Exhibit G053 John-
Mar 5, 2025Exhibit G052 Peer Review Corbett Nature-
Mar 5, 2025Exhibit G051 Hassett-
Mar 5, 2025Exhibit G050 Ema Assessment Report Spikevax-
Mar 5, 2025Exhibit G049 Epo Ar1 To Ar13-
Mar 5, 2025Exhibit G048 Ar13 Redlined-
Mar 5, 2025Exhibit G047 Mr Redlined-
Mar 5, 2025Exhibit G046 Mitchell Report-
Mar 5, 2025Exhibit G045 Petitioners Hearing Slides Slide 27-
Mar 5, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73-
Mar 5, 2025Exhibit G043 D44 Declaration Heyes-
Mar 5, 2025Exhibit G042 D43 Declaration Heyes-
Mar 5, 2025Exhibit G041 Modernas Goa Of 22 November-
Mar 5, 2025Exhibit G040 Arbutuss Goa Of 25 November-
Mar 5, 2025Exhibit G039 Main Request-
Mar 5, 2025Exhibit G038 US2006 0240554 (D25)-
Mar 5, 2025Exhibit G037 Auxiliary Request 13-
Mar 5, 2025Exhibit G036 Od Decision-
Mar 5, 2025Exhibit G035 T 0505 20-
Mar 5, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October-
Mar 5, 2025Exhibit G033 Od Decision-
Mar 5, 2025Exhibit G032 US20080020058(Chen)-
Mar 5, 2025Exhibit G031 Amended Claim With Annotations 13 September-
Mar 5, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May-
Mar 5, 2025Exhibit G029 Extended European Search Report 12 October-
Mar 5, 2025Exhibit G028 Amendments Received Before Examination 30 December-
Mar 5, 2025Exhibit G027 Withdrawal Of The Op Out-
Mar 5, 2025Exhibit G026 US20080045228P Priority Document-
Mar 5, 2025Exhibit G025 WO2009127060A1 Original Application-
Mar 5, 2025Exhibit G024 Samaridou-
Mar 5, 2025Exhibit G023 Genevant Press Release-
Mar 5, 2025Exhibit G022 Federal Circuit Opinion (435)-
Mar 5, 2025Exhibit G021 Federal Circuit Opinion (069)-
Mar 5, 2025Exhibit G020 Ipr Final Written Decision (435)-
Mar 5, 2025Exhibit G019 Ipr Final Written Decision (069)-
Mar 5, 2025Exhibit G018 US9364435-
Mar 5, 2025Exhibit G017 US8058069-
Mar 5, 2025Exhibit G016 Moore Harvard Business School-
Mar 5, 2025Exhibit G015 Moderna Nih Preprint-
Mar 5, 2025Exhibit G014 CR OSS Cen News-
Mar 5, 2025Exhibit G013 Regalado Mit Technology-
Mar 5, 2025Exhibit G012 Corbett Nature Review-
Mar 5, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration-
Mar 5, 2025Exhibit G010 Suzuki-
Mar 5, 2025Exhibit G009 Semple-
Mar 5, 2025Exhibit G008 Zimmerman-
Mar 5, 2025Exhibit G007 Spikevax Smpc-
Mar 5, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 5, 2025Exhibit G005 Genevant Sciences Trade Register-
Mar 5, 2025Exhibit G004 Proof Of Payment Court Fees-
Mar 5, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus-
Mar 5, 2025Exhibit G002 Patent Register Excerpts-
Mar 5, 2025Exhibit G001 EP2279254B1-
Mar 5, 2025Exhibit C Qualification Report-
Mar 5, 2025Exhibit B Cv Katharina Edenharter-
Mar 5, 2025Exhibit A Cv Thomas Lassak-
Mar 4, 2025Formal Checks Request For Correction-
Mar 3, 2025Statement Of Claim EP254 Signed-
Mar 3, 2025Raw Data Uv-
Mar 3, 2025Raw Data Lc Cad Sample C3-
Mar 3, 2025Raw Data Lc Cad Sample C2-
Mar 3, 2025Raw Data Lc Cad Sample C1-
Mar 3, 2025Raw Data Dls-
Mar 3, 2025Exhibit M.04 United States Pharmacopeia-
Mar 3, 2025Exhibit M.03 Semple-
Mar 3, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture-
Mar 3, 2025Exhibit M.01 Samaridou-
Mar 3, 2025Exhibit G113 Moderna Inc Annual Report Selection-
Mar 3, 2025Exhibit G112 Moderna Annual Report P. 119-
Mar 3, 2025Exhibit G111 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit G110 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit G109 Moderna Rovi Press Release-
Mar 3, 2025Exhibit G108 Moderna Rovi Press Release-
Mar 3, 2025Exhibit G107 Lonza Press Release-
Mar 3, 2025Exhibit G106 Moderna Press Release Lonza Nl-
Mar 3, 2025Exhibit G105 Moderna Ch Service Agreement Tr-
Mar 3, 2025Exhibit G104 Moderna Lonza Press Release-
Mar 3, 2025Exhibit G103 Moderna Portugal Trade Register-
Mar 3, 2025Exhibit G102 Moderna Norway Trade Register-
Mar 3, 2025Exhibit G101 Moderna Sweden Trade Register-
Mar 3, 2025Exhibit G100 Moderna Denmark Trade Register-
Mar 3, 2025Exhibit G099 Moderna Belgium Trade Register-
Mar 3, 2025Exhibit G098 Moderna Italy Trade Register-
Mar 3, 2025Exhibit G097 Moderna France Trade Register-
Mar 3, 2025Exhibit G096 Moderna Germany Trade Register-
Mar 3, 2025Exhibit G095 Moderna Uk Annual Report-
Mar 3, 2025Exhibit G094 Moderna Uk Trade Register-
Mar 3, 2025Exhibit G093 Moderna Poland Trade Register-
Mar 3, 2025Exhibit G092 Moderna Netherlands Madrid-
Mar 3, 2025Exhibit G091 Moderna Es Trade Register-
Mar 3, 2025Exhibit G090 Mresvia Lauer Taxe Germany-
Mar 3, 2025Exhibit G089 Spikevax Lauer Taxe Germany-
Mar 3, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl-
Mar 3, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl-
Mar 3, 2025Exhibit G086 Moderna Nl Hungary Contract-
Mar 3, 2025Exhibit G085 Moderna Nl Hungary Contract Hun-
Mar 3, 2025Exhibit G084 Moderna Nl Annual Report-
Mar 3, 2025Exhibit G083 Moderna Nl Trade Register-
Mar 3, 2025Exhibit G082 Ec Draft Framework Contract-
Mar 3, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 3, 2025Exhibit G080 Moderna Press Release Tender-
Mar 3, 2025Exhibit G079 Ec Press Release Tender-
Mar 3, 2025Exhibit G078 Ex Pa Ec Moderna Ch-
Mar 3, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61-
Mar 3, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60-
Mar 3, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53-
Mar 3, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44-
Mar 3, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35-
Mar 3, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26-
Mar 3, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17-
Mar 3, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8-
Mar 3, 2025Exhibit G076 Moderna Switzerland Trade Register-
Mar 3, 2025Exhibit G075 Modernacovid19Global Website-
Mar 3, 2025Exhibit G074 Modernatx Website-
Mar 3, 2025Exhibit G073 Domain Registrations Moderna-
Mar 3, 2025Exhibit G072 Modernatx Trade Register Excerpt-
Mar 3, 2025Exhibit G071 Moderna Inc Press Release-
Mar 3, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1-
Mar 3, 2025Exhibit G069 Moderna Inc Trade Register Excerpt-
Mar 3, 2025Exhibit G068 Coriolis Report-
Mar 3, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection-
Mar 3, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92-
Mar 3, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 3, 2025Exhibit G064 Ema Assesment Report Mresvia-
Mar 3, 2025Exhibit G063 Moderna Press Release 23 August-
Mar 3, 2025Exhibit G062 Mresvia Smpc-
Mar 3, 2025Exhibit G061 Mitchell Report Table Of Content-
Mar 3, 2025Exhibit G060 Coriolis Report Table Of Content-
Mar 3, 2025Exhibit G059 WO2022197624A1-
Mar 3, 2025Exhibit G058 WO2021222304A1-
Mar 3, 2025Exhibit G057 WO2021159130A2-
Mar 3, 2025Exhibit G056 Richner-
Mar 3, 2025Exhibit G055 Bahl-
Mar 3, 2025Exhibit G054 Espeseth-
Mar 3, 2025Exhibit G053 John-
Mar 3, 2025Exhibit G052 Peer Review Corbett Nature-
Mar 3, 2025Exhibit G051 Hassett-
Mar 3, 2025Exhibit G050 Ema Assessment Report Spikevax-
Mar 3, 2025Exhibit G049 Epo Ar1 To Ar13-
Mar 3, 2025Exhibit G048 Ar13 Redlined-
Mar 3, 2025Exhibit G047 Mr Redlined-
Mar 3, 2025Exhibit G046 Mitchell Report-
Mar 3, 2025Exhibit G045 Petitioners Hearing Slides Slide 27-
Mar 3, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73-
Mar 3, 2025Exhibit G043 D44 Declaration Heyes-
Mar 3, 2025Exhibit G042 D43 Declaration Heyes-
Mar 3, 2025Exhibit G041 Modernas Goa Of 22 November-
Mar 3, 2025Exhibit G040 Arbutuss Goa Of 25 November-
Mar 3, 2025Exhibit G039 Main Request-
Mar 3, 2025Exhibit G038 US2006 0240554 (D25)-
Mar 3, 2025Exhibit G037 Auxiliary Request 13-
Mar 3, 2025Exhibit G036 Od Decision-
Mar 3, 2025Exhibit G035 T 0505 20-
Mar 3, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October-
Mar 3, 2025Exhibit G033 Od Decision-
Mar 3, 2025Exhibit G032 US20080020058(Chen)-
Mar 3, 2025Exhibit G031 Amended Claim With Annotations 13 September-
Mar 3, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May-
Mar 3, 2025Exhibit G029 Extended European Search Report 12 October-
Mar 3, 2025Exhibit G028 Amendments Received Before Examination 30 December-
Mar 3, 2025Exhibit G027 Withdrawal Of The Op Out-
Mar 3, 2025Exhibit G026 US20080045228P Priority Document-
Mar 3, 2025Exhibit G025 WO2009127060A1 Original Application-
Mar 3, 2025Exhibit G024 Samaridou-
Mar 3, 2025Exhibit G023 Genevant Press Release-
Mar 3, 2025Exhibit G022 Federal Circuit Opinion (435)-
Mar 3, 2025Exhibit G021 Federal Circuit Opinion (069)-
Mar 3, 2025Exhibit G020 Ipr Final Written Decision (435)-
Mar 3, 2025Exhibit G019 Ipr Final Written Decision (069)-
Mar 3, 2025Exhibit G018 US9364435-
Mar 3, 2025Exhibit G017 US8058069-
Mar 3, 2025Exhibit G016 Moore Harvard Business School-
Mar 3, 2025Exhibit G015 Moderna Nih Preprint-
Mar 3, 2025Exhibit G014 CR OSS Cen News-
Mar 3, 2025Exhibit G013 Regalado Mit Technology-
Mar 3, 2025Exhibit G012 Corbett Nature Review-
Mar 3, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration-
Mar 3, 2025Exhibit G010 Suzuki-
Mar 3, 2025Exhibit G009 Semple-
Mar 3, 2025Exhibit G008 Zimmerman-
Mar 3, 2025Exhibit G007 Spikevax Smpc-
Mar 3, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 3, 2025Exhibit G005 Genevant Sciences Trade Register-
Mar 3, 2025Exhibit G004 Proof Of Payment Court Fees-
Mar 3, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus-
Mar 3, 2025Exhibit G002 Patent Register Excerpts-
Mar 3, 2025Exhibit G001 EP2279254B1-
Mar 3, 2025Exhibit C Qualification Report-
Mar 3, 2025Exhibit B Cv Katharina Edenharter-
Mar 3, 2025Exhibit A Cv Thomas Lassak-
Mar 3, 2025EP254Soc Da-
Mar 3, 2025Acknowledgement Of Lodging-
Oct 3, 2025Receipt-
Oct 3, 2025Exhibit-
Oct 3, 2025Cover Sheet-
Oct 3, 2025Application-
Sep 24, 2025Statement Of Reply-
Sep 24, 2025Receipt-
Sep 24, 2025Exhibit-
Sep 24, 2025Cover Sheet-
Sep 14, 2025Rejoinder On Request To Produce Evidence-
Sep 12, 2025Uploaded For Technical Reasons Only To Close Workflow
Sep 12, 2025Upc Genevant Arbutus Reply R 190 Request Signed-
Sep 12, 2025Outcome Of The Order-
Sep 12, 2025Opportunity To Comment-
Sep 2, 2025Receipt-
Sep 2, 2025Moderna R.9 Rop In Response To R.190 Rop Application-
Aug 28, 2025Receipt-
Aug 27, 202525 08 27 Ep 254 Further Comment On Request To Produce Evidence Moderna Vs Genevant-
Aug 26, 2025Reply Re R190 Request-
Aug 26, 2025Exhibit G126-
Aug 18, 2025Panel Appointment-
Aug 18, 2025Opportunity To Comment-
Aug 15, 2025R.37.2 Order
Aug 14, 2025Response To Request To Produce Evidence (Rule 190 Rop)-
Aug 14, 2025Exhibit Fs18 DI 457 Letter May-
Aug 14, 2025Exhibit Fs17 Protective Order-
Aug 13, 2025Joint Statement Regarding Bifurcation-
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop-
Aug 8, 2025Response To Deadline Extension Request-
Aug 6, 2025R.37-
Aug 6, 2025R
Aug 6, 2025Hearing Dates-
Aug 5, 2025Redacted Final Order Re R.262A Applications-
Aug 4, 2025R.262A Order-
Aug 4, 2025Outcome Of The Order-
Aug 4, 2025Opportunity To Comment-
Aug 1, 2025Request For Extension Of Deadlines-
Aug 1, 2025Receipt-
Aug 1, 2025Exhibit G125-
Aug 1, 2025Exhibit G124-
Aug 1, 2025Exhibit G123-
Aug 1, 2025Application For An Order To Produce Evidence-
Jul 28, 2025R.262A Reply-
Jul 28, 2025Exhibit G122-
Jul 25, 2025Receipt-
Jul 24, 2025R.262A Reply-
Jul 24, 2025Exhibit G122-
Jul 23, 2025Reference To Response Of Genevant-
Jul 23, 2025R.262.2 Application-
Jul 23, 2025Exhibit G121 Confidential-
Jul 23, 2025Exhibit G120-
Jul 23, 2025Exhibit G119-
Jul 23, 2025Confidential Response To Security-
Jul 11, 2025Formal Checks Notification Of Positive Outcome-
Jul 11, 2025Acknowledgement Of Lodging-
Jul 10, 2025Set Of Exhibits Fbd T 09 Confidential-
Jul 10, 2025Set Of Exhibits Fbd 11-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 5 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 4 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 3 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 2 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 1 Of 5-
Jul 10, 2025Opportunity To Comment-
Jul 10, 2025Formal Checks Request For Correction-
Jul 10, 2025Exhibit Fbd T 19-
Jul 10, 2025Exhibit Fbd T 18-
Jul 10, 2025Exhibit Fbd T 17-
Jul 10, 2025Exhibit Fbd T 16-
Jul 10, 2025Exhibit Fbd T 15-
Jul 10, 2025Exhibit Fbd T 14-
Jul 10, 2025Exhibit Fbd T 13-
Jul 10, 2025Exhibit Fbd T 12-
Jul 10, 2025Exhibit Fbd T 11-
Jul 10, 2025Exhibit Fbd T 10-
Jul 10, 2025Exhibit Fbd T 09A Confidential-
Jul 10, 2025Exhibit Fbd T 08-
Jul 10, 2025Exhibit Fbd T 07-
Jul 10, 2025Exhibit Fbd T 06-
Jul 10, 2025Exhibit Fbd T 05-
Jul 10, 2025Exhibit Fbd T 04-
Jul 10, 2025Exhibit Fbd T 03A-
Jul 10, 2025Exhibit Fbd T 03-
Jul 10, 2025Exhibit Fbd T 02-
Jul 10, 2025Exhibit Fbd T 01-
Jul 10, 2025Exhibit Fbd 16-
Jul 10, 2025Exhibit Fbd 15-
Jul 10, 2025Exhibit Fbd 14-
Jul 10, 2025Exhibit Fbd 13-
Jul 10, 2025Exhibit Fbd 12 Confidential-
Jul 10, 2025Exhibit Fbd 11A-
Jul 10, 2025Exhibit Fbd 09-
Jul 10, 2025Exhibit Fbd 08-
Jul 10, 2025Exhibit Fbd 07-
Jul 10, 2025Exhibit Fbd 06-
Jul 10, 2025Annex 7 To Exhibit Fbd T 4-
Jul 10, 2025Annex 6 To Exhibit Fbd T 4-
Jul 10, 2025Annex 5 To Exhibit Fbd T 4-
Jul 10, 2025Annex 4 To Exhibit Fbd T 4-
Jul 10, 2025Annex 3 To Exhibit Fbd T 4-
Jul 10, 2025Annex 2 To Exhibit Fbd T 4-
Jul 10, 2025Annex 1 To Exhibit Fbd T 4-
Jul 10, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025 V2-
Jul 9, 2025Set Of Exhibits Fbd T 09 Confidential-
Jul 9, 2025Set Of Exhibits Fbd 11-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 5 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 4 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 3 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 2 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 1 Of 5-
Jul 9, 2025Receipt-
Jul 9, 2025Opportunity To Comment-
Jul 9, 2025Exhibit Fbd T 19-
Jul 9, 2025Exhibit Fbd T 18-
Jul 9, 2025Exhibit Fbd T 17-
Jul 9, 2025Exhibit Fbd T 16-
Jul 9, 2025Exhibit Fbd T 15-
Jul 9, 2025Exhibit Fbd T 14-
Jul 9, 2025Exhibit Fbd T 13-
Jul 9, 2025Exhibit Fbd T 12-
Jul 9, 2025Exhibit Fbd T 11-
Jul 9, 2025Exhibit Fbd T 10-
Jul 9, 2025Exhibit Fbd T 09A Confidential-
Jul 9, 2025Exhibit Fbd T 08-
Jul 9, 2025Exhibit Fbd T 07-
Jul 9, 2025Exhibit Fbd T 06-
Jul 9, 2025Exhibit Fbd T 05-
Jul 9, 2025Exhibit Fbd T 04-
Jul 9, 2025Exhibit Fbd T 03A-
Jul 9, 2025Exhibit Fbd T 03-
Jul 9, 2025Exhibit Fbd T 02-
Jul 9, 2025Exhibit Fbd T 01-
Jul 9, 2025Exhibit Fbd 16-
Jul 9, 2025Exhibit Fbd 15-
Jul 9, 2025Exhibit Fbd 14-
Jul 9, 2025Exhibit Fbd 13-
Jul 9, 2025Exhibit Fbd 12 Confidential-
Jul 9, 2025Exhibit Fbd 11A-
Jul 9, 2025Exhibit Fbd 09-
Jul 9, 2025Exhibit Fbd 08-
Jul 9, 2025Exhibit Fbd 07-
Jul 9, 2025Exhibit Fbd 06-
Jul 9, 2025EP254 Moderna Reference To Statement Of Defence And Counterclaim For Revocation-
Jul 9, 2025Annex 7 To Exhibit Fbd T 4-
Jul 9, 2025Annex 6 To Exhibit Fbd T 4-
Jul 9, 2025Annex 5 To Exhibit Fbd T 4-
Jul 9, 2025Annex 4 To Exhibit Fbd T 4-
Jul 9, 2025Annex 3 To Exhibit Fbd T 4-
Jul 9, 2025Annex 2 To Exhibit Fbd T 4-
Jul 9, 2025Annex 1 To Exhibit Fbd T 4-
Jul 9, 2025Acknowledgement Of Lodging-
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Request Security Pursuant To R158 No 32591 2025-
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Confidentiality Request-
Jul 9, 202507 08 Upc1 EP254 Reference To Statement Of Defence For Other Defendants(307430487.1)-
Jul 9, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025-
Jun 19, 2025Response To Request For Review-
Jun 12, 2025Outcome Of The Order-
Jun 12, 2025Opportunity To Comment
Jun 11, 2025Acknowledgement Of Lodging-
Jun 6, 2025Exhibit Fbd 5-
Jun 6, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 27016 2025-
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order-
Jun 4, 2025Headnote And Keywords-
Jun 2, 2025Response To Request For Rectification-
May 28, 2025Opportunity To Comment-
May 27, 2025Receipt-
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025-
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome-
May 7, 2025Exhibit G118 Notice European Tender-
May 7, 2025Exhibit G117 Certificate Amalgamation-
May 7, 2025Exhibit G116 Opt Out Confirmation-
May 7, 2025Exhibit G115 Opt Out-
May 7, 2025Comment On Preliminary Objection-
May 7, 2025Comment On Preliminary Objection-
May 6, 2025Notification Of Service-
May 6, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Norway As-
May 5, 2025Acknowledgement Of Access To Case-
May 1, 2025Notification Of Service-
May 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Switzerland Gmbh-
Apr 25, 2025Preliminary Objection-
Apr 25, 2025Notification Of Service-
Apr 25, 2025Exhibit Fbd 4 Moderna Pl-
Apr 25, 2025Exhibit Fbd 3 Dutch Patent Register-
Apr 25, 2025Exhibit Fbd 2 National Registers-
Apr 25, 2025Act 10280 Upc Cfi 191 Confirmation Of Service-
Apr 25, 202525 04 24 EP254 Preliminary Objection Moderna VS Genevant Signed-
Apr 23, 2025Preliminary Objection-
Apr 22, 2025Preliminary Objection Moderna Uk Moderna VS Genevant (EP254) Signed-
Apr 22, 2025Notification Of Service-
Apr 22, 2025Exhibit Fbd 3 Dutch Patent Register-
Apr 22, 2025Exhibit Fbd 2 National Registers-
Apr 22, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Inc.-
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order-
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Response To Letter Brinkhof D.D17 April-
Apr 17, 2025Receipt-
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc-
Apr 17, 2025Outcome Of The Order-
Apr 17, 2025Headnote And Keywords-
Apr 17, 2025Exhibit G114 Letter Re Representation Mll Of Moderna Inc Modernatx Inc-
Apr 15, 2025Receipt-
Apr 15, 2025Notification Of Service-
Apr 15, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Sweden Ab-
Apr 15, 202525 04 15 EP254 Response Re Deadline Extension-
Apr 14, 2025Receipt-
Apr 14, 2025R 9 Aplication Reply To R 9 Request-
Apr 10, 2025Template Order-
Apr 10, 2025Opportunity To Comment-
Apr 9, 2025Receipt-
Apr 9, 2025Opportunity To Comment-
Apr 9, 2025Exhibit Fbd 1-
Apr 9, 202525 04 09 EP254 Request For Deadline Extension Moderna VS Genevant Arbutus Cfi 191 2025 Act 10280 2025-
Apr 1, 2025Notification Of Service-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Netherlands B.V.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Italy S.R.L.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Germany Gmbh-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna France Sasu-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Denmark Aps-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Uk Limited-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Spain Sl-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Belgium S.R.L.-
Mar 31, 2025Acknowledgement Of Access To Case-
Mar 28, 2025Acknowledgement Of Access To Case-
Mar 24, 2025Acknowledgement Of Access To Case-
Mar 17, 2025Panel Appointment-
Mar 13, 2025Letter For Service-
Mar 11, 2025Document From Epo-
Mar 6, 2025Receipt-
Mar 6, 2025Panel Appointment-
Mar 6, 2025Formal Checks Notification Of Positive Outcome-
Mar 6, 2025Epo Request For Case Pending-
Mar 5, 2025Statement Of Claim EP254 Signed-
Mar 5, 2025Statement Of Claim EP254Da-
Mar 5, 2025Raw Data Uv-
Mar 5, 2025Raw Data Lc Cad Sample C3-
Mar 5, 2025Raw Data Lc Cad Sample C2-
Mar 5, 2025Raw Data Lc Cad Sample C1-
Mar 5, 2025Raw Data Dls-
Mar 5, 2025Exhibit M.04 United States Pharmacopeia-
Mar 5, 2025Exhibit M.03 Semple-
Mar 5, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture-
Mar 5, 2025Exhibit M.01 Samaridou-
Mar 5, 2025Exhibit G113 Moderna Inc Annual Report Selection-
Mar 5, 2025Exhibit G112 Moderna Annual Report P. 119-
Mar 5, 2025Exhibit G111 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit G110 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit G109 Moderna Rovi Press Release-
Mar 5, 2025Exhibit G108 Moderna Rovi Press Release-
Mar 5, 2025Exhibit G107 Lonza Press Release-
Mar 5, 2025Exhibit G106 Moderna Press Release Lonza Nl-
Mar 5, 2025Exhibit G105 Moderna Ch Service Agreement Tr-
Mar 5, 2025Exhibit G104 Moderna Lonza Press Release-
Mar 5, 2025Exhibit G103 Moderna Portugal Trade Register-
Mar 5, 2025Exhibit G102 Moderna Norway Trade Register-
Mar 5, 2025Exhibit G101 Moderna Sweden Trade Register-
Mar 5, 2025Exhibit G100 Moderna Denmark Trade Register-
Mar 5, 2025Exhibit G099 Moderna Belgium Trade Register-
Mar 5, 2025Exhibit G098 Moderna Italy Trade Register-
Mar 5, 2025Exhibit G097 Moderna France Trade Register-
Mar 5, 2025Exhibit G096 Moderna Germany Trade Register-
Mar 5, 2025Exhibit G095 Moderna Uk Annual Report-
Mar 5, 2025Exhibit G094 Moderna Uk Trade Register-
Mar 5, 2025Exhibit G093 Moderna Poland Trade Register-
Mar 5, 2025Exhibit G092 Moderna Netherlands Madrid-
Mar 5, 2025Exhibit G091 Moderna Es Trade Register-
Mar 5, 2025Exhibit G090 Mresvia Lauer Taxe Germany-
Mar 5, 2025Exhibit G089 Spikevax Lauer Taxe Germany-
Mar 5, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl-
Mar 5, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl-
Mar 5, 2025Exhibit G086 Moderna Nl Hungary Contract-
Mar 5, 2025Exhibit G085 Moderna Nl Hungary Contract Hun-
Mar 5, 2025Exhibit G084 Moderna Nl Annual Report-
Mar 5, 2025Exhibit G083 Moderna Nl Trade Register-
Mar 5, 2025Exhibit G082 Ec Draft Framework Contract-
Mar 5, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 5, 2025Exhibit G080 Moderna Press Release Tender-
Mar 5, 2025Exhibit G079 Ec Press Release Tender-
Mar 5, 2025Exhibit G078 Ex Pa Ec Moderna Ch-
Mar 5, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61-
Mar 5, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60-
Mar 5, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53-
Mar 5, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44-
Mar 5, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35-
Mar 5, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26-
Mar 5, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17-
Mar 5, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8-
Mar 5, 2025Exhibit G076 Moderna Switzerland Trade Register-
Mar 5, 2025Exhibit G075 Modernacovid19Global Website-
Mar 5, 2025Exhibit G074 Modernatx Website-
Mar 5, 2025Exhibit G073 Domain Registrations Moderna-
Mar 5, 2025Exhibit G072 Modernatx Trade Register Excerpt-
Mar 5, 2025Exhibit G071 Moderna Inc Press Release-
Mar 5, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1-
Mar 5, 2025Exhibit G069 Moderna Inc Trade Register Excerpt-
Mar 5, 2025Exhibit G068 Coriolis Report-
Mar 5, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection-
Mar 5, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92-
Mar 5, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 5, 2025Exhibit G064 Ema Assesment Report Mresvia-
Mar 5, 2025Exhibit G063 Moderna Press Release 23 August-
Mar 5, 2025Exhibit G062 Mresvia Smpc-
Mar 5, 2025Exhibit G061 Mitchell Report Table Of Content-
Mar 5, 2025Exhibit G060 Coriolis Report Table Of Content-
Mar 5, 2025Exhibit G059 WO2022197624A1-
Mar 5, 2025Exhibit G058 WO2021222304A1-
Mar 5, 2025Exhibit G057 WO2021159130A2-
Mar 5, 2025Exhibit G056 Richner-
Mar 5, 2025Exhibit G055 Bahl-
Mar 5, 2025Exhibit G054 Espeseth-
Mar 5, 2025Exhibit G053 John-
Mar 5, 2025Exhibit G052 Peer Review Corbett Nature-
Mar 5, 2025Exhibit G051 Hassett-
Mar 5, 2025Exhibit G050 Ema Assessment Report Spikevax-
Mar 5, 2025Exhibit G049 Epo Ar1 To Ar13-
Mar 5, 2025Exhibit G048 Ar13 Redlined-
Mar 5, 2025Exhibit G047 Mr Redlined-
Mar 5, 2025Exhibit G046 Mitchell Report-
Mar 5, 2025Exhibit G045 Petitioners Hearing Slides Slide 27-
Mar 5, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73-
Mar 5, 2025Exhibit G043 D44 Declaration Heyes-
Mar 5, 2025Exhibit G042 D43 Declaration Heyes-
Mar 5, 2025Exhibit G041 Modernas Goa Of 22 November-
Mar 5, 2025Exhibit G040 Arbutuss Goa Of 25 November-
Mar 5, 2025Exhibit G039 Main Request-
Mar 5, 2025Exhibit G038 US2006 0240554 (D25)-
Mar 5, 2025Exhibit G037 Auxiliary Request 13-
Mar 5, 2025Exhibit G036 Od Decision-
Mar 5, 2025Exhibit G035 T 0505 20-
Mar 5, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October-
Mar 5, 2025Exhibit G033 Od Decision-
Mar 5, 2025Exhibit G032 US20080020058(Chen)-
Mar 5, 2025Exhibit G031 Amended Claim With Annotations 13 September-
Mar 5, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May-
Mar 5, 2025Exhibit G029 Extended European Search Report 12 October-
Mar 5, 2025Exhibit G028 Amendments Received Before Examination 30 December-
Mar 5, 2025Exhibit G027 Withdrawal Of The Op Out-
Mar 5, 2025Exhibit G026 US20080045228P Priority Document-
Mar 5, 2025Exhibit G025 WO2009127060A1 Original Application-
Mar 5, 2025Exhibit G024 Samaridou-
Mar 5, 2025Exhibit G023 Genevant Press Release-
Mar 5, 2025Exhibit G022 Federal Circuit Opinion (435)-
Mar 5, 2025Exhibit G021 Federal Circuit Opinion (069)-
Mar 5, 2025Exhibit G020 Ipr Final Written Decision (435)-
Mar 5, 2025Exhibit G019 Ipr Final Written Decision (069)-
Mar 5, 2025Exhibit G018 US9364435-
Mar 5, 2025Exhibit G017 US8058069-
Mar 5, 2025Exhibit G016 Moore Harvard Business School-
Mar 5, 2025Exhibit G015 Moderna Nih Preprint-
Mar 5, 2025Exhibit G014 CR OSS Cen News-
Mar 5, 2025Exhibit G013 Regalado Mit Technology-
Mar 5, 2025Exhibit G012 Corbett Nature Review-
Mar 5, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration-
Mar 5, 2025Exhibit G010 Suzuki-
Mar 5, 2025Exhibit G009 Semple-
Mar 5, 2025Exhibit G008 Zimmerman-
Mar 5, 2025Exhibit G007 Spikevax Smpc-
Mar 5, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 5, 2025Exhibit G005 Genevant Sciences Trade Register-
Mar 5, 2025Exhibit G004 Proof Of Payment Court Fees-
Mar 5, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus-
Mar 5, 2025Exhibit G002 Patent Register Excerpts-
Mar 5, 2025Exhibit G001 EP2279254B1-
Mar 5, 2025Exhibit C Qualification Report-
Mar 5, 2025Exhibit B Cv Katharina Edenharter-
Mar 5, 2025Exhibit A Cv Thomas Lassak-
Mar 4, 2025Formal Checks Request For Correction-
Mar 3, 2025Statement Of Claim EP254 Signed-
Mar 3, 2025Raw Data Uv-
Mar 3, 2025Raw Data Lc Cad Sample C3-
Mar 3, 2025Raw Data Lc Cad Sample C2-
Mar 3, 2025Raw Data Lc Cad Sample C1-
Mar 3, 2025Raw Data Dls-
Mar 3, 2025Exhibit M.04 United States Pharmacopeia-
Mar 3, 2025Exhibit M.03 Semple-
Mar 3, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture-
Mar 3, 2025Exhibit M.01 Samaridou-
Mar 3, 2025Exhibit G113 Moderna Inc Annual Report Selection-
Mar 3, 2025Exhibit G112 Moderna Annual Report P. 119-
Mar 3, 2025Exhibit G111 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit G110 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit G109 Moderna Rovi Press Release-
Mar 3, 2025Exhibit G108 Moderna Rovi Press Release-
Mar 3, 2025Exhibit G107 Lonza Press Release-
Mar 3, 2025Exhibit G106 Moderna Press Release Lonza Nl-
Mar 3, 2025Exhibit G105 Moderna Ch Service Agreement Tr-
Mar 3, 2025Exhibit G104 Moderna Lonza Press Release-
Mar 3, 2025Exhibit G103 Moderna Portugal Trade Register-
Mar 3, 2025Exhibit G102 Moderna Norway Trade Register-
Mar 3, 2025Exhibit G101 Moderna Sweden Trade Register-
Mar 3, 2025Exhibit G100 Moderna Denmark Trade Register-
Mar 3, 2025Exhibit G099 Moderna Belgium Trade Register-
Mar 3, 2025Exhibit G098 Moderna Italy Trade Register-
Mar 3, 2025Exhibit G097 Moderna France Trade Register-
Mar 3, 2025Exhibit G096 Moderna Germany Trade Register-
Mar 3, 2025Exhibit G095 Moderna Uk Annual Report-
Mar 3, 2025Exhibit G094 Moderna Uk Trade Register-
Mar 3, 2025Exhibit G093 Moderna Poland Trade Register-
Mar 3, 2025Exhibit G092 Moderna Netherlands Madrid-
Mar 3, 2025Exhibit G091 Moderna Es Trade Register-
Mar 3, 2025Exhibit G090 Mresvia Lauer Taxe Germany-
Mar 3, 2025Exhibit G089 Spikevax Lauer Taxe Germany-
Mar 3, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl-
Mar 3, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl-
Mar 3, 2025Exhibit G086 Moderna Nl Hungary Contract-
Mar 3, 2025Exhibit G085 Moderna Nl Hungary Contract Hun-
Mar 3, 2025Exhibit G084 Moderna Nl Annual Report-
Mar 3, 2025Exhibit G083 Moderna Nl Trade Register-
Mar 3, 2025Exhibit G082 Ec Draft Framework Contract-
Mar 3, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 3, 2025Exhibit G080 Moderna Press Release Tender-
Mar 3, 2025Exhibit G079 Ec Press Release Tender-
Mar 3, 2025Exhibit G078 Ex Pa Ec Moderna Ch-
Mar 3, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61-
Mar 3, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60-
Mar 3, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53-
Mar 3, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44-
Mar 3, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35-
Mar 3, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26-
Mar 3, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17-
Mar 3, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8-
Mar 3, 2025Exhibit G076 Moderna Switzerland Trade Register-
Mar 3, 2025Exhibit G075 Modernacovid19Global Website-
Mar 3, 2025Exhibit G074 Modernatx Website-
Mar 3, 2025Exhibit G073 Domain Registrations Moderna-
Mar 3, 2025Exhibit G072 Modernatx Trade Register Excerpt-
Mar 3, 2025Exhibit G071 Moderna Inc Press Release-
Mar 3, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1-
Mar 3, 2025Exhibit G069 Moderna Inc Trade Register Excerpt-
Mar 3, 2025Exhibit G068 Coriolis Report-
Mar 3, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection-
Mar 3, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92-
Mar 3, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 3, 2025Exhibit G064 Ema Assesment Report Mresvia-
Mar 3, 2025Exhibit G063 Moderna Press Release 23 August-
Mar 3, 2025Exhibit G062 Mresvia Smpc-
Mar 3, 2025Exhibit G061 Mitchell Report Table Of Content-
Mar 3, 2025Exhibit G060 Coriolis Report Table Of Content-
Mar 3, 2025Exhibit G059 WO2022197624A1-
Mar 3, 2025Exhibit G058 WO2021222304A1-
Mar 3, 2025Exhibit G057 WO2021159130A2-
Mar 3, 2025Exhibit G056 Richner-
Mar 3, 2025Exhibit G055 Bahl-
Mar 3, 2025Exhibit G054 Espeseth-
Mar 3, 2025Exhibit G053 John-
Mar 3, 2025Exhibit G052 Peer Review Corbett Nature-
Mar 3, 2025Exhibit G051 Hassett-
Mar 3, 2025Exhibit G050 Ema Assessment Report Spikevax-
Mar 3, 2025Exhibit G049 Epo Ar1 To Ar13-
Mar 3, 2025Exhibit G048 Ar13 Redlined-
Mar 3, 2025Exhibit G047 Mr Redlined-
Mar 3, 2025Exhibit G046 Mitchell Report-
Mar 3, 2025Exhibit G045 Petitioners Hearing Slides Slide 27-
Mar 3, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73-
Mar 3, 2025Exhibit G043 D44 Declaration Heyes-
Mar 3, 2025Exhibit G042 D43 Declaration Heyes-
Mar 3, 2025Exhibit G041 Modernas Goa Of 22 November-
Mar 3, 2025Exhibit G040 Arbutuss Goa Of 25 November-
Mar 3, 2025Exhibit G039 Main Request-
Mar 3, 2025Exhibit G038 US2006 0240554 (D25)-
Mar 3, 2025Exhibit G037 Auxiliary Request 13-
Mar 3, 2025Exhibit G036 Od Decision-
Mar 3, 2025Exhibit G035 T 0505 20-
Mar 3, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October-
Mar 3, 2025Exhibit G033 Od Decision-
Mar 3, 2025Exhibit G032 US20080020058(Chen)-
Mar 3, 2025Exhibit G031 Amended Claim With Annotations 13 September-
Mar 3, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May-
Mar 3, 2025Exhibit G029 Extended European Search Report 12 October-
Mar 3, 2025Exhibit G028 Amendments Received Before Examination 30 December-
Mar 3, 2025Exhibit G027 Withdrawal Of The Op Out-
Mar 3, 2025Exhibit G026 US20080045228P Priority Document-
Mar 3, 2025Exhibit G025 WO2009127060A1 Original Application-
Mar 3, 2025Exhibit G024 Samaridou-
Mar 3, 2025Exhibit G023 Genevant Press Release-
Mar 3, 2025Exhibit G022 Federal Circuit Opinion (435)-
Mar 3, 2025Exhibit G021 Federal Circuit Opinion (069)-
Mar 3, 2025Exhibit G020 Ipr Final Written Decision (435)-
Mar 3, 2025Exhibit G019 Ipr Final Written Decision (069)-
Mar 3, 2025Exhibit G018 US9364435-
Mar 3, 2025Exhibit G017 US8058069-
Mar 3, 2025Exhibit G016 Moore Harvard Business School-
Mar 3, 2025Exhibit G015 Moderna Nih Preprint-
Mar 3, 2025Exhibit G014 CR OSS Cen News-
Mar 3, 2025Exhibit G013 Regalado Mit Technology-
Mar 3, 2025Exhibit G012 Corbett Nature Review-
Mar 3, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration-
Mar 3, 2025Exhibit G010 Suzuki-
Mar 3, 2025Exhibit G009 Semple-
Mar 3, 2025Exhibit G008 Zimmerman-
Mar 3, 2025Exhibit G007 Spikevax Smpc-
Mar 3, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 3, 2025Exhibit G005 Genevant Sciences Trade Register-
Mar 3, 2025Exhibit G004 Proof Of Payment Court Fees-
Mar 3, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus-
Mar 3, 2025Exhibit G002 Patent Register Excerpts-
Mar 3, 2025Exhibit G001 EP2279254B1-
Mar 3, 2025Exhibit C Qualification Report-
Mar 3, 2025Exhibit B Cv Katharina Edenharter-
Mar 3, 2025Exhibit A Cv Thomas Lassak-
Mar 3, 2025EP254Soc Da-
Mar 3, 2025Acknowledgement Of Lodging-
Oct 3, 2025Receipt-
Oct 3, 2025Exhibit-
Oct 3, 2025Cover Sheet-
Oct 3, 2025Application-
Sep 24, 2025Statement Of Reply-
Sep 24, 2025Receipt-
Sep 24, 2025Exhibit-
Sep 24, 2025Cover Sheet-
Sep 14, 2025Rejoinder On Request To Produce Evidence-
Sep 12, 2025Uploaded For Technical Reasons Only To Close Workflow
Sep 12, 2025Upc Genevant Arbutus Reply R 190 Request Signed-
Sep 12, 2025Outcome Of The Order-
Sep 12, 2025Opportunity To Comment-
Sep 2, 2025Receipt-
Sep 2, 2025Moderna R.9 Rop In Response To R.190 Rop Application-
Aug 28, 2025Receipt-
Aug 27, 202525 08 27 Ep 254 Further Comment On Request To Produce Evidence Moderna Vs Genevant-
Aug 26, 2025Reply Re R190 Request-
Aug 26, 2025Exhibit G126-
Aug 18, 2025Panel Appointment-
Aug 18, 2025Opportunity To Comment-
Aug 15, 2025R.37.2 Order
Aug 14, 2025Response To Request To Produce Evidence (Rule 190 Rop)-
Aug 14, 2025Exhibit Fs18 DI 457 Letter May-
Aug 14, 2025Exhibit Fs17 Protective Order-
Aug 13, 2025Joint Statement Regarding Bifurcation-
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop-
Aug 8, 2025Response To Deadline Extension Request-
Aug 6, 2025R.37-
Aug 6, 2025R
Aug 6, 2025Hearing Dates-
Aug 5, 2025Redacted Final Order Re R.262A Applications-
Aug 4, 2025R.262A Order-
Aug 4, 2025Outcome Of The Order-
Aug 4, 2025Opportunity To Comment-
Aug 1, 2025Request For Extension Of Deadlines-
Aug 1, 2025Receipt-
Aug 1, 2025Exhibit G125-
Aug 1, 2025Exhibit G124-
Aug 1, 2025Exhibit G123-
Aug 1, 2025Application For An Order To Produce Evidence-
Jul 28, 2025R.262A Reply-
Jul 28, 2025Exhibit G122-
Jul 25, 2025Receipt-
Jul 24, 2025R.262A Reply-
Jul 24, 2025Exhibit G122-
Jul 23, 2025Reference To Response Of Genevant-
Jul 23, 2025R.262.2 Application-
Jul 23, 2025Exhibit G121 Confidential-
Jul 23, 2025Exhibit G120-
Jul 23, 2025Exhibit G119-
Jul 23, 2025Confidential Response To Security-
Jul 11, 2025Formal Checks Notification Of Positive Outcome-
Jul 11, 2025Acknowledgement Of Lodging-
Jul 10, 2025Set Of Exhibits Fbd T 09 Confidential-
Jul 10, 2025Set Of Exhibits Fbd 11-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 5 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 4 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 3 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 2 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 1 Of 5-
Jul 10, 2025Opportunity To Comment-
Jul 10, 2025Formal Checks Request For Correction-
Jul 10, 2025Exhibit Fbd T 19-
Jul 10, 2025Exhibit Fbd T 18-
Jul 10, 2025Exhibit Fbd T 17-
Jul 10, 2025Exhibit Fbd T 16-
Jul 10, 2025Exhibit Fbd T 15-
Jul 10, 2025Exhibit Fbd T 14-
Jul 10, 2025Exhibit Fbd T 13-
Jul 10, 2025Exhibit Fbd T 12-
Jul 10, 2025Exhibit Fbd T 11-
Jul 10, 2025Exhibit Fbd T 10-
Jul 10, 2025Exhibit Fbd T 09A Confidential-
Jul 10, 2025Exhibit Fbd T 08-
Jul 10, 2025Exhibit Fbd T 07-
Jul 10, 2025Exhibit Fbd T 06-
Jul 10, 2025Exhibit Fbd T 05-
Jul 10, 2025Exhibit Fbd T 04-
Jul 10, 2025Exhibit Fbd T 03A-
Jul 10, 2025Exhibit Fbd T 03-
Jul 10, 2025Exhibit Fbd T 02-
Jul 10, 2025Exhibit Fbd T 01-
Jul 10, 2025Exhibit Fbd 16-
Jul 10, 2025Exhibit Fbd 15-
Jul 10, 2025Exhibit Fbd 14-
Jul 10, 2025Exhibit Fbd 13-
Jul 10, 2025Exhibit Fbd 12 Confidential-
Jul 10, 2025Exhibit Fbd 11A-
Jul 10, 2025Exhibit Fbd 09-
Jul 10, 2025Exhibit Fbd 08-
Jul 10, 2025Exhibit Fbd 07-
Jul 10, 2025Exhibit Fbd 06-
Jul 10, 2025Annex 7 To Exhibit Fbd T 4-
Jul 10, 2025Annex 6 To Exhibit Fbd T 4-
Jul 10, 2025Annex 5 To Exhibit Fbd T 4-
Jul 10, 2025Annex 4 To Exhibit Fbd T 4-
Jul 10, 2025Annex 3 To Exhibit Fbd T 4-
Jul 10, 2025Annex 2 To Exhibit Fbd T 4-
Jul 10, 2025Annex 1 To Exhibit Fbd T 4-
Jul 10, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025 V2-
Jul 9, 2025Set Of Exhibits Fbd T 09 Confidential-
Jul 9, 2025Set Of Exhibits Fbd 11-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 5 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 4 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 3 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 2 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 1 Of 5-
Jul 9, 2025Receipt-
Jul 9, 2025Opportunity To Comment-
Jul 9, 2025Exhibit Fbd T 19-
Jul 9, 2025Exhibit Fbd T 18-
Jul 9, 2025Exhibit Fbd T 17-
Jul 9, 2025Exhibit Fbd T 16-
Jul 9, 2025Exhibit Fbd T 15-
Jul 9, 2025Exhibit Fbd T 14-
Jul 9, 2025Exhibit Fbd T 13-
Jul 9, 2025Exhibit Fbd T 12-
Jul 9, 2025Exhibit Fbd T 11-
Jul 9, 2025Exhibit Fbd T 10-
Jul 9, 2025Exhibit Fbd T 09A Confidential-
Jul 9, 2025Exhibit Fbd T 08-
Jul 9, 2025Exhibit Fbd T 07-
Jul 9, 2025Exhibit Fbd T 06-
Jul 9, 2025Exhibit Fbd T 05-
Jul 9, 2025Exhibit Fbd T 04-
Jul 9, 2025Exhibit Fbd T 03A-
Jul 9, 2025Exhibit Fbd T 03-
Jul 9, 2025Exhibit Fbd T 02-
Jul 9, 2025Exhibit Fbd T 01-
Jul 9, 2025Exhibit Fbd 16-
Jul 9, 2025Exhibit Fbd 15-
Jul 9, 2025Exhibit Fbd 14-
Jul 9, 2025Exhibit Fbd 13-
Jul 9, 2025Exhibit Fbd 12 Confidential-
Jul 9, 2025Exhibit Fbd 11A-
Jul 9, 2025Exhibit Fbd 09-
Jul 9, 2025Exhibit Fbd 08-
Jul 9, 2025Exhibit Fbd 07-
Jul 9, 2025Exhibit Fbd 06-
Jul 9, 2025EP254 Moderna Reference To Statement Of Defence And Counterclaim For Revocation-
Jul 9, 2025Annex 7 To Exhibit Fbd T 4-
Jul 9, 2025Annex 6 To Exhibit Fbd T 4-
Jul 9, 2025Annex 5 To Exhibit Fbd T 4-
Jul 9, 2025Annex 4 To Exhibit Fbd T 4-
Jul 9, 2025Annex 3 To Exhibit Fbd T 4-
Jul 9, 2025Annex 2 To Exhibit Fbd T 4-
Jul 9, 2025Annex 1 To Exhibit Fbd T 4-
Jul 9, 2025Acknowledgement Of Lodging-
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Request Security Pursuant To R158 No 32591 2025-
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Confidentiality Request-
Jul 9, 202507 08 Upc1 EP254 Reference To Statement Of Defence For Other Defendants(307430487.1)-
Jul 9, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025-
Jun 19, 2025Response To Request For Review-
Jun 12, 2025Outcome Of The Order-
Jun 12, 2025Opportunity To Comment
Jun 11, 2025Acknowledgement Of Lodging-
Jun 6, 2025Exhibit Fbd 5-
Jun 6, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 27016 2025-
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order-
Jun 4, 2025Headnote And Keywords-
Jun 2, 2025Response To Request For Rectification-
May 28, 2025Opportunity To Comment-
May 27, 2025Receipt-
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025-
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome-
May 7, 2025Exhibit G118 Notice European Tender-
May 7, 2025Exhibit G117 Certificate Amalgamation-
May 7, 2025Exhibit G116 Opt Out Confirmation-
May 7, 2025Exhibit G115 Opt Out-
May 7, 2025Comment On Preliminary Objection-
May 7, 2025Comment On Preliminary Objection-
May 6, 2025Notification Of Service-
May 6, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Norway As-
May 5, 2025Acknowledgement Of Access To Case-
May 1, 2025Notification Of Service-
May 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Switzerland Gmbh-
Apr 25, 2025Preliminary Objection-
Apr 25, 2025Notification Of Service-
Apr 25, 2025Exhibit Fbd 4 Moderna Pl-
Apr 25, 2025Exhibit Fbd 3 Dutch Patent Register-
Apr 25, 2025Exhibit Fbd 2 National Registers-
Apr 25, 2025Act 10280 Upc Cfi 191 Confirmation Of Service-
Apr 25, 202525 04 24 EP254 Preliminary Objection Moderna VS Genevant Signed-
Apr 23, 2025Preliminary Objection-
Apr 22, 2025Preliminary Objection Moderna Uk Moderna VS Genevant (EP254) Signed-
Apr 22, 2025Notification Of Service-
Apr 22, 2025Exhibit Fbd 3 Dutch Patent Register-
Apr 22, 2025Exhibit Fbd 2 National Registers-
Apr 22, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Inc.-
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order-
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Response To Letter Brinkhof D.D17 April-
Apr 17, 2025Receipt-
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc-
Apr 17, 2025Outcome Of The Order-
Apr 17, 2025Headnote And Keywords-
Apr 17, 2025Exhibit G114 Letter Re Representation Mll Of Moderna Inc Modernatx Inc-
Apr 15, 2025Receipt-
Apr 15, 2025Notification Of Service-
Apr 15, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Sweden Ab-
Apr 15, 202525 04 15 EP254 Response Re Deadline Extension-
Apr 14, 2025Receipt-
Apr 14, 2025R 9 Aplication Reply To R 9 Request-
Apr 10, 2025Template Order-
Apr 10, 2025Opportunity To Comment-
Apr 9, 2025Receipt-
Apr 9, 2025Opportunity To Comment-
Apr 9, 2025Exhibit Fbd 1-
Apr 9, 202525 04 09 EP254 Request For Deadline Extension Moderna VS Genevant Arbutus Cfi 191 2025 Act 10280 2025-
Apr 1, 2025Notification Of Service-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Netherlands B.V.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Italy S.R.L.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Germany Gmbh-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna France Sasu-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Denmark Aps-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Uk Limited-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Spain Sl-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Belgium S.R.L.-
Mar 31, 2025Acknowledgement Of Access To Case-
Mar 28, 2025Acknowledgement Of Access To Case-
Mar 24, 2025Acknowledgement Of Access To Case-
Mar 17, 2025Panel Appointment-
Mar 13, 2025Letter For Service-
Mar 11, 2025Document From Epo-
Mar 6, 2025Receipt-
Mar 6, 2025Panel Appointment-
Mar 6, 2025Formal Checks Notification Of Positive Outcome-
Mar 6, 2025Epo Request For Case Pending-
Mar 5, 2025Statement Of Claim EP254 Signed-
Mar 5, 2025Statement Of Claim EP254Da-
Mar 5, 2025Raw Data Uv-
Mar 5, 2025Raw Data Lc Cad Sample C3-
Mar 5, 2025Raw Data Lc Cad Sample C2-
Mar 5, 2025Raw Data Lc Cad Sample C1-
Mar 5, 2025Raw Data Dls-
Mar 5, 2025Exhibit M.04 United States Pharmacopeia-
Mar 5, 2025Exhibit M.03 Semple-
Mar 5, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture-
Mar 5, 2025Exhibit M.01 Samaridou-
Mar 5, 2025Exhibit G113 Moderna Inc Annual Report Selection-
Mar 5, 2025Exhibit G112 Moderna Annual Report P. 119-
Mar 5, 2025Exhibit G111 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit G110 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit G109 Moderna Rovi Press Release-
Mar 5, 2025Exhibit G108 Moderna Rovi Press Release-
Mar 5, 2025Exhibit G107 Lonza Press Release-
Mar 5, 2025Exhibit G106 Moderna Press Release Lonza Nl-
Mar 5, 2025Exhibit G105 Moderna Ch Service Agreement Tr-
Mar 5, 2025Exhibit G104 Moderna Lonza Press Release-
Mar 5, 2025Exhibit G103 Moderna Portugal Trade Register-
Mar 5, 2025Exhibit G102 Moderna Norway Trade Register-
Mar 5, 2025Exhibit G101 Moderna Sweden Trade Register-
Mar 5, 2025Exhibit G100 Moderna Denmark Trade Register-
Mar 5, 2025Exhibit G099 Moderna Belgium Trade Register-
Mar 5, 2025Exhibit G098 Moderna Italy Trade Register-
Mar 5, 2025Exhibit G097 Moderna France Trade Register-
Mar 5, 2025Exhibit G096 Moderna Germany Trade Register-
Mar 5, 2025Exhibit G095 Moderna Uk Annual Report-
Mar 5, 2025Exhibit G094 Moderna Uk Trade Register-
Mar 5, 2025Exhibit G093 Moderna Poland Trade Register-
Mar 5, 2025Exhibit G092 Moderna Netherlands Madrid-
Mar 5, 2025Exhibit G091 Moderna Es Trade Register-
Mar 5, 2025Exhibit G090 Mresvia Lauer Taxe Germany-
Mar 5, 2025Exhibit G089 Spikevax Lauer Taxe Germany-
Mar 5, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl-
Mar 5, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl-
Mar 5, 2025Exhibit G086 Moderna Nl Hungary Contract-
Mar 5, 2025Exhibit G085 Moderna Nl Hungary Contract Hun-
Mar 5, 2025Exhibit G084 Moderna Nl Annual Report-
Mar 5, 2025Exhibit G083 Moderna Nl Trade Register-
Mar 5, 2025Exhibit G082 Ec Draft Framework Contract-
Mar 5, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 5, 2025Exhibit G080 Moderna Press Release Tender-
Mar 5, 2025Exhibit G079 Ec Press Release Tender-
Mar 5, 2025Exhibit G078 Ex Pa Ec Moderna Ch-
Mar 5, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61-
Mar 5, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60-
Mar 5, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53-
Mar 5, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44-
Mar 5, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35-
Mar 5, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26-
Mar 5, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17-
Mar 5, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8-
Mar 5, 2025Exhibit G076 Moderna Switzerland Trade Register-
Mar 5, 2025Exhibit G075 Modernacovid19Global Website-
Mar 5, 2025Exhibit G074 Modernatx Website-
Mar 5, 2025Exhibit G073 Domain Registrations Moderna-
Mar 5, 2025Exhibit G072 Modernatx Trade Register Excerpt-
Mar 5, 2025Exhibit G071 Moderna Inc Press Release-
Mar 5, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1-
Mar 5, 2025Exhibit G069 Moderna Inc Trade Register Excerpt-
Mar 5, 2025Exhibit G068 Coriolis Report-
Mar 5, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection-
Mar 5, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92-
Mar 5, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 5, 2025Exhibit G064 Ema Assesment Report Mresvia-
Mar 5, 2025Exhibit G063 Moderna Press Release 23 August-
Mar 5, 2025Exhibit G062 Mresvia Smpc-
Mar 5, 2025Exhibit G061 Mitchell Report Table Of Content-
Mar 5, 2025Exhibit G060 Coriolis Report Table Of Content-
Mar 5, 2025Exhibit G059 WO2022197624A1-
Mar 5, 2025Exhibit G058 WO2021222304A1-
Mar 5, 2025Exhibit G057 WO2021159130A2-
Mar 5, 2025Exhibit G056 Richner-
Mar 5, 2025Exhibit G055 Bahl-
Mar 5, 2025Exhibit G054 Espeseth-
Mar 5, 2025Exhibit G053 John-
Mar 5, 2025Exhibit G052 Peer Review Corbett Nature-
Mar 5, 2025Exhibit G051 Hassett-
Mar 5, 2025Exhibit G050 Ema Assessment Report Spikevax-
Mar 5, 2025Exhibit G049 Epo Ar1 To Ar13-
Mar 5, 2025Exhibit G048 Ar13 Redlined-
Mar 5, 2025Exhibit G047 Mr Redlined-
Mar 5, 2025Exhibit G046 Mitchell Report-
Mar 5, 2025Exhibit G045 Petitioners Hearing Slides Slide 27-
Mar 5, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73-
Mar 5, 2025Exhibit G043 D44 Declaration Heyes-
Mar 5, 2025Exhibit G042 D43 Declaration Heyes-
Mar 5, 2025Exhibit G041 Modernas Goa Of 22 November-
Mar 5, 2025Exhibit G040 Arbutuss Goa Of 25 November-
Mar 5, 2025Exhibit G039 Main Request-
Mar 5, 2025Exhibit G038 US2006 0240554 (D25)-
Mar 5, 2025Exhibit G037 Auxiliary Request 13-
Mar 5, 2025Exhibit G036 Od Decision-
Mar 5, 2025Exhibit G035 T 0505 20-
Mar 5, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October-
Mar 5, 2025Exhibit G033 Od Decision-
Mar 5, 2025Exhibit G032 US20080020058(Chen)-
Mar 5, 2025Exhibit G031 Amended Claim With Annotations 13 September-
Mar 5, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May-
Mar 5, 2025Exhibit G029 Extended European Search Report 12 October-
Mar 5, 2025Exhibit G028 Amendments Received Before Examination 30 December-
Mar 5, 2025Exhibit G027 Withdrawal Of The Op Out-
Mar 5, 2025Exhibit G026 US20080045228P Priority Document-
Mar 5, 2025Exhibit G025 WO2009127060A1 Original Application-
Mar 5, 2025Exhibit G024 Samaridou-
Mar 5, 2025Exhibit G023 Genevant Press Release-
Mar 5, 2025Exhibit G022 Federal Circuit Opinion (435)-
Mar 5, 2025Exhibit G021 Federal Circuit Opinion (069)-
Mar 5, 2025Exhibit G020 Ipr Final Written Decision (435)-
Mar 5, 2025Exhibit G019 Ipr Final Written Decision (069)-
Mar 5, 2025Exhibit G018 US9364435-
Mar 5, 2025Exhibit G017 US8058069-
Mar 5, 2025Exhibit G016 Moore Harvard Business School-
Mar 5, 2025Exhibit G015 Moderna Nih Preprint-
Mar 5, 2025Exhibit G014 CR OSS Cen News-
Mar 5, 2025Exhibit G013 Regalado Mit Technology-
Mar 5, 2025Exhibit G012 Corbett Nature Review-
Mar 5, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration-
Mar 5, 2025Exhibit G010 Suzuki-
Mar 5, 2025Exhibit G009 Semple-
Mar 5, 2025Exhibit G008 Zimmerman-
Mar 5, 2025Exhibit G007 Spikevax Smpc-
Mar 5, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 5, 2025Exhibit G005 Genevant Sciences Trade Register-
Mar 5, 2025Exhibit G004 Proof Of Payment Court Fees-
Mar 5, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus-
Mar 5, 2025Exhibit G002 Patent Register Excerpts-
Mar 5, 2025Exhibit G001 EP2279254B1-
Mar 5, 2025Exhibit C Qualification Report-
Mar 5, 2025Exhibit B Cv Katharina Edenharter-
Mar 5, 2025Exhibit A Cv Thomas Lassak-
Mar 4, 2025Formal Checks Request For Correction-
Mar 3, 2025Statement Of Claim EP254 Signed-
Mar 3, 2025Raw Data Uv-
Mar 3, 2025Raw Data Lc Cad Sample C3-
Mar 3, 2025Raw Data Lc Cad Sample C2-
Mar 3, 2025Raw Data Lc Cad Sample C1-
Mar 3, 2025Raw Data Dls-
Mar 3, 2025Exhibit M.04 United States Pharmacopeia-
Mar 3, 2025Exhibit M.03 Semple-
Mar 3, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture-
Mar 3, 2025Exhibit M.01 Samaridou-
Mar 3, 2025Exhibit G113 Moderna Inc Annual Report Selection-
Mar 3, 2025Exhibit G112 Moderna Annual Report P. 119-
Mar 3, 2025Exhibit G111 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit G110 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit G109 Moderna Rovi Press Release-
Mar 3, 2025Exhibit G108 Moderna Rovi Press Release-
Mar 3, 2025Exhibit G107 Lonza Press Release-
Mar 3, 2025Exhibit G106 Moderna Press Release Lonza Nl-
Mar 3, 2025Exhibit G105 Moderna Ch Service Agreement Tr-
Mar 3, 2025Exhibit G104 Moderna Lonza Press Release-
Mar 3, 2025Exhibit G103 Moderna Portugal Trade Register-
Mar 3, 2025Exhibit G102 Moderna Norway Trade Register-
Mar 3, 2025Exhibit G101 Moderna Sweden Trade Register-
Mar 3, 2025Exhibit G100 Moderna Denmark Trade Register-
Mar 3, 2025Exhibit G099 Moderna Belgium Trade Register-
Mar 3, 2025Exhibit G098 Moderna Italy Trade Register-
Mar 3, 2025Exhibit G097 Moderna France Trade Register-
Mar 3, 2025Exhibit G096 Moderna Germany Trade Register-
Mar 3, 2025Exhibit G095 Moderna Uk Annual Report-
Mar 3, 2025Exhibit G094 Moderna Uk Trade Register-
Mar 3, 2025Exhibit G093 Moderna Poland Trade Register-
Mar 3, 2025Exhibit G092 Moderna Netherlands Madrid-
Mar 3, 2025Exhibit G091 Moderna Es Trade Register-
Mar 3, 2025Exhibit G090 Mresvia Lauer Taxe Germany-
Mar 3, 2025Exhibit G089 Spikevax Lauer Taxe Germany-
Mar 3, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl-
Mar 3, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl-
Mar 3, 2025Exhibit G086 Moderna Nl Hungary Contract-
Mar 3, 2025Exhibit G085 Moderna Nl Hungary Contract Hun-
Mar 3, 2025Exhibit G084 Moderna Nl Annual Report-
Mar 3, 2025Exhibit G083 Moderna Nl Trade Register-
Mar 3, 2025Exhibit G082 Ec Draft Framework Contract-
Mar 3, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 3, 2025Exhibit G080 Moderna Press Release Tender-
Mar 3, 2025Exhibit G079 Ec Press Release Tender-
Mar 3, 2025Exhibit G078 Ex Pa Ec Moderna Ch-
Mar 3, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61-
Mar 3, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60-
Mar 3, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53-
Mar 3, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44-
Mar 3, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35-
Mar 3, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26-
Mar 3, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17-
Mar 3, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8-
Mar 3, 2025Exhibit G076 Moderna Switzerland Trade Register-
Mar 3, 2025Exhibit G075 Modernacovid19Global Website-
Mar 3, 2025Exhibit G074 Modernatx Website-
Mar 3, 2025Exhibit G073 Domain Registrations Moderna-
Mar 3, 2025Exhibit G072 Modernatx Trade Register Excerpt-
Mar 3, 2025Exhibit G071 Moderna Inc Press Release-
Mar 3, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1-
Mar 3, 2025Exhibit G069 Moderna Inc Trade Register Excerpt-
Mar 3, 2025Exhibit G068 Coriolis Report-
Mar 3, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection-
Mar 3, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92-
Mar 3, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 3, 2025Exhibit G064 Ema Assesment Report Mresvia-
Mar 3, 2025Exhibit G063 Moderna Press Release 23 August-
Mar 3, 2025Exhibit G062 Mresvia Smpc-
Mar 3, 2025Exhibit G061 Mitchell Report Table Of Content-
Mar 3, 2025Exhibit G060 Coriolis Report Table Of Content-
Mar 3, 2025Exhibit G059 WO2022197624A1-
Mar 3, 2025Exhibit G058 WO2021222304A1-
Mar 3, 2025Exhibit G057 WO2021159130A2-
Mar 3, 2025Exhibit G056 Richner-
Mar 3, 2025Exhibit G055 Bahl-
Mar 3, 2025Exhibit G054 Espeseth-
Mar 3, 2025Exhibit G053 John-
Mar 3, 2025Exhibit G052 Peer Review Corbett Nature-
Mar 3, 2025Exhibit G051 Hassett-
Mar 3, 2025Exhibit G050 Ema Assessment Report Spikevax-
Mar 3, 2025Exhibit G049 Epo Ar1 To Ar13-
Mar 3, 2025Exhibit G048 Ar13 Redlined-
Mar 3, 2025Exhibit G047 Mr Redlined-
Mar 3, 2025Exhibit G046 Mitchell Report-
Mar 3, 2025Exhibit G045 Petitioners Hearing Slides Slide 27-
Mar 3, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73-
Mar 3, 2025Exhibit G043 D44 Declaration Heyes-
Mar 3, 2025Exhibit G042 D43 Declaration Heyes-
Mar 3, 2025Exhibit G041 Modernas Goa Of 22 November-
Mar 3, 2025Exhibit G040 Arbutuss Goa Of 25 November-
Mar 3, 2025Exhibit G039 Main Request-
Mar 3, 2025Exhibit G038 US2006 0240554 (D25)-
Mar 3, 2025Exhibit G037 Auxiliary Request 13-
Mar 3, 2025Exhibit G036 Od Decision-
Mar 3, 2025Exhibit G035 T 0505 20-
Mar 3, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October-
Mar 3, 2025Exhibit G033 Od Decision-
Mar 3, 2025Exhibit G032 US20080020058(Chen)-
Mar 3, 2025Exhibit G031 Amended Claim With Annotations 13 September-
Mar 3, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May-
Mar 3, 2025Exhibit G029 Extended European Search Report 12 October-
Mar 3, 2025Exhibit G028 Amendments Received Before Examination 30 December-
Mar 3, 2025Exhibit G027 Withdrawal Of The Op Out-
Mar 3, 2025Exhibit G026 US20080045228P Priority Document-
Mar 3, 2025Exhibit G025 WO2009127060A1 Original Application-
Mar 3, 2025Exhibit G024 Samaridou-
Mar 3, 2025Exhibit G023 Genevant Press Release-
Mar 3, 2025Exhibit G022 Federal Circuit Opinion (435)-
Mar 3, 2025Exhibit G021 Federal Circuit Opinion (069)-
Mar 3, 2025Exhibit G020 Ipr Final Written Decision (435)-
Mar 3, 2025Exhibit G019 Ipr Final Written Decision (069)-
Mar 3, 2025Exhibit G018 US9364435-
Mar 3, 2025Exhibit G017 US8058069-
Mar 3, 2025Exhibit G016 Moore Harvard Business School-
Mar 3, 2025Exhibit G015 Moderna Nih Preprint-
Mar 3, 2025Exhibit G014 CR OSS Cen News-
Mar 3, 2025Exhibit G013 Regalado Mit Technology-
Mar 3, 2025Exhibit G012 Corbett Nature Review-
Mar 3, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration-
Mar 3, 2025Exhibit G010 Suzuki-
Mar 3, 2025Exhibit G009 Semple-
Mar 3, 2025Exhibit G008 Zimmerman-
Mar 3, 2025Exhibit G007 Spikevax Smpc-
Mar 3, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 3, 2025Exhibit G005 Genevant Sciences Trade Register-
Mar 3, 2025Exhibit G004 Proof Of Payment Court Fees-
Mar 3, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus-
Mar 3, 2025Exhibit G002 Patent Register Excerpts-
Mar 3, 2025Exhibit G001 EP2279254B1-
Mar 3, 2025Exhibit C Qualification Report-
Mar 3, 2025Exhibit B Cv Katharina Edenharter-
Mar 3, 2025Exhibit A Cv Thomas Lassak-
Mar 3, 2025EP254Soc Da-
Mar 3, 2025Acknowledgement Of Lodging-
Oct 3, 2025Receipt-
Oct 3, 2025Exhibit-
Oct 3, 2025Cover Sheet-
Oct 3, 2025Application-
Sep 24, 2025Statement Of Reply-
Sep 24, 2025Receipt-
Sep 24, 2025Exhibit-
Sep 24, 2025Cover Sheet-
Sep 14, 2025Rejoinder On Request To Produce Evidence-
Sep 12, 2025Uploaded For Technical Reasons Only To Close Workflow
Sep 12, 2025Upc Genevant Arbutus Reply R 190 Request Signed-
Sep 12, 2025Outcome Of The Order-
Sep 12, 2025Opportunity To Comment-
Sep 2, 2025Receipt-
Sep 2, 2025Moderna R.9 Rop In Response To R.190 Rop Application-
Aug 28, 2025Receipt-
Aug 27, 202525 08 27 Ep 254 Further Comment On Request To Produce Evidence Moderna Vs Genevant-
Aug 26, 2025Reply Re R190 Request-
Aug 26, 2025Exhibit G126-
Aug 18, 2025Panel Appointment-
Aug 18, 2025Opportunity To Comment-
Aug 15, 2025R.37.2 Order
Aug 14, 2025Response To Request To Produce Evidence (Rule 190 Rop)-
Aug 14, 2025Exhibit Fs18 DI 457 Letter May-
Aug 14, 2025Exhibit Fs17 Protective Order-
Aug 13, 2025Joint Statement Regarding Bifurcation-
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop-
Aug 8, 2025Response To Deadline Extension Request-
Aug 6, 2025R.37-
Aug 6, 2025R
Aug 6, 2025Hearing Dates-
Aug 5, 2025Redacted Final Order Re R.262A Applications-
Aug 4, 2025R.262A Order-
Aug 4, 2025Outcome Of The Order-
Aug 4, 2025Opportunity To Comment-
Aug 1, 2025Request For Extension Of Deadlines-
Aug 1, 2025Receipt-
Aug 1, 2025Exhibit G125-
Aug 1, 2025Exhibit G124-
Aug 1, 2025Exhibit G123-
Aug 1, 2025Application For An Order To Produce Evidence-
Jul 28, 2025R.262A Reply-
Jul 28, 2025Exhibit G122-
Jul 25, 2025Receipt-
Jul 24, 2025R.262A Reply-
Jul 24, 2025Exhibit G122-
Jul 23, 2025Reference To Response Of Genevant-
Jul 23, 2025R.262.2 Application-
Jul 23, 2025Exhibit G121 Confidential-
Jul 23, 2025Exhibit G120-
Jul 23, 2025Exhibit G119-
Jul 23, 2025Confidential Response To Security-
Jul 11, 2025Formal Checks Notification Of Positive Outcome-
Jul 11, 2025Acknowledgement Of Lodging-
Jul 10, 2025Set Of Exhibits Fbd T 09 Confidential-
Jul 10, 2025Set Of Exhibits Fbd 11-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 5 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 4 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 3 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 2 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 1 Of 5-
Jul 10, 2025Opportunity To Comment-
Jul 10, 2025Formal Checks Request For Correction-
Jul 10, 2025Exhibit Fbd T 19-
Jul 10, 2025Exhibit Fbd T 18-
Jul 10, 2025Exhibit Fbd T 17-
Jul 10, 2025Exhibit Fbd T 16-
Jul 10, 2025Exhibit Fbd T 15-
Jul 10, 2025Exhibit Fbd T 14-
Jul 10, 2025Exhibit Fbd T 13-
Jul 10, 2025Exhibit Fbd T 12-
Jul 10, 2025Exhibit Fbd T 11-
Jul 10, 2025Exhibit Fbd T 10-
Jul 10, 2025Exhibit Fbd T 09A Confidential-
Jul 10, 2025Exhibit Fbd T 08-
Jul 10, 2025Exhibit Fbd T 07-
Jul 10, 2025Exhibit Fbd T 06-
Jul 10, 2025Exhibit Fbd T 05-
Jul 10, 2025Exhibit Fbd T 04-
Jul 10, 2025Exhibit Fbd T 03A-
Jul 10, 2025Exhibit Fbd T 03-
Jul 10, 2025Exhibit Fbd T 02-
Jul 10, 2025Exhibit Fbd T 01-
Jul 10, 2025Exhibit Fbd 16-
Jul 10, 2025Exhibit Fbd 15-
Jul 10, 2025Exhibit Fbd 14-
Jul 10, 2025Exhibit Fbd 13-
Jul 10, 2025Exhibit Fbd 12 Confidential-
Jul 10, 2025Exhibit Fbd 11A-
Jul 10, 2025Exhibit Fbd 09-
Jul 10, 2025Exhibit Fbd 08-
Jul 10, 2025Exhibit Fbd 07-
Jul 10, 2025Exhibit Fbd 06-
Jul 10, 2025Annex 7 To Exhibit Fbd T 4-
Jul 10, 2025Annex 6 To Exhibit Fbd T 4-
Jul 10, 2025Annex 5 To Exhibit Fbd T 4-
Jul 10, 2025Annex 4 To Exhibit Fbd T 4-
Jul 10, 2025Annex 3 To Exhibit Fbd T 4-
Jul 10, 2025Annex 2 To Exhibit Fbd T 4-
Jul 10, 2025Annex 1 To Exhibit Fbd T 4-
Jul 10, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025 V2-
Jul 9, 2025Set Of Exhibits Fbd T 09 Confidential-
Jul 9, 2025Set Of Exhibits Fbd 11-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 5 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 4 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 3 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 2 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 1 Of 5-
Jul 9, 2025Receipt-
Jul 9, 2025Opportunity To Comment-
Jul 9, 2025Exhibit Fbd T 19-
Jul 9, 2025Exhibit Fbd T 18-
Jul 9, 2025Exhibit Fbd T 17-
Jul 9, 2025Exhibit Fbd T 16-
Jul 9, 2025Exhibit Fbd T 15-
Jul 9, 2025Exhibit Fbd T 14-
Jul 9, 2025Exhibit Fbd T 13-
Jul 9, 2025Exhibit Fbd T 12-
Jul 9, 2025Exhibit Fbd T 11-
Jul 9, 2025Exhibit Fbd T 10-
Jul 9, 2025Exhibit Fbd T 09A Confidential-
Jul 9, 2025Exhibit Fbd T 08-
Jul 9, 2025Exhibit Fbd T 07-
Jul 9, 2025Exhibit Fbd T 06-
Jul 9, 2025Exhibit Fbd T 05-
Jul 9, 2025Exhibit Fbd T 04-
Jul 9, 2025Exhibit Fbd T 03A-
Jul 9, 2025Exhibit Fbd T 03-
Jul 9, 2025Exhibit Fbd T 02-
Jul 9, 2025Exhibit Fbd T 01-
Jul 9, 2025Exhibit Fbd 16-
Jul 9, 2025Exhibit Fbd 15-
Jul 9, 2025Exhibit Fbd 14-
Jul 9, 2025Exhibit Fbd 13-
Jul 9, 2025Exhibit Fbd 12 Confidential-
Jul 9, 2025Exhibit Fbd 11A-
Jul 9, 2025Exhibit Fbd 09-
Jul 9, 2025Exhibit Fbd 08-
Jul 9, 2025Exhibit Fbd 07-
Jul 9, 2025Exhibit Fbd 06-
Jul 9, 2025EP254 Moderna Reference To Statement Of Defence And Counterclaim For Revocation-
Jul 9, 2025Annex 7 To Exhibit Fbd T 4-
Jul 9, 2025Annex 6 To Exhibit Fbd T 4-
Jul 9, 2025Annex 5 To Exhibit Fbd T 4-
Jul 9, 2025Annex 4 To Exhibit Fbd T 4-
Jul 9, 2025Annex 3 To Exhibit Fbd T 4-
Jul 9, 2025Annex 2 To Exhibit Fbd T 4-
Jul 9, 2025Annex 1 To Exhibit Fbd T 4-
Jul 9, 2025Acknowledgement Of Lodging-
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Request Security Pursuant To R158 No 32591 2025-
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Confidentiality Request-
Jul 9, 202507 08 Upc1 EP254 Reference To Statement Of Defence For Other Defendants(307430487.1)-
Jul 9, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025-
Jun 19, 2025Response To Request For Review-
Jun 12, 2025Outcome Of The Order-
Jun 12, 2025Opportunity To Comment
Jun 11, 2025Acknowledgement Of Lodging-
Jun 6, 2025Exhibit Fbd 5-
Jun 6, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 27016 2025-
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order-
Jun 4, 2025Headnote And Keywords-
Jun 2, 2025Response To Request For Rectification-
May 28, 2025Opportunity To Comment-
May 27, 2025Receipt-
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025-
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome-
May 7, 2025Exhibit G118 Notice European Tender-
May 7, 2025Exhibit G117 Certificate Amalgamation-
May 7, 2025Exhibit G116 Opt Out Confirmation-
May 7, 2025Exhibit G115 Opt Out-
May 7, 2025Comment On Preliminary Objection-
May 7, 2025Comment On Preliminary Objection-
May 6, 2025Notification Of Service-
May 6, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Norway As-
May 5, 2025Acknowledgement Of Access To Case-
May 1, 2025Notification Of Service-
May 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Switzerland Gmbh-
Apr 25, 2025Preliminary Objection-
Apr 25, 2025Notification Of Service-
Apr 25, 2025Exhibit Fbd 4 Moderna Pl-
Apr 25, 2025Exhibit Fbd 3 Dutch Patent Register-
Apr 25, 2025Exhibit Fbd 2 National Registers-
Apr 25, 2025Act 10280 Upc Cfi 191 Confirmation Of Service-
Apr 25, 202525 04 24 EP254 Preliminary Objection Moderna VS Genevant Signed-
Apr 23, 2025Preliminary Objection-
Apr 22, 2025Preliminary Objection Moderna Uk Moderna VS Genevant (EP254) Signed-
Apr 22, 2025Notification Of Service-
Apr 22, 2025Exhibit Fbd 3 Dutch Patent Register-
Apr 22, 2025Exhibit Fbd 2 National Registers-
Apr 22, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Inc.-
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order-
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Response To Letter Brinkhof D.D17 April-
Apr 17, 2025Receipt-
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc-
Apr 17, 2025Outcome Of The Order-
Apr 17, 2025Headnote And Keywords-
Apr 17, 2025Exhibit G114 Letter Re Representation Mll Of Moderna Inc Modernatx Inc-
Apr 15, 2025Receipt-
Apr 15, 2025Notification Of Service-
Apr 15, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Sweden Ab-
Apr 15, 202525 04 15 EP254 Response Re Deadline Extension-
Apr 14, 2025Receipt-
Apr 14, 2025R 9 Aplication Reply To R 9 Request-
Apr 10, 2025Template Order-
Apr 10, 2025Opportunity To Comment-
Apr 9, 2025Receipt-
Apr 9, 2025Opportunity To Comment-
Apr 9, 2025Exhibit Fbd 1-
Apr 9, 202525 04 09 EP254 Request For Deadline Extension Moderna VS Genevant Arbutus Cfi 191 2025 Act 10280 2025-
Apr 1, 2025Notification Of Service-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Netherlands B.V.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Italy S.R.L.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Germany Gmbh-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna France Sasu-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Denmark Aps-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Uk Limited-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Spain Sl-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Belgium S.R.L.-
Mar 31, 2025Acknowledgement Of Access To Case-
Mar 28, 2025Acknowledgement Of Access To Case-
Mar 24, 2025Acknowledgement Of Access To Case-
Mar 17, 2025Panel Appointment-
Mar 13, 2025Letter For Service-
Mar 11, 2025Document From Epo-
Mar 6, 2025Receipt-
Mar 6, 2025Panel Appointment-
Mar 6, 2025Formal Checks Notification Of Positive Outcome-
Mar 6, 2025Epo Request For Case Pending-
Mar 5, 2025Statement Of Claim EP254 Signed-
Mar 5, 2025Statement Of Claim EP254Da-
Mar 5, 2025Raw Data Uv-
Mar 5, 2025Raw Data Lc Cad Sample C3-
Mar 5, 2025Raw Data Lc Cad Sample C2-
Mar 5, 2025Raw Data Lc Cad Sample C1-
Mar 5, 2025Raw Data Dls-
Mar 5, 2025Exhibit M.04 United States Pharmacopeia-
Mar 5, 2025Exhibit M.03 Semple-
Mar 5, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture-
Mar 5, 2025Exhibit M.01 Samaridou-
Mar 5, 2025Exhibit G113 Moderna Inc Annual Report Selection-
Mar 5, 2025Exhibit G112 Moderna Annual Report P. 119-
Mar 5, 2025Exhibit G111 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit G110 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit G109 Moderna Rovi Press Release-
Mar 5, 2025Exhibit G108 Moderna Rovi Press Release-
Mar 5, 2025Exhibit G107 Lonza Press Release-
Mar 5, 2025Exhibit G106 Moderna Press Release Lonza Nl-
Mar 5, 2025Exhibit G105 Moderna Ch Service Agreement Tr-
Mar 5, 2025Exhibit G104 Moderna Lonza Press Release-
Mar 5, 2025Exhibit G103 Moderna Portugal Trade Register-
Mar 5, 2025Exhibit G102 Moderna Norway Trade Register-
Mar 5, 2025Exhibit G101 Moderna Sweden Trade Register-
Mar 5, 2025Exhibit G100 Moderna Denmark Trade Register-
Mar 5, 2025Exhibit G099 Moderna Belgium Trade Register-
Mar 5, 2025Exhibit G098 Moderna Italy Trade Register-
Mar 5, 2025Exhibit G097 Moderna France Trade Register-
Mar 5, 2025Exhibit G096 Moderna Germany Trade Register-
Mar 5, 2025Exhibit G095 Moderna Uk Annual Report-
Mar 5, 2025Exhibit G094 Moderna Uk Trade Register-
Mar 5, 2025Exhibit G093 Moderna Poland Trade Register-
Mar 5, 2025Exhibit G092 Moderna Netherlands Madrid-
Mar 5, 2025Exhibit G091 Moderna Es Trade Register-
Mar 5, 2025Exhibit G090 Mresvia Lauer Taxe Germany-
Mar 5, 2025Exhibit G089 Spikevax Lauer Taxe Germany-
Mar 5, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl-
Mar 5, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl-
Mar 5, 2025Exhibit G086 Moderna Nl Hungary Contract-
Mar 5, 2025Exhibit G085 Moderna Nl Hungary Contract Hun-
Mar 5, 2025Exhibit G084 Moderna Nl Annual Report-
Mar 5, 2025Exhibit G083 Moderna Nl Trade Register-
Mar 5, 2025Exhibit G082 Ec Draft Framework Contract-
Mar 5, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 5, 2025Exhibit G080 Moderna Press Release Tender-
Mar 5, 2025Exhibit G079 Ec Press Release Tender-
Mar 5, 2025Exhibit G078 Ex Pa Ec Moderna Ch-
Mar 5, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61-
Mar 5, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60-
Mar 5, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53-
Mar 5, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44-
Mar 5, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35-
Mar 5, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26-
Mar 5, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17-
Mar 5, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8-
Mar 5, 2025Exhibit G076 Moderna Switzerland Trade Register-
Mar 5, 2025Exhibit G075 Modernacovid19Global Website-
Mar 5, 2025Exhibit G074 Modernatx Website-
Mar 5, 2025Exhibit G073 Domain Registrations Moderna-
Mar 5, 2025Exhibit G072 Modernatx Trade Register Excerpt-
Mar 5, 2025Exhibit G071 Moderna Inc Press Release-
Mar 5, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1-
Mar 5, 2025Exhibit G069 Moderna Inc Trade Register Excerpt-
Mar 5, 2025Exhibit G068 Coriolis Report-
Mar 5, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection-
Mar 5, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92-
Mar 5, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 5, 2025Exhibit G064 Ema Assesment Report Mresvia-
Mar 5, 2025Exhibit G063 Moderna Press Release 23 August-
Mar 5, 2025Exhibit G062 Mresvia Smpc-
Mar 5, 2025Exhibit G061 Mitchell Report Table Of Content-
Mar 5, 2025Exhibit G060 Coriolis Report Table Of Content-
Mar 5, 2025Exhibit G059 WO2022197624A1-
Mar 5, 2025Exhibit G058 WO2021222304A1-
Mar 5, 2025Exhibit G057 WO2021159130A2-
Mar 5, 2025Exhibit G056 Richner-
Mar 5, 2025Exhibit G055 Bahl-
Mar 5, 2025Exhibit G054 Espeseth-
Mar 5, 2025Exhibit G053 John-
Mar 5, 2025Exhibit G052 Peer Review Corbett Nature-
Mar 5, 2025Exhibit G051 Hassett-
Mar 5, 2025Exhibit G050 Ema Assessment Report Spikevax-
Mar 5, 2025Exhibit G049 Epo Ar1 To Ar13-
Mar 5, 2025Exhibit G048 Ar13 Redlined-
Mar 5, 2025Exhibit G047 Mr Redlined-
Mar 5, 2025Exhibit G046 Mitchell Report-
Mar 5, 2025Exhibit G045 Petitioners Hearing Slides Slide 27-
Mar 5, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73-
Mar 5, 2025Exhibit G043 D44 Declaration Heyes-
Mar 5, 2025Exhibit G042 D43 Declaration Heyes-
Mar 5, 2025Exhibit G041 Modernas Goa Of 22 November-
Mar 5, 2025Exhibit G040 Arbutuss Goa Of 25 November-
Mar 5, 2025Exhibit G039 Main Request-
Mar 5, 2025Exhibit G038 US2006 0240554 (D25)-
Mar 5, 2025Exhibit G037 Auxiliary Request 13-
Mar 5, 2025Exhibit G036 Od Decision-
Mar 5, 2025Exhibit G035 T 0505 20-
Mar 5, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October-
Mar 5, 2025Exhibit G033 Od Decision-
Mar 5, 2025Exhibit G032 US20080020058(Chen)-
Mar 5, 2025Exhibit G031 Amended Claim With Annotations 13 September-
Mar 5, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May-
Mar 5, 2025Exhibit G029 Extended European Search Report 12 October-
Mar 5, 2025Exhibit G028 Amendments Received Before Examination 30 December-
Mar 5, 2025Exhibit G027 Withdrawal Of The Op Out-
Mar 5, 2025Exhibit G026 US20080045228P Priority Document-
Mar 5, 2025Exhibit G025 WO2009127060A1 Original Application-
Mar 5, 2025Exhibit G024 Samaridou-
Mar 5, 2025Exhibit G023 Genevant Press Release-
Mar 5, 2025Exhibit G022 Federal Circuit Opinion (435)-
Mar 5, 2025Exhibit G021 Federal Circuit Opinion (069)-
Mar 5, 2025Exhibit G020 Ipr Final Written Decision (435)-
Mar 5, 2025Exhibit G019 Ipr Final Written Decision (069)-
Mar 5, 2025Exhibit G018 US9364435-
Mar 5, 2025Exhibit G017 US8058069-
Mar 5, 2025Exhibit G016 Moore Harvard Business School-
Mar 5, 2025Exhibit G015 Moderna Nih Preprint-
Mar 5, 2025Exhibit G014 CR OSS Cen News-
Mar 5, 2025Exhibit G013 Regalado Mit Technology-
Mar 5, 2025Exhibit G012 Corbett Nature Review-
Mar 5, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration-
Mar 5, 2025Exhibit G010 Suzuki-
Mar 5, 2025Exhibit G009 Semple-
Mar 5, 2025Exhibit G008 Zimmerman-
Mar 5, 2025Exhibit G007 Spikevax Smpc-
Mar 5, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 5, 2025Exhibit G005 Genevant Sciences Trade Register-
Mar 5, 2025Exhibit G004 Proof Of Payment Court Fees-
Mar 5, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus-
Mar 5, 2025Exhibit G002 Patent Register Excerpts-
Mar 5, 2025Exhibit G001 EP2279254B1-
Mar 5, 2025Exhibit C Qualification Report-
Mar 5, 2025Exhibit B Cv Katharina Edenharter-
Mar 5, 2025Exhibit A Cv Thomas Lassak-
Mar 4, 2025Formal Checks Request For Correction-
Mar 3, 2025Statement Of Claim EP254 Signed-
Mar 3, 2025Raw Data Uv-
Mar 3, 2025Raw Data Lc Cad Sample C3-
Mar 3, 2025Raw Data Lc Cad Sample C2-
Mar 3, 2025Raw Data Lc Cad Sample C1-
Mar 3, 2025Raw Data Dls-
Mar 3, 2025Exhibit M.04 United States Pharmacopeia-
Mar 3, 2025Exhibit M.03 Semple-
Mar 3, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture-
Mar 3, 2025Exhibit M.01 Samaridou-
Mar 3, 2025Exhibit G113 Moderna Inc Annual Report Selection-
Mar 3, 2025Exhibit G112 Moderna Annual Report P. 119-
Mar 3, 2025Exhibit G111 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit G110 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit G109 Moderna Rovi Press Release-
Mar 3, 2025Exhibit G108 Moderna Rovi Press Release-
Mar 3, 2025Exhibit G107 Lonza Press Release-
Mar 3, 2025Exhibit G106 Moderna Press Release Lonza Nl-
Mar 3, 2025Exhibit G105 Moderna Ch Service Agreement Tr-
Mar 3, 2025Exhibit G104 Moderna Lonza Press Release-
Mar 3, 2025Exhibit G103 Moderna Portugal Trade Register-
Mar 3, 2025Exhibit G102 Moderna Norway Trade Register-
Mar 3, 2025Exhibit G101 Moderna Sweden Trade Register-
Mar 3, 2025Exhibit G100 Moderna Denmark Trade Register-
Mar 3, 2025Exhibit G099 Moderna Belgium Trade Register-
Mar 3, 2025Exhibit G098 Moderna Italy Trade Register-
Mar 3, 2025Exhibit G097 Moderna France Trade Register-
Mar 3, 2025Exhibit G096 Moderna Germany Trade Register-
Mar 3, 2025Exhibit G095 Moderna Uk Annual Report-
Mar 3, 2025Exhibit G094 Moderna Uk Trade Register-
Mar 3, 2025Exhibit G093 Moderna Poland Trade Register-
Mar 3, 2025Exhibit G092 Moderna Netherlands Madrid-
Mar 3, 2025Exhibit G091 Moderna Es Trade Register-
Mar 3, 2025Exhibit G090 Mresvia Lauer Taxe Germany-
Mar 3, 2025Exhibit G089 Spikevax Lauer Taxe Germany-
Mar 3, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl-
Mar 3, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl-
Mar 3, 2025Exhibit G086 Moderna Nl Hungary Contract-
Mar 3, 2025Exhibit G085 Moderna Nl Hungary Contract Hun-
Mar 3, 2025Exhibit G084 Moderna Nl Annual Report-
Mar 3, 2025Exhibit G083 Moderna Nl Trade Register-
Mar 3, 2025Exhibit G082 Ec Draft Framework Contract-
Mar 3, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 3, 2025Exhibit G080 Moderna Press Release Tender-
Mar 3, 2025Exhibit G079 Ec Press Release Tender-
Mar 3, 2025Exhibit G078 Ex Pa Ec Moderna Ch-
Mar 3, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61-
Mar 3, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60-
Mar 3, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53-
Mar 3, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44-
Mar 3, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35-
Mar 3, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26-
Mar 3, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17-
Mar 3, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8-
Mar 3, 2025Exhibit G076 Moderna Switzerland Trade Register-
Mar 3, 2025Exhibit G075 Modernacovid19Global Website-
Mar 3, 2025Exhibit G074 Modernatx Website-
Mar 3, 2025Exhibit G073 Domain Registrations Moderna-
Mar 3, 2025Exhibit G072 Modernatx Trade Register Excerpt-
Mar 3, 2025Exhibit G071 Moderna Inc Press Release-
Mar 3, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1-
Mar 3, 2025Exhibit G069 Moderna Inc Trade Register Excerpt-
Mar 3, 2025Exhibit G068 Coriolis Report-
Mar 3, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection-
Mar 3, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92-
Mar 3, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 3, 2025Exhibit G064 Ema Assesment Report Mresvia-
Mar 3, 2025Exhibit G063 Moderna Press Release 23 August-
Mar 3, 2025Exhibit G062 Mresvia Smpc-
Mar 3, 2025Exhibit G061 Mitchell Report Table Of Content-
Mar 3, 2025Exhibit G060 Coriolis Report Table Of Content-
Mar 3, 2025Exhibit G059 WO2022197624A1-
Mar 3, 2025Exhibit G058 WO2021222304A1-
Mar 3, 2025Exhibit G057 WO2021159130A2-
Mar 3, 2025Exhibit G056 Richner-
Mar 3, 2025Exhibit G055 Bahl-
Mar 3, 2025Exhibit G054 Espeseth-
Mar 3, 2025Exhibit G053 John-
Mar 3, 2025Exhibit G052 Peer Review Corbett Nature-
Mar 3, 2025Exhibit G051 Hassett-
Mar 3, 2025Exhibit G050 Ema Assessment Report Spikevax-
Mar 3, 2025Exhibit G049 Epo Ar1 To Ar13-
Mar 3, 2025Exhibit G048 Ar13 Redlined-
Mar 3, 2025Exhibit G047 Mr Redlined-
Mar 3, 2025Exhibit G046 Mitchell Report-
Mar 3, 2025Exhibit G045 Petitioners Hearing Slides Slide 27-
Mar 3, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73-
Mar 3, 2025Exhibit G043 D44 Declaration Heyes-
Mar 3, 2025Exhibit G042 D43 Declaration Heyes-
Mar 3, 2025Exhibit G041 Modernas Goa Of 22 November-
Mar 3, 2025Exhibit G040 Arbutuss Goa Of 25 November-
Mar 3, 2025Exhibit G039 Main Request-
Mar 3, 2025Exhibit G038 US2006 0240554 (D25)-
Mar 3, 2025Exhibit G037 Auxiliary Request 13-
Mar 3, 2025Exhibit G036 Od Decision-
Mar 3, 2025Exhibit G035 T 0505 20-
Mar 3, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October-
Mar 3, 2025Exhibit G033 Od Decision-
Mar 3, 2025Exhibit G032 US20080020058(Chen)-
Mar 3, 2025Exhibit G031 Amended Claim With Annotations 13 September-
Mar 3, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May-
Mar 3, 2025Exhibit G029 Extended European Search Report 12 October-
Mar 3, 2025Exhibit G028 Amendments Received Before Examination 30 December-
Mar 3, 2025Exhibit G027 Withdrawal Of The Op Out-
Mar 3, 2025Exhibit G026 US20080045228P Priority Document-
Mar 3, 2025Exhibit G025 WO2009127060A1 Original Application-
Mar 3, 2025Exhibit G024 Samaridou-
Mar 3, 2025Exhibit G023 Genevant Press Release-
Mar 3, 2025Exhibit G022 Federal Circuit Opinion (435)-
Mar 3, 2025Exhibit G021 Federal Circuit Opinion (069)-
Mar 3, 2025Exhibit G020 Ipr Final Written Decision (435)-
Mar 3, 2025Exhibit G019 Ipr Final Written Decision (069)-
Mar 3, 2025Exhibit G018 US9364435-
Mar 3, 2025Exhibit G017 US8058069-
Mar 3, 2025Exhibit G016 Moore Harvard Business School-
Mar 3, 2025Exhibit G015 Moderna Nih Preprint-
Mar 3, 2025Exhibit G014 CR OSS Cen News-
Mar 3, 2025Exhibit G013 Regalado Mit Technology-
Mar 3, 2025Exhibit G012 Corbett Nature Review-
Mar 3, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration-
Mar 3, 2025Exhibit G010 Suzuki-
Mar 3, 2025Exhibit G009 Semple-
Mar 3, 2025Exhibit G008 Zimmerman-
Mar 3, 2025Exhibit G007 Spikevax Smpc-
Mar 3, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 3, 2025Exhibit G005 Genevant Sciences Trade Register-
Mar 3, 2025Exhibit G004 Proof Of Payment Court Fees-
Mar 3, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus-
Mar 3, 2025Exhibit G002 Patent Register Excerpts-
Mar 3, 2025Exhibit G001 EP2279254B1-
Mar 3, 2025Exhibit C Qualification Report-
Mar 3, 2025Exhibit B Cv Katharina Edenharter-
Mar 3, 2025Exhibit A Cv Thomas Lassak-
Mar 3, 2025EP254Soc Da-
Mar 3, 2025Acknowledgement Of Lodging-
Oct 3, 2025Receipt-
Oct 3, 2025Exhibit-
Oct 3, 2025Cover Sheet-
Oct 3, 2025Application-
Sep 24, 2025Statement Of Reply-
Sep 24, 2025Receipt-
Sep 24, 2025Exhibit-
Sep 24, 2025Cover Sheet-
Sep 14, 2025Rejoinder On Request To Produce Evidence-
Sep 12, 2025Uploaded For Technical Reasons Only To Close Workflow
Sep 12, 2025Upc Genevant Arbutus Reply R 190 Request Signed-
Sep 12, 2025Outcome Of The Order-
Sep 12, 2025Opportunity To Comment-
Sep 2, 2025Receipt-
Sep 2, 2025Moderna R.9 Rop In Response To R.190 Rop Application-
Aug 28, 2025Receipt-
Aug 27, 202525 08 27 Ep 254 Further Comment On Request To Produce Evidence Moderna Vs Genevant-
Aug 26, 2025Reply Re R190 Request-
Aug 26, 2025Exhibit G126-
Aug 18, 2025Panel Appointment-
Aug 18, 2025Opportunity To Comment-
Aug 15, 2025R.37.2 Order
Aug 14, 2025Response To Request To Produce Evidence (Rule 190 Rop)-
Aug 14, 2025Exhibit Fs18 DI 457 Letter May-
Aug 14, 2025Exhibit Fs17 Protective Order-
Aug 13, 2025Joint Statement Regarding Bifurcation-
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop-
Aug 8, 2025Response To Deadline Extension Request-
Aug 6, 2025R.37-
Aug 6, 2025R
Aug 6, 2025Hearing Dates-
Aug 5, 2025Redacted Final Order Re R.262A Applications-
Aug 4, 2025R.262A Order-
Aug 4, 2025Outcome Of The Order-
Aug 4, 2025Opportunity To Comment-
Aug 1, 2025Request For Extension Of Deadlines-
Aug 1, 2025Receipt-
Aug 1, 2025Exhibit G125-
Aug 1, 2025Exhibit G124-
Aug 1, 2025Exhibit G123-
Aug 1, 2025Application For An Order To Produce Evidence-
Jul 28, 2025R.262A Reply-
Jul 28, 2025Exhibit G122-
Jul 25, 2025Receipt-
Jul 24, 2025R.262A Reply-
Jul 24, 2025Exhibit G122-
Jul 23, 2025Reference To Response Of Genevant-
Jul 23, 2025R.262.2 Application-
Jul 23, 2025Exhibit G121 Confidential-
Jul 23, 2025Exhibit G120-
Jul 23, 2025Exhibit G119-
Jul 23, 2025Confidential Response To Security-
Jul 11, 2025Formal Checks Notification Of Positive Outcome-
Jul 11, 2025Acknowledgement Of Lodging-
Jul 10, 2025Set Of Exhibits Fbd T 09 Confidential-
Jul 10, 2025Set Of Exhibits Fbd 11-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 5 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 4 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 3 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 2 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 1 Of 5-
Jul 10, 2025Opportunity To Comment-
Jul 10, 2025Formal Checks Request For Correction-
Jul 10, 2025Exhibit Fbd T 19-
Jul 10, 2025Exhibit Fbd T 18-
Jul 10, 2025Exhibit Fbd T 17-
Jul 10, 2025Exhibit Fbd T 16-
Jul 10, 2025Exhibit Fbd T 15-
Jul 10, 2025Exhibit Fbd T 14-
Jul 10, 2025Exhibit Fbd T 13-
Jul 10, 2025Exhibit Fbd T 12-
Jul 10, 2025Exhibit Fbd T 11-
Jul 10, 2025Exhibit Fbd T 10-
Jul 10, 2025Exhibit Fbd T 09A Confidential-
Jul 10, 2025Exhibit Fbd T 08-
Jul 10, 2025Exhibit Fbd T 07-
Jul 10, 2025Exhibit Fbd T 06-
Jul 10, 2025Exhibit Fbd T 05-
Jul 10, 2025Exhibit Fbd T 04-
Jul 10, 2025Exhibit Fbd T 03A-
Jul 10, 2025Exhibit Fbd T 03-
Jul 10, 2025Exhibit Fbd T 02-
Jul 10, 2025Exhibit Fbd T 01-
Jul 10, 2025Exhibit Fbd 16-
Jul 10, 2025Exhibit Fbd 15-
Jul 10, 2025Exhibit Fbd 14-
Jul 10, 2025Exhibit Fbd 13-
Jul 10, 2025Exhibit Fbd 12 Confidential-
Jul 10, 2025Exhibit Fbd 11A-
Jul 10, 2025Exhibit Fbd 09-
Jul 10, 2025Exhibit Fbd 08-
Jul 10, 2025Exhibit Fbd 07-
Jul 10, 2025Exhibit Fbd 06-
Jul 10, 2025Annex 7 To Exhibit Fbd T 4-
Jul 10, 2025Annex 6 To Exhibit Fbd T 4-
Jul 10, 2025Annex 5 To Exhibit Fbd T 4-
Jul 10, 2025Annex 4 To Exhibit Fbd T 4-
Jul 10, 2025Annex 3 To Exhibit Fbd T 4-
Jul 10, 2025Annex 2 To Exhibit Fbd T 4-
Jul 10, 2025Annex 1 To Exhibit Fbd T 4-
Jul 10, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025 V2-
Jul 9, 2025Set Of Exhibits Fbd T 09 Confidential-
Jul 9, 2025Set Of Exhibits Fbd 11-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 5 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 4 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 3 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 2 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 1 Of 5-
Jul 9, 2025Receipt-
Jul 9, 2025Opportunity To Comment-
Jul 9, 2025Exhibit Fbd T 19-
Jul 9, 2025Exhibit Fbd T 18-
Jul 9, 2025Exhibit Fbd T 17-
Jul 9, 2025Exhibit Fbd T 16-
Jul 9, 2025Exhibit Fbd T 15-
Jul 9, 2025Exhibit Fbd T 14-
Jul 9, 2025Exhibit Fbd T 13-
Jul 9, 2025Exhibit Fbd T 12-
Jul 9, 2025Exhibit Fbd T 11-
Jul 9, 2025Exhibit Fbd T 10-
Jul 9, 2025Exhibit Fbd T 09A Confidential-
Jul 9, 2025Exhibit Fbd T 08-
Jul 9, 2025Exhibit Fbd T 07-
Jul 9, 2025Exhibit Fbd T 06-
Jul 9, 2025Exhibit Fbd T 05-
Jul 9, 2025Exhibit Fbd T 04-
Jul 9, 2025Exhibit Fbd T 03A-
Jul 9, 2025Exhibit Fbd T 03-
Jul 9, 2025Exhibit Fbd T 02-
Jul 9, 2025Exhibit Fbd T 01-
Jul 9, 2025Exhibit Fbd 16-
Jul 9, 2025Exhibit Fbd 15-
Jul 9, 2025Exhibit Fbd 14-
Jul 9, 2025Exhibit Fbd 13-
Jul 9, 2025Exhibit Fbd 12 Confidential-
Jul 9, 2025Exhibit Fbd 11A-
Jul 9, 2025Exhibit Fbd 09-
Jul 9, 2025Exhibit Fbd 08-
Jul 9, 2025Exhibit Fbd 07-
Jul 9, 2025Exhibit Fbd 06-
Jul 9, 2025EP254 Moderna Reference To Statement Of Defence And Counterclaim For Revocation-
Jul 9, 2025Annex 7 To Exhibit Fbd T 4-
Jul 9, 2025Annex 6 To Exhibit Fbd T 4-
Jul 9, 2025Annex 5 To Exhibit Fbd T 4-
Jul 9, 2025Annex 4 To Exhibit Fbd T 4-
Jul 9, 2025Annex 3 To Exhibit Fbd T 4-
Jul 9, 2025Annex 2 To Exhibit Fbd T 4-
Jul 9, 2025Annex 1 To Exhibit Fbd T 4-
Jul 9, 2025Acknowledgement Of Lodging-
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Request Security Pursuant To R158 No 32591 2025-
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Confidentiality Request-
Jul 9, 202507 08 Upc1 EP254 Reference To Statement Of Defence For Other Defendants(307430487.1)-
Jul 9, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025-
Jun 19, 2025Response To Request For Review-
Jun 12, 2025Outcome Of The Order-
Jun 12, 2025Opportunity To Comment
Jun 11, 2025Acknowledgement Of Lodging-
Jun 6, 2025Exhibit Fbd 5-
Jun 6, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 27016 2025-
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order-
Jun 4, 2025Headnote And Keywords-
Jun 2, 2025Response To Request For Rectification-
May 28, 2025Opportunity To Comment-
May 27, 2025Receipt-
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025-
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome-
May 7, 2025Exhibit G118 Notice European Tender-
May 7, 2025Exhibit G117 Certificate Amalgamation-
May 7, 2025Exhibit G116 Opt Out Confirmation-
May 7, 2025Exhibit G115 Opt Out-
May 7, 2025Comment On Preliminary Objection-
May 7, 2025Comment On Preliminary Objection-
May 6, 2025Notification Of Service-
May 6, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Norway As-
May 5, 2025Acknowledgement Of Access To Case-
May 1, 2025Notification Of Service-
May 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Switzerland Gmbh-
Apr 25, 2025Preliminary Objection-
Apr 25, 2025Notification Of Service-
Apr 25, 2025Exhibit Fbd 4 Moderna Pl-
Apr 25, 2025Exhibit Fbd 3 Dutch Patent Register-
Apr 25, 2025Exhibit Fbd 2 National Registers-
Apr 25, 2025Act 10280 Upc Cfi 191 Confirmation Of Service-
Apr 25, 202525 04 24 EP254 Preliminary Objection Moderna VS Genevant Signed-
Apr 23, 2025Preliminary Objection-
Apr 22, 2025Preliminary Objection Moderna Uk Moderna VS Genevant (EP254) Signed-
Apr 22, 2025Notification Of Service-
Apr 22, 2025Exhibit Fbd 3 Dutch Patent Register-
Apr 22, 2025Exhibit Fbd 2 National Registers-
Apr 22, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Inc.-
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order-
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Response To Letter Brinkhof D.D17 April-
Apr 17, 2025Receipt-
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc-
Apr 17, 2025Outcome Of The Order-
Apr 17, 2025Headnote And Keywords-
Apr 17, 2025Exhibit G114 Letter Re Representation Mll Of Moderna Inc Modernatx Inc-
Apr 15, 2025Receipt-
Apr 15, 2025Notification Of Service-
Apr 15, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Sweden Ab-
Apr 15, 202525 04 15 EP254 Response Re Deadline Extension-
Apr 14, 2025Receipt-
Apr 14, 2025R 9 Aplication Reply To R 9 Request-
Apr 10, 2025Template Order-
Apr 10, 2025Opportunity To Comment-
Apr 9, 2025Receipt-
Apr 9, 2025Opportunity To Comment-
Apr 9, 2025Exhibit Fbd 1-
Apr 9, 202525 04 09 EP254 Request For Deadline Extension Moderna VS Genevant Arbutus Cfi 191 2025 Act 10280 2025-
Apr 1, 2025Notification Of Service-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Netherlands B.V.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Italy S.R.L.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Germany Gmbh-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna France Sasu-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Denmark Aps-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Uk Limited-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Spain Sl-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Belgium S.R.L.-
Mar 31, 2025Acknowledgement Of Access To Case-
Mar 28, 2025Acknowledgement Of Access To Case-
Mar 24, 2025Acknowledgement Of Access To Case-
Mar 17, 2025Panel Appointment-
Mar 13, 2025Letter For Service-
Mar 11, 2025Document From Epo-
Mar 6, 2025Receipt-
Mar 6, 2025Panel Appointment-
Mar 6, 2025Formal Checks Notification Of Positive Outcome-
Mar 6, 2025Epo Request For Case Pending-
Mar 5, 2025Statement Of Claim EP254 Signed-
Mar 5, 2025Statement Of Claim EP254Da-
Mar 5, 2025Raw Data Uv-
Mar 5, 2025Raw Data Lc Cad Sample C3-
Mar 5, 2025Raw Data Lc Cad Sample C2-
Mar 5, 2025Raw Data Lc Cad Sample C1-
Mar 5, 2025Raw Data Dls-
Mar 5, 2025Exhibit M.04 United States Pharmacopeia-
Mar 5, 2025Exhibit M.03 Semple-
Mar 5, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture-
Mar 5, 2025Exhibit M.01 Samaridou-
Mar 5, 2025Exhibit G113 Moderna Inc Annual Report Selection-
Mar 5, 2025Exhibit G112 Moderna Annual Report P. 119-
Mar 5, 2025Exhibit G111 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit G110 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit G109 Moderna Rovi Press Release-
Mar 5, 2025Exhibit G108 Moderna Rovi Press Release-
Mar 5, 2025Exhibit G107 Lonza Press Release-
Mar 5, 2025Exhibit G106 Moderna Press Release Lonza Nl-
Mar 5, 2025Exhibit G105 Moderna Ch Service Agreement Tr-
Mar 5, 2025Exhibit G104 Moderna Lonza Press Release-
Mar 5, 2025Exhibit G103 Moderna Portugal Trade Register-
Mar 5, 2025Exhibit G102 Moderna Norway Trade Register-
Mar 5, 2025Exhibit G101 Moderna Sweden Trade Register-
Mar 5, 2025Exhibit G100 Moderna Denmark Trade Register-
Mar 5, 2025Exhibit G099 Moderna Belgium Trade Register-
Mar 5, 2025Exhibit G098 Moderna Italy Trade Register-
Mar 5, 2025Exhibit G097 Moderna France Trade Register-
Mar 5, 2025Exhibit G096 Moderna Germany Trade Register-
Mar 5, 2025Exhibit G095 Moderna Uk Annual Report-
Mar 5, 2025Exhibit G094 Moderna Uk Trade Register-
Mar 5, 2025Exhibit G093 Moderna Poland Trade Register-
Mar 5, 2025Exhibit G092 Moderna Netherlands Madrid-
Mar 5, 2025Exhibit G091 Moderna Es Trade Register-
Mar 5, 2025Exhibit G090 Mresvia Lauer Taxe Germany-
Mar 5, 2025Exhibit G089 Spikevax Lauer Taxe Germany-
Mar 5, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl-
Mar 5, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl-
Mar 5, 2025Exhibit G086 Moderna Nl Hungary Contract-
Mar 5, 2025Exhibit G085 Moderna Nl Hungary Contract Hun-
Mar 5, 2025Exhibit G084 Moderna Nl Annual Report-
Mar 5, 2025Exhibit G083 Moderna Nl Trade Register-
Mar 5, 2025Exhibit G082 Ec Draft Framework Contract-
Mar 5, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 5, 2025Exhibit G080 Moderna Press Release Tender-
Mar 5, 2025Exhibit G079 Ec Press Release Tender-
Mar 5, 2025Exhibit G078 Ex Pa Ec Moderna Ch-
Mar 5, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61-
Mar 5, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60-
Mar 5, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53-
Mar 5, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44-
Mar 5, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35-
Mar 5, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26-
Mar 5, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17-
Mar 5, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8-
Mar 5, 2025Exhibit G076 Moderna Switzerland Trade Register-
Mar 5, 2025Exhibit G075 Modernacovid19Global Website-
Mar 5, 2025Exhibit G074 Modernatx Website-
Mar 5, 2025Exhibit G073 Domain Registrations Moderna-
Mar 5, 2025Exhibit G072 Modernatx Trade Register Excerpt-
Mar 5, 2025Exhibit G071 Moderna Inc Press Release-
Mar 5, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1-
Mar 5, 2025Exhibit G069 Moderna Inc Trade Register Excerpt-
Mar 5, 2025Exhibit G068 Coriolis Report-
Mar 5, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection-
Mar 5, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92-
Mar 5, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 5, 2025Exhibit G064 Ema Assesment Report Mresvia-
Mar 5, 2025Exhibit G063 Moderna Press Release 23 August-
Mar 5, 2025Exhibit G062 Mresvia Smpc-
Mar 5, 2025Exhibit G061 Mitchell Report Table Of Content-
Mar 5, 2025Exhibit G060 Coriolis Report Table Of Content-
Mar 5, 2025Exhibit G059 WO2022197624A1-
Mar 5, 2025Exhibit G058 WO2021222304A1-
Mar 5, 2025Exhibit G057 WO2021159130A2-
Mar 5, 2025Exhibit G056 Richner-
Mar 5, 2025Exhibit G055 Bahl-
Mar 5, 2025Exhibit G054 Espeseth-
Mar 5, 2025Exhibit G053 John-
Mar 5, 2025Exhibit G052 Peer Review Corbett Nature-
Mar 5, 2025Exhibit G051 Hassett-
Mar 5, 2025Exhibit G050 Ema Assessment Report Spikevax-
Mar 5, 2025Exhibit G049 Epo Ar1 To Ar13-
Mar 5, 2025Exhibit G048 Ar13 Redlined-
Mar 5, 2025Exhibit G047 Mr Redlined-
Mar 5, 2025Exhibit G046 Mitchell Report-
Mar 5, 2025Exhibit G045 Petitioners Hearing Slides Slide 27-
Mar 5, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73-
Mar 5, 2025Exhibit G043 D44 Declaration Heyes-
Mar 5, 2025Exhibit G042 D43 Declaration Heyes-
Mar 5, 2025Exhibit G041 Modernas Goa Of 22 November-
Mar 5, 2025Exhibit G040 Arbutuss Goa Of 25 November-
Mar 5, 2025Exhibit G039 Main Request-
Mar 5, 2025Exhibit G038 US2006 0240554 (D25)-
Mar 5, 2025Exhibit G037 Auxiliary Request 13-
Mar 5, 2025Exhibit G036 Od Decision-
Mar 5, 2025Exhibit G035 T 0505 20-
Mar 5, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October-
Mar 5, 2025Exhibit G033 Od Decision-
Mar 5, 2025Exhibit G032 US20080020058(Chen)-
Mar 5, 2025Exhibit G031 Amended Claim With Annotations 13 September-
Mar 5, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May-
Mar 5, 2025Exhibit G029 Extended European Search Report 12 October-
Mar 5, 2025Exhibit G028 Amendments Received Before Examination 30 December-
Mar 5, 2025Exhibit G027 Withdrawal Of The Op Out-
Mar 5, 2025Exhibit G026 US20080045228P Priority Document-
Mar 5, 2025Exhibit G025 WO2009127060A1 Original Application-
Mar 5, 2025Exhibit G024 Samaridou-
Mar 5, 2025Exhibit G023 Genevant Press Release-
Mar 5, 2025Exhibit G022 Federal Circuit Opinion (435)-
Mar 5, 2025Exhibit G021 Federal Circuit Opinion (069)-
Mar 5, 2025Exhibit G020 Ipr Final Written Decision (435)-
Mar 5, 2025Exhibit G019 Ipr Final Written Decision (069)-
Mar 5, 2025Exhibit G018 US9364435-
Mar 5, 2025Exhibit G017 US8058069-
Mar 5, 2025Exhibit G016 Moore Harvard Business School-
Mar 5, 2025Exhibit G015 Moderna Nih Preprint-
Mar 5, 2025Exhibit G014 CR OSS Cen News-
Mar 5, 2025Exhibit G013 Regalado Mit Technology-
Mar 5, 2025Exhibit G012 Corbett Nature Review-
Mar 5, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration-
Mar 5, 2025Exhibit G010 Suzuki-
Mar 5, 2025Exhibit G009 Semple-
Mar 5, 2025Exhibit G008 Zimmerman-
Mar 5, 2025Exhibit G007 Spikevax Smpc-
Mar 5, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 5, 2025Exhibit G005 Genevant Sciences Trade Register-
Mar 5, 2025Exhibit G004 Proof Of Payment Court Fees-
Mar 5, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus-
Mar 5, 2025Exhibit G002 Patent Register Excerpts-
Mar 5, 2025Exhibit G001 EP2279254B1-
Mar 5, 2025Exhibit C Qualification Report-
Mar 5, 2025Exhibit B Cv Katharina Edenharter-
Mar 5, 2025Exhibit A Cv Thomas Lassak-
Mar 4, 2025Formal Checks Request For Correction-
Mar 3, 2025Statement Of Claim EP254 Signed-
Mar 3, 2025Raw Data Uv-
Mar 3, 2025Raw Data Lc Cad Sample C3-
Mar 3, 2025Raw Data Lc Cad Sample C2-
Mar 3, 2025Raw Data Lc Cad Sample C1-
Mar 3, 2025Raw Data Dls-
Mar 3, 2025Exhibit M.04 United States Pharmacopeia-
Mar 3, 2025Exhibit M.03 Semple-
Mar 3, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture-
Mar 3, 2025Exhibit M.01 Samaridou-
Mar 3, 2025Exhibit G113 Moderna Inc Annual Report Selection-
Mar 3, 2025Exhibit G112 Moderna Annual Report P. 119-
Mar 3, 2025Exhibit G111 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit G110 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit G109 Moderna Rovi Press Release-
Mar 3, 2025Exhibit G108 Moderna Rovi Press Release-
Mar 3, 2025Exhibit G107 Lonza Press Release-
Mar 3, 2025Exhibit G106 Moderna Press Release Lonza Nl-
Mar 3, 2025Exhibit G105 Moderna Ch Service Agreement Tr-
Mar 3, 2025Exhibit G104 Moderna Lonza Press Release-
Mar 3, 2025Exhibit G103 Moderna Portugal Trade Register-
Mar 3, 2025Exhibit G102 Moderna Norway Trade Register-
Mar 3, 2025Exhibit G101 Moderna Sweden Trade Register-
Mar 3, 2025Exhibit G100 Moderna Denmark Trade Register-
Mar 3, 2025Exhibit G099 Moderna Belgium Trade Register-
Mar 3, 2025Exhibit G098 Moderna Italy Trade Register-
Mar 3, 2025Exhibit G097 Moderna France Trade Register-
Mar 3, 2025Exhibit G096 Moderna Germany Trade Register-
Mar 3, 2025Exhibit G095 Moderna Uk Annual Report-
Mar 3, 2025Exhibit G094 Moderna Uk Trade Register-
Mar 3, 2025Exhibit G093 Moderna Poland Trade Register-
Mar 3, 2025Exhibit G092 Moderna Netherlands Madrid-
Mar 3, 2025Exhibit G091 Moderna Es Trade Register-
Mar 3, 2025Exhibit G090 Mresvia Lauer Taxe Germany-
Mar 3, 2025Exhibit G089 Spikevax Lauer Taxe Germany-
Mar 3, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl-
Mar 3, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl-
Mar 3, 2025Exhibit G086 Moderna Nl Hungary Contract-
Mar 3, 2025Exhibit G085 Moderna Nl Hungary Contract Hun-
Mar 3, 2025Exhibit G084 Moderna Nl Annual Report-
Mar 3, 2025Exhibit G083 Moderna Nl Trade Register-
Mar 3, 2025Exhibit G082 Ec Draft Framework Contract-
Mar 3, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 3, 2025Exhibit G080 Moderna Press Release Tender-
Mar 3, 2025Exhibit G079 Ec Press Release Tender-
Mar 3, 2025Exhibit G078 Ex Pa Ec Moderna Ch-
Mar 3, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61-
Mar 3, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60-
Mar 3, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53-
Mar 3, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44-
Mar 3, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35-
Mar 3, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26-
Mar 3, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17-
Mar 3, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8-
Mar 3, 2025Exhibit G076 Moderna Switzerland Trade Register-
Mar 3, 2025Exhibit G075 Modernacovid19Global Website-
Mar 3, 2025Exhibit G074 Modernatx Website-
Mar 3, 2025Exhibit G073 Domain Registrations Moderna-
Mar 3, 2025Exhibit G072 Modernatx Trade Register Excerpt-
Mar 3, 2025Exhibit G071 Moderna Inc Press Release-
Mar 3, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1-
Mar 3, 2025Exhibit G069 Moderna Inc Trade Register Excerpt-
Mar 3, 2025Exhibit G068 Coriolis Report-
Mar 3, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection-
Mar 3, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92-
Mar 3, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 3, 2025Exhibit G064 Ema Assesment Report Mresvia-
Mar 3, 2025Exhibit G063 Moderna Press Release 23 August-
Mar 3, 2025Exhibit G062 Mresvia Smpc-
Mar 3, 2025Exhibit G061 Mitchell Report Table Of Content-
Mar 3, 2025Exhibit G060 Coriolis Report Table Of Content-
Mar 3, 2025Exhibit G059 WO2022197624A1-
Mar 3, 2025Exhibit G058 WO2021222304A1-
Mar 3, 2025Exhibit G057 WO2021159130A2-
Mar 3, 2025Exhibit G056 Richner-
Mar 3, 2025Exhibit G055 Bahl-
Mar 3, 2025Exhibit G054 Espeseth-
Mar 3, 2025Exhibit G053 John-
Mar 3, 2025Exhibit G052 Peer Review Corbett Nature-
Mar 3, 2025Exhibit G051 Hassett-
Mar 3, 2025Exhibit G050 Ema Assessment Report Spikevax-
Mar 3, 2025Exhibit G049 Epo Ar1 To Ar13-
Mar 3, 2025Exhibit G048 Ar13 Redlined-
Mar 3, 2025Exhibit G047 Mr Redlined-
Mar 3, 2025Exhibit G046 Mitchell Report-
Mar 3, 2025Exhibit G045 Petitioners Hearing Slides Slide 27-
Mar 3, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73-
Mar 3, 2025Exhibit G043 D44 Declaration Heyes-
Mar 3, 2025Exhibit G042 D43 Declaration Heyes-
Mar 3, 2025Exhibit G041 Modernas Goa Of 22 November-
Mar 3, 2025Exhibit G040 Arbutuss Goa Of 25 November-
Mar 3, 2025Exhibit G039 Main Request-
Mar 3, 2025Exhibit G038 US2006 0240554 (D25)-
Mar 3, 2025Exhibit G037 Auxiliary Request 13-
Mar 3, 2025Exhibit G036 Od Decision-
Mar 3, 2025Exhibit G035 T 0505 20-
Mar 3, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October-
Mar 3, 2025Exhibit G033 Od Decision-
Mar 3, 2025Exhibit G032 US20080020058(Chen)-
Mar 3, 2025Exhibit G031 Amended Claim With Annotations 13 September-
Mar 3, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May-
Mar 3, 2025Exhibit G029 Extended European Search Report 12 October-
Mar 3, 2025Exhibit G028 Amendments Received Before Examination 30 December-
Mar 3, 2025Exhibit G027 Withdrawal Of The Op Out-
Mar 3, 2025Exhibit G026 US20080045228P Priority Document-
Mar 3, 2025Exhibit G025 WO2009127060A1 Original Application-
Mar 3, 2025Exhibit G024 Samaridou-
Mar 3, 2025Exhibit G023 Genevant Press Release-
Mar 3, 2025Exhibit G022 Federal Circuit Opinion (435)-
Mar 3, 2025Exhibit G021 Federal Circuit Opinion (069)-
Mar 3, 2025Exhibit G020 Ipr Final Written Decision (435)-
Mar 3, 2025Exhibit G019 Ipr Final Written Decision (069)-
Mar 3, 2025Exhibit G018 US9364435-
Mar 3, 2025Exhibit G017 US8058069-
Mar 3, 2025Exhibit G016 Moore Harvard Business School-
Mar 3, 2025Exhibit G015 Moderna Nih Preprint-
Mar 3, 2025Exhibit G014 CR OSS Cen News-
Mar 3, 2025Exhibit G013 Regalado Mit Technology-
Mar 3, 2025Exhibit G012 Corbett Nature Review-
Mar 3, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration-
Mar 3, 2025Exhibit G010 Suzuki-
Mar 3, 2025Exhibit G009 Semple-
Mar 3, 2025Exhibit G008 Zimmerman-
Mar 3, 2025Exhibit G007 Spikevax Smpc-
Mar 3, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 3, 2025Exhibit G005 Genevant Sciences Trade Register-
Mar 3, 2025Exhibit G004 Proof Of Payment Court Fees-
Mar 3, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus-
Mar 3, 2025Exhibit G002 Patent Register Excerpts-
Mar 3, 2025Exhibit G001 EP2279254B1-
Mar 3, 2025Exhibit C Qualification Report-
Mar 3, 2025Exhibit B Cv Katharina Edenharter-
Mar 3, 2025Exhibit A Cv Thomas Lassak-
Mar 3, 2025EP254Soc Da-
Mar 3, 2025Acknowledgement Of Lodging-
Oct 3, 2025Receipt-
Oct 3, 2025Exhibit-
Oct 3, 2025Cover Sheet-
Oct 3, 2025Application-
Sep 24, 2025Statement Of Reply-
Sep 24, 2025Receipt-
Sep 24, 2025Exhibit-
Sep 24, 2025Cover Sheet-
Sep 14, 2025Rejoinder On Request To Produce Evidence-
Sep 12, 2025Uploaded For Technical Reasons Only To Close Workflow
Sep 12, 2025Upc Genevant Arbutus Reply R 190 Request Signed-
Sep 12, 2025Outcome Of The Order-
Sep 12, 2025Opportunity To Comment-
Sep 2, 2025Receipt-
Sep 2, 2025Moderna R.9 Rop In Response To R.190 Rop Application-
Aug 28, 2025Receipt-
Aug 27, 202525 08 27 Ep 254 Further Comment On Request To Produce Evidence Moderna Vs Genevant-
Aug 26, 2025Reply Re R190 Request-
Aug 26, 2025Exhibit G126-
Aug 18, 2025Panel Appointment-
Aug 18, 2025Opportunity To Comment-
Aug 15, 2025R.37.2 Order
Aug 14, 2025Response To Request To Produce Evidence (Rule 190 Rop)-
Aug 14, 2025Exhibit Fs18 DI 457 Letter May-
Aug 14, 2025Exhibit Fs17 Protective Order-
Aug 13, 2025Joint Statement Regarding Bifurcation-
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop-
Aug 8, 2025Response To Deadline Extension Request-
Aug 6, 2025R.37-
Aug 6, 2025R
Aug 6, 2025Hearing Dates-
Aug 5, 2025Redacted Final Order Re R.262A Applications-
Aug 4, 2025R.262A Order-
Aug 4, 2025Outcome Of The Order-
Aug 4, 2025Opportunity To Comment-
Aug 1, 2025Request For Extension Of Deadlines-
Aug 1, 2025Receipt-
Aug 1, 2025Exhibit G125-
Aug 1, 2025Exhibit G124-
Aug 1, 2025Exhibit G123-
Aug 1, 2025Application For An Order To Produce Evidence-
Jul 28, 2025R.262A Reply-
Jul 28, 2025Exhibit G122-
Jul 25, 2025Receipt-
Jul 24, 2025R.262A Reply-
Jul 24, 2025Exhibit G122-
Jul 23, 2025Reference To Response Of Genevant-
Jul 23, 2025R.262.2 Application-
Jul 23, 2025Exhibit G121 Confidential-
Jul 23, 2025Exhibit G120-
Jul 23, 2025Exhibit G119-
Jul 23, 2025Confidential Response To Security-
Jul 11, 2025Formal Checks Notification Of Positive Outcome-
Jul 11, 2025Acknowledgement Of Lodging-
Jul 10, 2025Set Of Exhibits Fbd T 09 Confidential-
Jul 10, 2025Set Of Exhibits Fbd 11-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 5 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 4 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 3 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 2 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 1 Of 5-
Jul 10, 2025Opportunity To Comment-
Jul 10, 2025Formal Checks Request For Correction-
Jul 10, 2025Exhibit Fbd T 19-
Jul 10, 2025Exhibit Fbd T 18-
Jul 10, 2025Exhibit Fbd T 17-
Jul 10, 2025Exhibit Fbd T 16-
Jul 10, 2025Exhibit Fbd T 15-
Jul 10, 2025Exhibit Fbd T 14-
Jul 10, 2025Exhibit Fbd T 13-
Jul 10, 2025Exhibit Fbd T 12-
Jul 10, 2025Exhibit Fbd T 11-
Jul 10, 2025Exhibit Fbd T 10-
Jul 10, 2025Exhibit Fbd T 09A Confidential-
Jul 10, 2025Exhibit Fbd T 08-
Jul 10, 2025Exhibit Fbd T 07-
Jul 10, 2025Exhibit Fbd T 06-
Jul 10, 2025Exhibit Fbd T 05-
Jul 10, 2025Exhibit Fbd T 04-
Jul 10, 2025Exhibit Fbd T 03A-
Jul 10, 2025Exhibit Fbd T 03-
Jul 10, 2025Exhibit Fbd T 02-
Jul 10, 2025Exhibit Fbd T 01-
Jul 10, 2025Exhibit Fbd 16-
Jul 10, 2025Exhibit Fbd 15-
Jul 10, 2025Exhibit Fbd 14-
Jul 10, 2025Exhibit Fbd 13-
Jul 10, 2025Exhibit Fbd 12 Confidential-
Jul 10, 2025Exhibit Fbd 11A-
Jul 10, 2025Exhibit Fbd 09-
Jul 10, 2025Exhibit Fbd 08-
Jul 10, 2025Exhibit Fbd 07-
Jul 10, 2025Exhibit Fbd 06-
Jul 10, 2025Annex 7 To Exhibit Fbd T 4-
Jul 10, 2025Annex 6 To Exhibit Fbd T 4-
Jul 10, 2025Annex 5 To Exhibit Fbd T 4-
Jul 10, 2025Annex 4 To Exhibit Fbd T 4-
Jul 10, 2025Annex 3 To Exhibit Fbd T 4-
Jul 10, 2025Annex 2 To Exhibit Fbd T 4-
Jul 10, 2025Annex 1 To Exhibit Fbd T 4-
Jul 10, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025 V2-
Jul 9, 2025Set Of Exhibits Fbd T 09 Confidential-
Jul 9, 2025Set Of Exhibits Fbd 11-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 5 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 4 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 3 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 2 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 1 Of 5-
Jul 9, 2025Receipt-
Jul 9, 2025Opportunity To Comment-
Jul 9, 2025Exhibit Fbd T 19-
Jul 9, 2025Exhibit Fbd T 18-
Jul 9, 2025Exhibit Fbd T 17-
Jul 9, 2025Exhibit Fbd T 16-
Jul 9, 2025Exhibit Fbd T 15-
Jul 9, 2025Exhibit Fbd T 14-
Jul 9, 2025Exhibit Fbd T 13-
Jul 9, 2025Exhibit Fbd T 12-
Jul 9, 2025Exhibit Fbd T 11-
Jul 9, 2025Exhibit Fbd T 10-
Jul 9, 2025Exhibit Fbd T 09A Confidential-
Jul 9, 2025Exhibit Fbd T 08-
Jul 9, 2025Exhibit Fbd T 07-
Jul 9, 2025Exhibit Fbd T 06-
Jul 9, 2025Exhibit Fbd T 05-
Jul 9, 2025Exhibit Fbd T 04-
Jul 9, 2025Exhibit Fbd T 03A-
Jul 9, 2025Exhibit Fbd T 03-
Jul 9, 2025Exhibit Fbd T 02-
Jul 9, 2025Exhibit Fbd T 01-
Jul 9, 2025Exhibit Fbd 16-
Jul 9, 2025Exhibit Fbd 15-
Jul 9, 2025Exhibit Fbd 14-
Jul 9, 2025Exhibit Fbd 13-
Jul 9, 2025Exhibit Fbd 12 Confidential-
Jul 9, 2025Exhibit Fbd 11A-
Jul 9, 2025Exhibit Fbd 09-
Jul 9, 2025Exhibit Fbd 08-
Jul 9, 2025Exhibit Fbd 07-
Jul 9, 2025Exhibit Fbd 06-
Jul 9, 2025EP254 Moderna Reference To Statement Of Defence And Counterclaim For Revocation-
Jul 9, 2025Annex 7 To Exhibit Fbd T 4-
Jul 9, 2025Annex 6 To Exhibit Fbd T 4-
Jul 9, 2025Annex 5 To Exhibit Fbd T 4-
Jul 9, 2025Annex 4 To Exhibit Fbd T 4-
Jul 9, 2025Annex 3 To Exhibit Fbd T 4-
Jul 9, 2025Annex 2 To Exhibit Fbd T 4-
Jul 9, 2025Annex 1 To Exhibit Fbd T 4-
Jul 9, 2025Acknowledgement Of Lodging-
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Request Security Pursuant To R158 No 32591 2025-
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Confidentiality Request-
Jul 9, 202507 08 Upc1 EP254 Reference To Statement Of Defence For Other Defendants(307430487.1)-
Jul 9, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025-
Jun 19, 2025Response To Request For Review-
Jun 12, 2025Outcome Of The Order-
Jun 12, 2025Opportunity To Comment
Jun 11, 2025Acknowledgement Of Lodging-
Jun 6, 2025Exhibit Fbd 5-
Jun 6, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 27016 2025-
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order-
Jun 4, 2025Headnote And Keywords-
Jun 2, 2025Response To Request For Rectification-
May 28, 2025Opportunity To Comment-
May 27, 2025Receipt-
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025-
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome-
May 7, 2025Exhibit G118 Notice European Tender-
May 7, 2025Exhibit G117 Certificate Amalgamation-
May 7, 2025Exhibit G116 Opt Out Confirmation-
May 7, 2025Exhibit G115 Opt Out-
May 7, 2025Comment On Preliminary Objection-
May 7, 2025Comment On Preliminary Objection-
May 6, 2025Notification Of Service-
May 6, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Norway As-
May 5, 2025Acknowledgement Of Access To Case-
May 1, 2025Notification Of Service-
May 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Switzerland Gmbh-
Apr 25, 2025Preliminary Objection-
Apr 25, 2025Notification Of Service-
Apr 25, 2025Exhibit Fbd 4 Moderna Pl-
Apr 25, 2025Exhibit Fbd 3 Dutch Patent Register-
Apr 25, 2025Exhibit Fbd 2 National Registers-
Apr 25, 2025Act 10280 Upc Cfi 191 Confirmation Of Service-
Apr 25, 202525 04 24 EP254 Preliminary Objection Moderna VS Genevant Signed-
Apr 23, 2025Preliminary Objection-
Apr 22, 2025Preliminary Objection Moderna Uk Moderna VS Genevant (EP254) Signed-
Apr 22, 2025Notification Of Service-
Apr 22, 2025Exhibit Fbd 3 Dutch Patent Register-
Apr 22, 2025Exhibit Fbd 2 National Registers-
Apr 22, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Inc.-
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order-
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Response To Letter Brinkhof D.D17 April-
Apr 17, 2025Receipt-
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc-
Apr 17, 2025Outcome Of The Order-
Apr 17, 2025Headnote And Keywords-
Apr 17, 2025Exhibit G114 Letter Re Representation Mll Of Moderna Inc Modernatx Inc-
Apr 15, 2025Receipt-
Apr 15, 2025Notification Of Service-
Apr 15, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Sweden Ab-
Apr 15, 202525 04 15 EP254 Response Re Deadline Extension-
Apr 14, 2025Receipt-
Apr 14, 2025R 9 Aplication Reply To R 9 Request-
Apr 10, 2025Template Order-
Apr 10, 2025Opportunity To Comment-
Apr 9, 2025Receipt-
Apr 9, 2025Opportunity To Comment-
Apr 9, 2025Exhibit Fbd 1-
Apr 9, 202525 04 09 EP254 Request For Deadline Extension Moderna VS Genevant Arbutus Cfi 191 2025 Act 10280 2025-
Apr 1, 2025Notification Of Service-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Netherlands B.V.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Italy S.R.L.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Germany Gmbh-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna France Sasu-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Denmark Aps-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Uk Limited-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Spain Sl-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Belgium S.R.L.-
Mar 31, 2025Acknowledgement Of Access To Case-
Mar 28, 2025Acknowledgement Of Access To Case-
Mar 24, 2025Acknowledgement Of Access To Case-
Mar 17, 2025Panel Appointment-
Mar 13, 2025Letter For Service-
Mar 11, 2025Document From Epo-
Mar 6, 2025Receipt-
Mar 6, 2025Panel Appointment-
Mar 6, 2025Formal Checks Notification Of Positive Outcome-
Mar 6, 2025Epo Request For Case Pending-
Mar 5, 2025Statement Of Claim EP254 Signed-
Mar 5, 2025Statement Of Claim EP254Da-
Mar 5, 2025Raw Data Uv-
Mar 5, 2025Raw Data Lc Cad Sample C3-
Mar 5, 2025Raw Data Lc Cad Sample C2-
Mar 5, 2025Raw Data Lc Cad Sample C1-
Mar 5, 2025Raw Data Dls-
Mar 5, 2025Exhibit M.04 United States Pharmacopeia-
Mar 5, 2025Exhibit M.03 Semple-
Mar 5, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture-
Mar 5, 2025Exhibit M.01 Samaridou-
Mar 5, 2025Exhibit G113 Moderna Inc Annual Report Selection-
Mar 5, 2025Exhibit G112 Moderna Annual Report P. 119-
Mar 5, 2025Exhibit G111 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit G110 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit G109 Moderna Rovi Press Release-
Mar 5, 2025Exhibit G108 Moderna Rovi Press Release-
Mar 5, 2025Exhibit G107 Lonza Press Release-
Mar 5, 2025Exhibit G106 Moderna Press Release Lonza Nl-
Mar 5, 2025Exhibit G105 Moderna Ch Service Agreement Tr-
Mar 5, 2025Exhibit G104 Moderna Lonza Press Release-
Mar 5, 2025Exhibit G103 Moderna Portugal Trade Register-
Mar 5, 2025Exhibit G102 Moderna Norway Trade Register-
Mar 5, 2025Exhibit G101 Moderna Sweden Trade Register-
Mar 5, 2025Exhibit G100 Moderna Denmark Trade Register-
Mar 5, 2025Exhibit G099 Moderna Belgium Trade Register-
Mar 5, 2025Exhibit G098 Moderna Italy Trade Register-
Mar 5, 2025Exhibit G097 Moderna France Trade Register-
Mar 5, 2025Exhibit G096 Moderna Germany Trade Register-
Mar 5, 2025Exhibit G095 Moderna Uk Annual Report-
Mar 5, 2025Exhibit G094 Moderna Uk Trade Register-
Mar 5, 2025Exhibit G093 Moderna Poland Trade Register-
Mar 5, 2025Exhibit G092 Moderna Netherlands Madrid-
Mar 5, 2025Exhibit G091 Moderna Es Trade Register-
Mar 5, 2025Exhibit G090 Mresvia Lauer Taxe Germany-
Mar 5, 2025Exhibit G089 Spikevax Lauer Taxe Germany-
Mar 5, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl-
Mar 5, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl-
Mar 5, 2025Exhibit G086 Moderna Nl Hungary Contract-
Mar 5, 2025Exhibit G085 Moderna Nl Hungary Contract Hun-
Mar 5, 2025Exhibit G084 Moderna Nl Annual Report-
Mar 5, 2025Exhibit G083 Moderna Nl Trade Register-
Mar 5, 2025Exhibit G082 Ec Draft Framework Contract-
Mar 5, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 5, 2025Exhibit G080 Moderna Press Release Tender-
Mar 5, 2025Exhibit G079 Ec Press Release Tender-
Mar 5, 2025Exhibit G078 Ex Pa Ec Moderna Ch-
Mar 5, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61-
Mar 5, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60-
Mar 5, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53-
Mar 5, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44-
Mar 5, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35-
Mar 5, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26-
Mar 5, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17-
Mar 5, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8-
Mar 5, 2025Exhibit G076 Moderna Switzerland Trade Register-
Mar 5, 2025Exhibit G075 Modernacovid19Global Website-
Mar 5, 2025Exhibit G074 Modernatx Website-
Mar 5, 2025Exhibit G073 Domain Registrations Moderna-
Mar 5, 2025Exhibit G072 Modernatx Trade Register Excerpt-
Mar 5, 2025Exhibit G071 Moderna Inc Press Release-
Mar 5, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1-
Mar 5, 2025Exhibit G069 Moderna Inc Trade Register Excerpt-
Mar 5, 2025Exhibit G068 Coriolis Report-
Mar 5, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection-
Mar 5, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92-
Mar 5, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 5, 2025Exhibit G064 Ema Assesment Report Mresvia-
Mar 5, 2025Exhibit G063 Moderna Press Release 23 August-
Mar 5, 2025Exhibit G062 Mresvia Smpc-
Mar 5, 2025Exhibit G061 Mitchell Report Table Of Content-
Mar 5, 2025Exhibit G060 Coriolis Report Table Of Content-
Mar 5, 2025Exhibit G059 WO2022197624A1-
Mar 5, 2025Exhibit G058 WO2021222304A1-
Mar 5, 2025Exhibit G057 WO2021159130A2-
Mar 5, 2025Exhibit G056 Richner-
Mar 5, 2025Exhibit G055 Bahl-
Mar 5, 2025Exhibit G054 Espeseth-
Mar 5, 2025Exhibit G053 John-
Mar 5, 2025Exhibit G052 Peer Review Corbett Nature-
Mar 5, 2025Exhibit G051 Hassett-
Mar 5, 2025Exhibit G050 Ema Assessment Report Spikevax-
Mar 5, 2025Exhibit G049 Epo Ar1 To Ar13-
Mar 5, 2025Exhibit G048 Ar13 Redlined-
Mar 5, 2025Exhibit G047 Mr Redlined-
Mar 5, 2025Exhibit G046 Mitchell Report-
Mar 5, 2025Exhibit G045 Petitioners Hearing Slides Slide 27-
Mar 5, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73-
Mar 5, 2025Exhibit G043 D44 Declaration Heyes-
Mar 5, 2025Exhibit G042 D43 Declaration Heyes-
Mar 5, 2025Exhibit G041 Modernas Goa Of 22 November-
Mar 5, 2025Exhibit G040 Arbutuss Goa Of 25 November-
Mar 5, 2025Exhibit G039 Main Request-
Mar 5, 2025Exhibit G038 US2006 0240554 (D25)-
Mar 5, 2025Exhibit G037 Auxiliary Request 13-
Mar 5, 2025Exhibit G036 Od Decision-
Mar 5, 2025Exhibit G035 T 0505 20-
Mar 5, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October-
Mar 5, 2025Exhibit G033 Od Decision-
Mar 5, 2025Exhibit G032 US20080020058(Chen)-
Mar 5, 2025Exhibit G031 Amended Claim With Annotations 13 September-
Mar 5, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May-
Mar 5, 2025Exhibit G029 Extended European Search Report 12 October-
Mar 5, 2025Exhibit G028 Amendments Received Before Examination 30 December-
Mar 5, 2025Exhibit G027 Withdrawal Of The Op Out-
Mar 5, 2025Exhibit G026 US20080045228P Priority Document-
Mar 5, 2025Exhibit G025 WO2009127060A1 Original Application-
Mar 5, 2025Exhibit G024 Samaridou-
Mar 5, 2025Exhibit G023 Genevant Press Release-
Mar 5, 2025Exhibit G022 Federal Circuit Opinion (435)-
Mar 5, 2025Exhibit G021 Federal Circuit Opinion (069)-
Mar 5, 2025Exhibit G020 Ipr Final Written Decision (435)-
Mar 5, 2025Exhibit G019 Ipr Final Written Decision (069)-
Mar 5, 2025Exhibit G018 US9364435-
Mar 5, 2025Exhibit G017 US8058069-
Mar 5, 2025Exhibit G016 Moore Harvard Business School-
Mar 5, 2025Exhibit G015 Moderna Nih Preprint-
Mar 5, 2025Exhibit G014 CR OSS Cen News-
Mar 5, 2025Exhibit G013 Regalado Mit Technology-
Mar 5, 2025Exhibit G012 Corbett Nature Review-
Mar 5, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration-
Mar 5, 2025Exhibit G010 Suzuki-
Mar 5, 2025Exhibit G009 Semple-
Mar 5, 2025Exhibit G008 Zimmerman-
Mar 5, 2025Exhibit G007 Spikevax Smpc-
Mar 5, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 5, 2025Exhibit G005 Genevant Sciences Trade Register-
Mar 5, 2025Exhibit G004 Proof Of Payment Court Fees-
Mar 5, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus-
Mar 5, 2025Exhibit G002 Patent Register Excerpts-
Mar 5, 2025Exhibit G001 EP2279254B1-
Mar 5, 2025Exhibit C Qualification Report-
Mar 5, 2025Exhibit B Cv Katharina Edenharter-
Mar 5, 2025Exhibit A Cv Thomas Lassak-
Mar 4, 2025Formal Checks Request For Correction-
Mar 3, 2025Statement Of Claim EP254 Signed-
Mar 3, 2025Raw Data Uv-
Mar 3, 2025Raw Data Lc Cad Sample C3-
Mar 3, 2025Raw Data Lc Cad Sample C2-
Mar 3, 2025Raw Data Lc Cad Sample C1-
Mar 3, 2025Raw Data Dls-
Mar 3, 2025Exhibit M.04 United States Pharmacopeia-
Mar 3, 2025Exhibit M.03 Semple-
Mar 3, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture-
Mar 3, 2025Exhibit M.01 Samaridou-
Mar 3, 2025Exhibit G113 Moderna Inc Annual Report Selection-
Mar 3, 2025Exhibit G112 Moderna Annual Report P. 119-
Mar 3, 2025Exhibit G111 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit G110 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit G109 Moderna Rovi Press Release-
Mar 3, 2025Exhibit G108 Moderna Rovi Press Release-
Mar 3, 2025Exhibit G107 Lonza Press Release-
Mar 3, 2025Exhibit G106 Moderna Press Release Lonza Nl-
Mar 3, 2025Exhibit G105 Moderna Ch Service Agreement Tr-
Mar 3, 2025Exhibit G104 Moderna Lonza Press Release-
Mar 3, 2025Exhibit G103 Moderna Portugal Trade Register-
Mar 3, 2025Exhibit G102 Moderna Norway Trade Register-
Mar 3, 2025Exhibit G101 Moderna Sweden Trade Register-
Mar 3, 2025Exhibit G100 Moderna Denmark Trade Register-
Mar 3, 2025Exhibit G099 Moderna Belgium Trade Register-
Mar 3, 2025Exhibit G098 Moderna Italy Trade Register-
Mar 3, 2025Exhibit G097 Moderna France Trade Register-
Mar 3, 2025Exhibit G096 Moderna Germany Trade Register-
Mar 3, 2025Exhibit G095 Moderna Uk Annual Report-
Mar 3, 2025Exhibit G094 Moderna Uk Trade Register-
Mar 3, 2025Exhibit G093 Moderna Poland Trade Register-
Mar 3, 2025Exhibit G092 Moderna Netherlands Madrid-
Mar 3, 2025Exhibit G091 Moderna Es Trade Register-
Mar 3, 2025Exhibit G090 Mresvia Lauer Taxe Germany-
Mar 3, 2025Exhibit G089 Spikevax Lauer Taxe Germany-
Mar 3, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl-
Mar 3, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl-
Mar 3, 2025Exhibit G086 Moderna Nl Hungary Contract-
Mar 3, 2025Exhibit G085 Moderna Nl Hungary Contract Hun-
Mar 3, 2025Exhibit G084 Moderna Nl Annual Report-
Mar 3, 2025Exhibit G083 Moderna Nl Trade Register-
Mar 3, 2025Exhibit G082 Ec Draft Framework Contract-
Mar 3, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 3, 2025Exhibit G080 Moderna Press Release Tender-
Mar 3, 2025Exhibit G079 Ec Press Release Tender-
Mar 3, 2025Exhibit G078 Ex Pa Ec Moderna Ch-
Mar 3, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61-
Mar 3, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60-
Mar 3, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53-
Mar 3, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44-
Mar 3, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35-
Mar 3, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26-
Mar 3, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17-
Mar 3, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8-
Mar 3, 2025Exhibit G076 Moderna Switzerland Trade Register-
Mar 3, 2025Exhibit G075 Modernacovid19Global Website-
Mar 3, 2025Exhibit G074 Modernatx Website-
Mar 3, 2025Exhibit G073 Domain Registrations Moderna-
Mar 3, 2025Exhibit G072 Modernatx Trade Register Excerpt-
Mar 3, 2025Exhibit G071 Moderna Inc Press Release-
Mar 3, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1-
Mar 3, 2025Exhibit G069 Moderna Inc Trade Register Excerpt-
Mar 3, 2025Exhibit G068 Coriolis Report-
Mar 3, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection-
Mar 3, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92-
Mar 3, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 3, 2025Exhibit G064 Ema Assesment Report Mresvia-
Mar 3, 2025Exhibit G063 Moderna Press Release 23 August-
Mar 3, 2025Exhibit G062 Mresvia Smpc-
Mar 3, 2025Exhibit G061 Mitchell Report Table Of Content-
Mar 3, 2025Exhibit G060 Coriolis Report Table Of Content-
Mar 3, 2025Exhibit G059 WO2022197624A1-
Mar 3, 2025Exhibit G058 WO2021222304A1-
Mar 3, 2025Exhibit G057 WO2021159130A2-
Mar 3, 2025Exhibit G056 Richner-
Mar 3, 2025Exhibit G055 Bahl-
Mar 3, 2025Exhibit G054 Espeseth-
Mar 3, 2025Exhibit G053 John-
Mar 3, 2025Exhibit G052 Peer Review Corbett Nature-
Mar 3, 2025Exhibit G051 Hassett-
Mar 3, 2025Exhibit G050 Ema Assessment Report Spikevax-
Mar 3, 2025Exhibit G049 Epo Ar1 To Ar13-
Mar 3, 2025Exhibit G048 Ar13 Redlined-
Mar 3, 2025Exhibit G047 Mr Redlined-
Mar 3, 2025Exhibit G046 Mitchell Report-
Mar 3, 2025Exhibit G045 Petitioners Hearing Slides Slide 27-
Mar 3, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73-
Mar 3, 2025Exhibit G043 D44 Declaration Heyes-
Mar 3, 2025Exhibit G042 D43 Declaration Heyes-
Mar 3, 2025Exhibit G041 Modernas Goa Of 22 November-
Mar 3, 2025Exhibit G040 Arbutuss Goa Of 25 November-
Mar 3, 2025Exhibit G039 Main Request-
Mar 3, 2025Exhibit G038 US2006 0240554 (D25)-
Mar 3, 2025Exhibit G037 Auxiliary Request 13-
Mar 3, 2025Exhibit G036 Od Decision-
Mar 3, 2025Exhibit G035 T 0505 20-
Mar 3, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October-
Mar 3, 2025Exhibit G033 Od Decision-
Mar 3, 2025Exhibit G032 US20080020058(Chen)-
Mar 3, 2025Exhibit G031 Amended Claim With Annotations 13 September-
Mar 3, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May-
Mar 3, 2025Exhibit G029 Extended European Search Report 12 October-
Mar 3, 2025Exhibit G028 Amendments Received Before Examination 30 December-
Mar 3, 2025Exhibit G027 Withdrawal Of The Op Out-
Mar 3, 2025Exhibit G026 US20080045228P Priority Document-
Mar 3, 2025Exhibit G025 WO2009127060A1 Original Application-
Mar 3, 2025Exhibit G024 Samaridou-
Mar 3, 2025Exhibit G023 Genevant Press Release-
Mar 3, 2025Exhibit G022 Federal Circuit Opinion (435)-
Mar 3, 2025Exhibit G021 Federal Circuit Opinion (069)-
Mar 3, 2025Exhibit G020 Ipr Final Written Decision (435)-
Mar 3, 2025Exhibit G019 Ipr Final Written Decision (069)-
Mar 3, 2025Exhibit G018 US9364435-
Mar 3, 2025Exhibit G017 US8058069-
Mar 3, 2025Exhibit G016 Moore Harvard Business School-
Mar 3, 2025Exhibit G015 Moderna Nih Preprint-
Mar 3, 2025Exhibit G014 CR OSS Cen News-
Mar 3, 2025Exhibit G013 Regalado Mit Technology-
Mar 3, 2025Exhibit G012 Corbett Nature Review-
Mar 3, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration-
Mar 3, 2025Exhibit G010 Suzuki-
Mar 3, 2025Exhibit G009 Semple-
Mar 3, 2025Exhibit G008 Zimmerman-
Mar 3, 2025Exhibit G007 Spikevax Smpc-
Mar 3, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 3, 2025Exhibit G005 Genevant Sciences Trade Register-
Mar 3, 2025Exhibit G004 Proof Of Payment Court Fees-
Mar 3, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus-
Mar 3, 2025Exhibit G002 Patent Register Excerpts-
Mar 3, 2025Exhibit G001 EP2279254B1-
Mar 3, 2025Exhibit C Qualification Report-
Mar 3, 2025Exhibit B Cv Katharina Edenharter-
Mar 3, 2025Exhibit A Cv Thomas Lassak-
Mar 3, 2025EP254Soc Da-
Mar 3, 2025Acknowledgement Of Lodging-
Oct 3, 2025Receipt-
Oct 3, 2025Exhibit-
Oct 3, 2025Cover Sheet-
Oct 3, 2025Application-
Sep 24, 2025Statement Of Reply-
Sep 24, 2025Receipt-
Sep 24, 2025Exhibit-
Sep 24, 2025Cover Sheet-
Sep 14, 2025Rejoinder On Request To Produce Evidence-
Sep 12, 2025Uploaded For Technical Reasons Only To Close Workflow
Sep 12, 2025Upc Genevant Arbutus Reply R 190 Request Signed-
Sep 12, 2025Outcome Of The Order-
Sep 12, 2025Opportunity To Comment-
Sep 2, 2025Receipt-
Sep 2, 2025Moderna R.9 Rop In Response To R.190 Rop Application-
Aug 28, 2025Receipt-
Aug 27, 202525 08 27 Ep 254 Further Comment On Request To Produce Evidence Moderna Vs Genevant-
Aug 26, 2025Reply Re R190 Request-
Aug 26, 2025Exhibit G126-
Aug 18, 2025Panel Appointment-
Aug 18, 2025Opportunity To Comment-
Aug 15, 2025R.37.2 Order
Aug 14, 2025Response To Request To Produce Evidence (Rule 190 Rop)-
Aug 14, 2025Exhibit Fs18 DI 457 Letter May-
Aug 14, 2025Exhibit Fs17 Protective Order-
Aug 13, 2025Joint Statement Regarding Bifurcation-
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop-
Aug 8, 2025Response To Deadline Extension Request-
Aug 6, 2025R.37-
Aug 6, 2025R
Aug 6, 2025Hearing Dates-
Aug 5, 2025Redacted Final Order Re R.262A Applications-
Aug 4, 2025R.262A Order-
Aug 4, 2025Outcome Of The Order-
Aug 4, 2025Opportunity To Comment-
Aug 1, 2025Request For Extension Of Deadlines-
Aug 1, 2025Receipt-
Aug 1, 2025Exhibit G125-
Aug 1, 2025Exhibit G124-
Aug 1, 2025Exhibit G123-
Aug 1, 2025Application For An Order To Produce Evidence-
Jul 28, 2025R.262A Reply-
Jul 28, 2025Exhibit G122-
Jul 25, 2025Receipt-
Jul 24, 2025R.262A Reply-
Jul 24, 2025Exhibit G122-
Jul 23, 2025Reference To Response Of Genevant-
Jul 23, 2025R.262.2 Application-
Jul 23, 2025Exhibit G121 Confidential-
Jul 23, 2025Exhibit G120-
Jul 23, 2025Exhibit G119-
Jul 23, 2025Confidential Response To Security-
Jul 11, 2025Formal Checks Notification Of Positive Outcome-
Jul 11, 2025Acknowledgement Of Lodging-
Jul 10, 2025Set Of Exhibits Fbd T 09 Confidential-
Jul 10, 2025Set Of Exhibits Fbd 11-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 5 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 4 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 3 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 2 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 1 Of 5-
Jul 10, 2025Opportunity To Comment-
Jul 10, 2025Formal Checks Request For Correction-
Jul 10, 2025Exhibit Fbd T 19-
Jul 10, 2025Exhibit Fbd T 18-
Jul 10, 2025Exhibit Fbd T 17-
Jul 10, 2025Exhibit Fbd T 16-
Jul 10, 2025Exhibit Fbd T 15-
Jul 10, 2025Exhibit Fbd T 14-
Jul 10, 2025Exhibit Fbd T 13-
Jul 10, 2025Exhibit Fbd T 12-
Jul 10, 2025Exhibit Fbd T 11-
Jul 10, 2025Exhibit Fbd T 10-
Jul 10, 2025Exhibit Fbd T 09A Confidential-
Jul 10, 2025Exhibit Fbd T 08-
Jul 10, 2025Exhibit Fbd T 07-
Jul 10, 2025Exhibit Fbd T 06-
Jul 10, 2025Exhibit Fbd T 05-
Jul 10, 2025Exhibit Fbd T 04-
Jul 10, 2025Exhibit Fbd T 03A-
Jul 10, 2025Exhibit Fbd T 03-
Jul 10, 2025Exhibit Fbd T 02-
Jul 10, 2025Exhibit Fbd T 01-
Jul 10, 2025Exhibit Fbd 16-
Jul 10, 2025Exhibit Fbd 15-
Jul 10, 2025Exhibit Fbd 14-
Jul 10, 2025Exhibit Fbd 13-
Jul 10, 2025Exhibit Fbd 12 Confidential-
Jul 10, 2025Exhibit Fbd 11A-
Jul 10, 2025Exhibit Fbd 09-
Jul 10, 2025Exhibit Fbd 08-
Jul 10, 2025Exhibit Fbd 07-
Jul 10, 2025Exhibit Fbd 06-
Jul 10, 2025Annex 7 To Exhibit Fbd T 4-
Jul 10, 2025Annex 6 To Exhibit Fbd T 4-
Jul 10, 2025Annex 5 To Exhibit Fbd T 4-
Jul 10, 2025Annex 4 To Exhibit Fbd T 4-
Jul 10, 2025Annex 3 To Exhibit Fbd T 4-
Jul 10, 2025Annex 2 To Exhibit Fbd T 4-
Jul 10, 2025Annex 1 To Exhibit Fbd T 4-
Jul 10, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025 V2-
Jul 9, 2025Set Of Exhibits Fbd T 09 Confidential-
Jul 9, 2025Set Of Exhibits Fbd 11-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 5 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 4 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 3 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 2 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 1 Of 5-
Jul 9, 2025Receipt-
Jul 9, 2025Opportunity To Comment-
Jul 9, 2025Exhibit Fbd T 19-
Jul 9, 2025Exhibit Fbd T 18-
Jul 9, 2025Exhibit Fbd T 17-
Jul 9, 2025Exhibit Fbd T 16-
Jul 9, 2025Exhibit Fbd T 15-
Jul 9, 2025Exhibit Fbd T 14-
Jul 9, 2025Exhibit Fbd T 13-
Jul 9, 2025Exhibit Fbd T 12-
Jul 9, 2025Exhibit Fbd T 11-
Jul 9, 2025Exhibit Fbd T 10-
Jul 9, 2025Exhibit Fbd T 09A Confidential-
Jul 9, 2025Exhibit Fbd T 08-
Jul 9, 2025Exhibit Fbd T 07-
Jul 9, 2025Exhibit Fbd T 06-
Jul 9, 2025Exhibit Fbd T 05-
Jul 9, 2025Exhibit Fbd T 04-
Jul 9, 2025Exhibit Fbd T 03A-
Jul 9, 2025Exhibit Fbd T 03-
Jul 9, 2025Exhibit Fbd T 02-
Jul 9, 2025Exhibit Fbd T 01-
Jul 9, 2025Exhibit Fbd 16-
Jul 9, 2025Exhibit Fbd 15-
Jul 9, 2025Exhibit Fbd 14-
Jul 9, 2025Exhibit Fbd 13-
Jul 9, 2025Exhibit Fbd 12 Confidential-
Jul 9, 2025Exhibit Fbd 11A-
Jul 9, 2025Exhibit Fbd 09-
Jul 9, 2025Exhibit Fbd 08-
Jul 9, 2025Exhibit Fbd 07-
Jul 9, 2025Exhibit Fbd 06-
Jul 9, 2025EP254 Moderna Reference To Statement Of Defence And Counterclaim For Revocation-
Jul 9, 2025Annex 7 To Exhibit Fbd T 4-
Jul 9, 2025Annex 6 To Exhibit Fbd T 4-
Jul 9, 2025Annex 5 To Exhibit Fbd T 4-
Jul 9, 2025Annex 4 To Exhibit Fbd T 4-
Jul 9, 2025Annex 3 To Exhibit Fbd T 4-
Jul 9, 2025Annex 2 To Exhibit Fbd T 4-
Jul 9, 2025Annex 1 To Exhibit Fbd T 4-
Jul 9, 2025Acknowledgement Of Lodging-
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Request Security Pursuant To R158 No 32591 2025-
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Confidentiality Request-
Jul 9, 202507 08 Upc1 EP254 Reference To Statement Of Defence For Other Defendants(307430487.1)-
Jul 9, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025-
Jun 19, 2025Response To Request For Review-
Jun 12, 2025Outcome Of The Order-
Jun 12, 2025Opportunity To Comment
Jun 11, 2025Acknowledgement Of Lodging-
Jun 6, 2025Exhibit Fbd 5-
Jun 6, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 27016 2025-
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order-
Jun 4, 2025Headnote And Keywords-
Jun 2, 2025Response To Request For Rectification-
May 28, 2025Opportunity To Comment-
May 27, 2025Receipt-
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025-
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome-
May 7, 2025Exhibit G118 Notice European Tender-
May 7, 2025Exhibit G117 Certificate Amalgamation-
May 7, 2025Exhibit G116 Opt Out Confirmation-
May 7, 2025Exhibit G115 Opt Out-
May 7, 2025Comment On Preliminary Objection-
May 7, 2025Comment On Preliminary Objection-
May 6, 2025Notification Of Service-
May 6, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Norway As-
May 5, 2025Acknowledgement Of Access To Case-
May 1, 2025Notification Of Service-
May 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Switzerland Gmbh-
Apr 25, 2025Preliminary Objection-
Apr 25, 2025Notification Of Service-
Apr 25, 2025Exhibit Fbd 4 Moderna Pl-
Apr 25, 2025Exhibit Fbd 3 Dutch Patent Register-
Apr 25, 2025Exhibit Fbd 2 National Registers-
Apr 25, 2025Act 10280 Upc Cfi 191 Confirmation Of Service-
Apr 25, 202525 04 24 EP254 Preliminary Objection Moderna VS Genevant Signed-
Apr 23, 2025Preliminary Objection-
Apr 22, 2025Preliminary Objection Moderna Uk Moderna VS Genevant (EP254) Signed-
Apr 22, 2025Notification Of Service-
Apr 22, 2025Exhibit Fbd 3 Dutch Patent Register-
Apr 22, 2025Exhibit Fbd 2 National Registers-
Apr 22, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Inc.-
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order-
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Response To Letter Brinkhof D.D17 April-
Apr 17, 2025Receipt-
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc-
Apr 17, 2025Outcome Of The Order-
Apr 17, 2025Headnote And Keywords-
Apr 17, 2025Exhibit G114 Letter Re Representation Mll Of Moderna Inc Modernatx Inc-
Apr 15, 2025Receipt-
Apr 15, 2025Notification Of Service-
Apr 15, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Sweden Ab-
Apr 15, 202525 04 15 EP254 Response Re Deadline Extension-
Apr 14, 2025Receipt-
Apr 14, 2025R 9 Aplication Reply To R 9 Request-
Apr 10, 2025Template Order-
Apr 10, 2025Opportunity To Comment-
Apr 9, 2025Receipt-
Apr 9, 2025Opportunity To Comment-
Apr 9, 2025Exhibit Fbd 1-
Apr 9, 202525 04 09 EP254 Request For Deadline Extension Moderna VS Genevant Arbutus Cfi 191 2025 Act 10280 2025-
Apr 1, 2025Notification Of Service-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Netherlands B.V.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Italy S.R.L.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Germany Gmbh-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna France Sasu-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Denmark Aps-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Uk Limited-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Spain Sl-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Belgium S.R.L.-
Mar 31, 2025Acknowledgement Of Access To Case-
Mar 28, 2025Acknowledgement Of Access To Case-
Mar 24, 2025Acknowledgement Of Access To Case-
Mar 17, 2025Panel Appointment-
Mar 13, 2025Letter For Service-
Mar 11, 2025Document From Epo-
Mar 6, 2025Receipt-
Mar 6, 2025Panel Appointment-
Mar 6, 2025Formal Checks Notification Of Positive Outcome-
Mar 6, 2025Epo Request For Case Pending-
Mar 5, 2025Statement Of Claim EP254 Signed-
Mar 5, 2025Statement Of Claim EP254Da-
Mar 5, 2025Raw Data Uv-
Mar 5, 2025Raw Data Lc Cad Sample C3-
Mar 5, 2025Raw Data Lc Cad Sample C2-
Mar 5, 2025Raw Data Lc Cad Sample C1-
Mar 5, 2025Raw Data Dls-
Mar 5, 2025Exhibit M.04 United States Pharmacopeia-
Mar 5, 2025Exhibit M.03 Semple-
Mar 5, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture-
Mar 5, 2025Exhibit M.01 Samaridou-
Mar 5, 2025Exhibit G113 Moderna Inc Annual Report Selection-
Mar 5, 2025Exhibit G112 Moderna Annual Report P. 119-
Mar 5, 2025Exhibit G111 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit G110 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit G109 Moderna Rovi Press Release-
Mar 5, 2025Exhibit G108 Moderna Rovi Press Release-
Mar 5, 2025Exhibit G107 Lonza Press Release-
Mar 5, 2025Exhibit G106 Moderna Press Release Lonza Nl-
Mar 5, 2025Exhibit G105 Moderna Ch Service Agreement Tr-
Mar 5, 2025Exhibit G104 Moderna Lonza Press Release-
Mar 5, 2025Exhibit G103 Moderna Portugal Trade Register-
Mar 5, 2025Exhibit G102 Moderna Norway Trade Register-
Mar 5, 2025Exhibit G101 Moderna Sweden Trade Register-
Mar 5, 2025Exhibit G100 Moderna Denmark Trade Register-
Mar 5, 2025Exhibit G099 Moderna Belgium Trade Register-
Mar 5, 2025Exhibit G098 Moderna Italy Trade Register-
Mar 5, 2025Exhibit G097 Moderna France Trade Register-
Mar 5, 2025Exhibit G096 Moderna Germany Trade Register-
Mar 5, 2025Exhibit G095 Moderna Uk Annual Report-
Mar 5, 2025Exhibit G094 Moderna Uk Trade Register-
Mar 5, 2025Exhibit G093 Moderna Poland Trade Register-
Mar 5, 2025Exhibit G092 Moderna Netherlands Madrid-
Mar 5, 2025Exhibit G091 Moderna Es Trade Register-
Mar 5, 2025Exhibit G090 Mresvia Lauer Taxe Germany-
Mar 5, 2025Exhibit G089 Spikevax Lauer Taxe Germany-
Mar 5, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl-
Mar 5, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl-
Mar 5, 2025Exhibit G086 Moderna Nl Hungary Contract-
Mar 5, 2025Exhibit G085 Moderna Nl Hungary Contract Hun-
Mar 5, 2025Exhibit G084 Moderna Nl Annual Report-
Mar 5, 2025Exhibit G083 Moderna Nl Trade Register-
Mar 5, 2025Exhibit G082 Ec Draft Framework Contract-
Mar 5, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 5, 2025Exhibit G080 Moderna Press Release Tender-
Mar 5, 2025Exhibit G079 Ec Press Release Tender-
Mar 5, 2025Exhibit G078 Ex Pa Ec Moderna Ch-
Mar 5, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61-
Mar 5, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60-
Mar 5, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53-
Mar 5, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44-
Mar 5, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35-
Mar 5, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26-
Mar 5, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17-
Mar 5, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8-
Mar 5, 2025Exhibit G076 Moderna Switzerland Trade Register-
Mar 5, 2025Exhibit G075 Modernacovid19Global Website-
Mar 5, 2025Exhibit G074 Modernatx Website-
Mar 5, 2025Exhibit G073 Domain Registrations Moderna-
Mar 5, 2025Exhibit G072 Modernatx Trade Register Excerpt-
Mar 5, 2025Exhibit G071 Moderna Inc Press Release-
Mar 5, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1-
Mar 5, 2025Exhibit G069 Moderna Inc Trade Register Excerpt-
Mar 5, 2025Exhibit G068 Coriolis Report-
Mar 5, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection-
Mar 5, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92-
Mar 5, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 5, 2025Exhibit G064 Ema Assesment Report Mresvia-
Mar 5, 2025Exhibit G063 Moderna Press Release 23 August-
Mar 5, 2025Exhibit G062 Mresvia Smpc-
Mar 5, 2025Exhibit G061 Mitchell Report Table Of Content-
Mar 5, 2025Exhibit G060 Coriolis Report Table Of Content-
Mar 5, 2025Exhibit G059 WO2022197624A1-
Mar 5, 2025Exhibit G058 WO2021222304A1-
Mar 5, 2025Exhibit G057 WO2021159130A2-
Mar 5, 2025Exhibit G056 Richner-
Mar 5, 2025Exhibit G055 Bahl-
Mar 5, 2025Exhibit G054 Espeseth-
Mar 5, 2025Exhibit G053 John-
Mar 5, 2025Exhibit G052 Peer Review Corbett Nature-
Mar 5, 2025Exhibit G051 Hassett-
Mar 5, 2025Exhibit G050 Ema Assessment Report Spikevax-
Mar 5, 2025Exhibit G049 Epo Ar1 To Ar13-
Mar 5, 2025Exhibit G048 Ar13 Redlined-
Mar 5, 2025Exhibit G047 Mr Redlined-
Mar 5, 2025Exhibit G046 Mitchell Report-
Mar 5, 2025Exhibit G045 Petitioners Hearing Slides Slide 27-
Mar 5, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73-
Mar 5, 2025Exhibit G043 D44 Declaration Heyes-
Mar 5, 2025Exhibit G042 D43 Declaration Heyes-
Mar 5, 2025Exhibit G041 Modernas Goa Of 22 November-
Mar 5, 2025Exhibit G040 Arbutuss Goa Of 25 November-
Mar 5, 2025Exhibit G039 Main Request-
Mar 5, 2025Exhibit G038 US2006 0240554 (D25)-
Mar 5, 2025Exhibit G037 Auxiliary Request 13-
Mar 5, 2025Exhibit G036 Od Decision-
Mar 5, 2025Exhibit G035 T 0505 20-
Mar 5, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October-
Mar 5, 2025Exhibit G033 Od Decision-
Mar 5, 2025Exhibit G032 US20080020058(Chen)-
Mar 5, 2025Exhibit G031 Amended Claim With Annotations 13 September-
Mar 5, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May-
Mar 5, 2025Exhibit G029 Extended European Search Report 12 October-
Mar 5, 2025Exhibit G028 Amendments Received Before Examination 30 December-
Mar 5, 2025Exhibit G027 Withdrawal Of The Op Out-
Mar 5, 2025Exhibit G026 US20080045228P Priority Document-
Mar 5, 2025Exhibit G025 WO2009127060A1 Original Application-
Mar 5, 2025Exhibit G024 Samaridou-
Mar 5, 2025Exhibit G023 Genevant Press Release-
Mar 5, 2025Exhibit G022 Federal Circuit Opinion (435)-
Mar 5, 2025Exhibit G021 Federal Circuit Opinion (069)-
Mar 5, 2025Exhibit G020 Ipr Final Written Decision (435)-
Mar 5, 2025Exhibit G019 Ipr Final Written Decision (069)-
Mar 5, 2025Exhibit G018 US9364435-
Mar 5, 2025Exhibit G017 US8058069-
Mar 5, 2025Exhibit G016 Moore Harvard Business School-
Mar 5, 2025Exhibit G015 Moderna Nih Preprint-
Mar 5, 2025Exhibit G014 CR OSS Cen News-
Mar 5, 2025Exhibit G013 Regalado Mit Technology-
Mar 5, 2025Exhibit G012 Corbett Nature Review-
Mar 5, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration-
Mar 5, 2025Exhibit G010 Suzuki-
Mar 5, 2025Exhibit G009 Semple-
Mar 5, 2025Exhibit G008 Zimmerman-
Mar 5, 2025Exhibit G007 Spikevax Smpc-
Mar 5, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 5, 2025Exhibit G005 Genevant Sciences Trade Register-
Mar 5, 2025Exhibit G004 Proof Of Payment Court Fees-
Mar 5, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus-
Mar 5, 2025Exhibit G002 Patent Register Excerpts-
Mar 5, 2025Exhibit G001 EP2279254B1-
Mar 5, 2025Exhibit C Qualification Report-
Mar 5, 2025Exhibit B Cv Katharina Edenharter-
Mar 5, 2025Exhibit A Cv Thomas Lassak-
Mar 4, 2025Formal Checks Request For Correction-
Mar 3, 2025Statement Of Claim EP254 Signed-
Mar 3, 2025Raw Data Uv-
Mar 3, 2025Raw Data Lc Cad Sample C3-
Mar 3, 2025Raw Data Lc Cad Sample C2-
Mar 3, 2025Raw Data Lc Cad Sample C1-
Mar 3, 2025Raw Data Dls-
Mar 3, 2025Exhibit M.04 United States Pharmacopeia-
Mar 3, 2025Exhibit M.03 Semple-
Mar 3, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture-
Mar 3, 2025Exhibit M.01 Samaridou-
Mar 3, 2025Exhibit G113 Moderna Inc Annual Report Selection-
Mar 3, 2025Exhibit G112 Moderna Annual Report P. 119-
Mar 3, 2025Exhibit G111 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit G110 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit G109 Moderna Rovi Press Release-
Mar 3, 2025Exhibit G108 Moderna Rovi Press Release-
Mar 3, 2025Exhibit G107 Lonza Press Release-
Mar 3, 2025Exhibit G106 Moderna Press Release Lonza Nl-
Mar 3, 2025Exhibit G105 Moderna Ch Service Agreement Tr-
Mar 3, 2025Exhibit G104 Moderna Lonza Press Release-
Mar 3, 2025Exhibit G103 Moderna Portugal Trade Register-
Mar 3, 2025Exhibit G102 Moderna Norway Trade Register-
Mar 3, 2025Exhibit G101 Moderna Sweden Trade Register-
Mar 3, 2025Exhibit G100 Moderna Denmark Trade Register-
Mar 3, 2025Exhibit G099 Moderna Belgium Trade Register-
Mar 3, 2025Exhibit G098 Moderna Italy Trade Register-
Mar 3, 2025Exhibit G097 Moderna France Trade Register-
Mar 3, 2025Exhibit G096 Moderna Germany Trade Register-
Mar 3, 2025Exhibit G095 Moderna Uk Annual Report-
Mar 3, 2025Exhibit G094 Moderna Uk Trade Register-
Mar 3, 2025Exhibit G093 Moderna Poland Trade Register-
Mar 3, 2025Exhibit G092 Moderna Netherlands Madrid-
Mar 3, 2025Exhibit G091 Moderna Es Trade Register-
Mar 3, 2025Exhibit G090 Mresvia Lauer Taxe Germany-
Mar 3, 2025Exhibit G089 Spikevax Lauer Taxe Germany-
Mar 3, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl-
Mar 3, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl-
Mar 3, 2025Exhibit G086 Moderna Nl Hungary Contract-
Mar 3, 2025Exhibit G085 Moderna Nl Hungary Contract Hun-
Mar 3, 2025Exhibit G084 Moderna Nl Annual Report-
Mar 3, 2025Exhibit G083 Moderna Nl Trade Register-
Mar 3, 2025Exhibit G082 Ec Draft Framework Contract-
Mar 3, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 3, 2025Exhibit G080 Moderna Press Release Tender-
Mar 3, 2025Exhibit G079 Ec Press Release Tender-
Mar 3, 2025Exhibit G078 Ex Pa Ec Moderna Ch-
Mar 3, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61-
Mar 3, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60-
Mar 3, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53-
Mar 3, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44-
Mar 3, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35-
Mar 3, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26-
Mar 3, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17-
Mar 3, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8-
Mar 3, 2025Exhibit G076 Moderna Switzerland Trade Register-
Mar 3, 2025Exhibit G075 Modernacovid19Global Website-
Mar 3, 2025Exhibit G074 Modernatx Website-
Mar 3, 2025Exhibit G073 Domain Registrations Moderna-
Mar 3, 2025Exhibit G072 Modernatx Trade Register Excerpt-
Mar 3, 2025Exhibit G071 Moderna Inc Press Release-
Mar 3, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1-
Mar 3, 2025Exhibit G069 Moderna Inc Trade Register Excerpt-
Mar 3, 2025Exhibit G068 Coriolis Report-
Mar 3, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection-
Mar 3, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92-
Mar 3, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 3, 2025Exhibit G064 Ema Assesment Report Mresvia-
Mar 3, 2025Exhibit G063 Moderna Press Release 23 August-
Mar 3, 2025Exhibit G062 Mresvia Smpc-
Mar 3, 2025Exhibit G061 Mitchell Report Table Of Content-
Mar 3, 2025Exhibit G060 Coriolis Report Table Of Content-
Mar 3, 2025Exhibit G059 WO2022197624A1-
Mar 3, 2025Exhibit G058 WO2021222304A1-
Mar 3, 2025Exhibit G057 WO2021159130A2-
Mar 3, 2025Exhibit G056 Richner-
Mar 3, 2025Exhibit G055 Bahl-
Mar 3, 2025Exhibit G054 Espeseth-
Mar 3, 2025Exhibit G053 John-
Mar 3, 2025Exhibit G052 Peer Review Corbett Nature-
Mar 3, 2025Exhibit G051 Hassett-
Mar 3, 2025Exhibit G050 Ema Assessment Report Spikevax-
Mar 3, 2025Exhibit G049 Epo Ar1 To Ar13-
Mar 3, 2025Exhibit G048 Ar13 Redlined-
Mar 3, 2025Exhibit G047 Mr Redlined-
Mar 3, 2025Exhibit G046 Mitchell Report-
Mar 3, 2025Exhibit G045 Petitioners Hearing Slides Slide 27-
Mar 3, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73-
Mar 3, 2025Exhibit G043 D44 Declaration Heyes-
Mar 3, 2025Exhibit G042 D43 Declaration Heyes-
Mar 3, 2025Exhibit G041 Modernas Goa Of 22 November-
Mar 3, 2025Exhibit G040 Arbutuss Goa Of 25 November-
Mar 3, 2025Exhibit G039 Main Request-
Mar 3, 2025Exhibit G038 US2006 0240554 (D25)-
Mar 3, 2025Exhibit G037 Auxiliary Request 13-
Mar 3, 2025Exhibit G036 Od Decision-
Mar 3, 2025Exhibit G035 T 0505 20-
Mar 3, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October-
Mar 3, 2025Exhibit G033 Od Decision-
Mar 3, 2025Exhibit G032 US20080020058(Chen)-
Mar 3, 2025Exhibit G031 Amended Claim With Annotations 13 September-
Mar 3, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May-
Mar 3, 2025Exhibit G029 Extended European Search Report 12 October-
Mar 3, 2025Exhibit G028 Amendments Received Before Examination 30 December-
Mar 3, 2025Exhibit G027 Withdrawal Of The Op Out-
Mar 3, 2025Exhibit G026 US20080045228P Priority Document-
Mar 3, 2025Exhibit G025 WO2009127060A1 Original Application-
Mar 3, 2025Exhibit G024 Samaridou-
Mar 3, 2025Exhibit G023 Genevant Press Release-
Mar 3, 2025Exhibit G022 Federal Circuit Opinion (435)-
Mar 3, 2025Exhibit G021 Federal Circuit Opinion (069)-
Mar 3, 2025Exhibit G020 Ipr Final Written Decision (435)-
Mar 3, 2025Exhibit G019 Ipr Final Written Decision (069)-
Mar 3, 2025Exhibit G018 US9364435-
Mar 3, 2025Exhibit G017 US8058069-
Mar 3, 2025Exhibit G016 Moore Harvard Business School-
Mar 3, 2025Exhibit G015 Moderna Nih Preprint-
Mar 3, 2025Exhibit G014 CR OSS Cen News-
Mar 3, 2025Exhibit G013 Regalado Mit Technology-
Mar 3, 2025Exhibit G012 Corbett Nature Review-
Mar 3, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration-
Mar 3, 2025Exhibit G010 Suzuki-
Mar 3, 2025Exhibit G009 Semple-
Mar 3, 2025Exhibit G008 Zimmerman-
Mar 3, 2025Exhibit G007 Spikevax Smpc-
Mar 3, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 3, 2025Exhibit G005 Genevant Sciences Trade Register-
Mar 3, 2025Exhibit G004 Proof Of Payment Court Fees-
Mar 3, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus-
Mar 3, 2025Exhibit G002 Patent Register Excerpts-
Mar 3, 2025Exhibit G001 EP2279254B1-
Mar 3, 2025Exhibit C Qualification Report-
Mar 3, 2025Exhibit B Cv Katharina Edenharter-
Mar 3, 2025Exhibit A Cv Thomas Lassak-
Mar 3, 2025EP254Soc Da-
Mar 3, 2025Acknowledgement Of Lodging-
Oct 3, 2025Receipt-
Oct 3, 2025Exhibit-
Oct 3, 2025Cover Sheet-
Oct 3, 2025Application-
Sep 24, 2025Statement Of Reply-
Sep 24, 2025Receipt-
Sep 24, 2025Exhibit-
Sep 24, 2025Cover Sheet-
Sep 14, 2025Rejoinder On Request To Produce Evidence-
Sep 12, 2025Uploaded For Technical Reasons Only To Close Workflow
Sep 12, 2025Upc Genevant Arbutus Reply R 190 Request Signed-
Sep 12, 2025Outcome Of The Order-
Sep 12, 2025Opportunity To Comment-
Sep 2, 2025Receipt-
Sep 2, 2025Moderna R.9 Rop In Response To R.190 Rop Application-
Aug 28, 2025Receipt-
Aug 27, 202525 08 27 Ep 254 Further Comment On Request To Produce Evidence Moderna Vs Genevant-
Aug 26, 2025Reply Re R190 Request-
Aug 26, 2025Exhibit G126-
Aug 18, 2025Panel Appointment-
Aug 18, 2025Opportunity To Comment-
Aug 15, 2025R.37.2 Order
Aug 14, 2025Response To Request To Produce Evidence (Rule 190 Rop)-
Aug 14, 2025Exhibit Fs18 DI 457 Letter May-
Aug 14, 2025Exhibit Fs17 Protective Order-
Aug 13, 2025Joint Statement Regarding Bifurcation-
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop-
Aug 8, 2025Response To Deadline Extension Request-
Aug 6, 2025R.37-
Aug 6, 2025R
Aug 6, 2025Hearing Dates-
Aug 5, 2025Redacted Final Order Re R.262A Applications-
Aug 4, 2025R.262A Order-
Aug 4, 2025Outcome Of The Order-
Aug 4, 2025Opportunity To Comment-
Aug 1, 2025Request For Extension Of Deadlines-
Aug 1, 2025Receipt-
Aug 1, 2025Exhibit G125-
Aug 1, 2025Exhibit G124-
Aug 1, 2025Exhibit G123-
Aug 1, 2025Application For An Order To Produce Evidence-
Jul 28, 2025R.262A Reply-
Jul 28, 2025Exhibit G122-
Jul 25, 2025Receipt-
Jul 24, 2025R.262A Reply-
Jul 24, 2025Exhibit G122-
Jul 23, 2025Reference To Response Of Genevant-
Jul 23, 2025R.262.2 Application-
Jul 23, 2025Exhibit G121 Confidential-
Jul 23, 2025Exhibit G120-
Jul 23, 2025Exhibit G119-
Jul 23, 2025Confidential Response To Security-
Jul 11, 2025Formal Checks Notification Of Positive Outcome-
Jul 11, 2025Acknowledgement Of Lodging-
Jul 10, 2025Set Of Exhibits Fbd T 09 Confidential-
Jul 10, 2025Set Of Exhibits Fbd 11-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 5 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 4 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 3 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 2 Of 5-
Jul 10, 2025Set Of Exhibits Fbd 10 Part 1 Of 5-
Jul 10, 2025Opportunity To Comment-
Jul 10, 2025Formal Checks Request For Correction-
Jul 10, 2025Exhibit Fbd T 19-
Jul 10, 2025Exhibit Fbd T 18-
Jul 10, 2025Exhibit Fbd T 17-
Jul 10, 2025Exhibit Fbd T 16-
Jul 10, 2025Exhibit Fbd T 15-
Jul 10, 2025Exhibit Fbd T 14-
Jul 10, 2025Exhibit Fbd T 13-
Jul 10, 2025Exhibit Fbd T 12-
Jul 10, 2025Exhibit Fbd T 11-
Jul 10, 2025Exhibit Fbd T 10-
Jul 10, 2025Exhibit Fbd T 09A Confidential-
Jul 10, 2025Exhibit Fbd T 08-
Jul 10, 2025Exhibit Fbd T 07-
Jul 10, 2025Exhibit Fbd T 06-
Jul 10, 2025Exhibit Fbd T 05-
Jul 10, 2025Exhibit Fbd T 04-
Jul 10, 2025Exhibit Fbd T 03A-
Jul 10, 2025Exhibit Fbd T 03-
Jul 10, 2025Exhibit Fbd T 02-
Jul 10, 2025Exhibit Fbd T 01-
Jul 10, 2025Exhibit Fbd 16-
Jul 10, 2025Exhibit Fbd 15-
Jul 10, 2025Exhibit Fbd 14-
Jul 10, 2025Exhibit Fbd 13-
Jul 10, 2025Exhibit Fbd 12 Confidential-
Jul 10, 2025Exhibit Fbd 11A-
Jul 10, 2025Exhibit Fbd 09-
Jul 10, 2025Exhibit Fbd 08-
Jul 10, 2025Exhibit Fbd 07-
Jul 10, 2025Exhibit Fbd 06-
Jul 10, 2025Annex 7 To Exhibit Fbd T 4-
Jul 10, 2025Annex 6 To Exhibit Fbd T 4-
Jul 10, 2025Annex 5 To Exhibit Fbd T 4-
Jul 10, 2025Annex 4 To Exhibit Fbd T 4-
Jul 10, 2025Annex 3 To Exhibit Fbd T 4-
Jul 10, 2025Annex 2 To Exhibit Fbd T 4-
Jul 10, 2025Annex 1 To Exhibit Fbd T 4-
Jul 10, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025 V2-
Jul 9, 2025Set Of Exhibits Fbd T 09 Confidential-
Jul 9, 2025Set Of Exhibits Fbd 11-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 5 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 4 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 3 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 2 Of 5-
Jul 9, 2025Set Of Exhibits Fbd 10 Part 1 Of 5-
Jul 9, 2025Receipt-
Jul 9, 2025Opportunity To Comment-
Jul 9, 2025Exhibit Fbd T 19-
Jul 9, 2025Exhibit Fbd T 18-
Jul 9, 2025Exhibit Fbd T 17-
Jul 9, 2025Exhibit Fbd T 16-
Jul 9, 2025Exhibit Fbd T 15-
Jul 9, 2025Exhibit Fbd T 14-
Jul 9, 2025Exhibit Fbd T 13-
Jul 9, 2025Exhibit Fbd T 12-
Jul 9, 2025Exhibit Fbd T 11-
Jul 9, 2025Exhibit Fbd T 10-
Jul 9, 2025Exhibit Fbd T 09A Confidential-
Jul 9, 2025Exhibit Fbd T 08-
Jul 9, 2025Exhibit Fbd T 07-
Jul 9, 2025Exhibit Fbd T 06-
Jul 9, 2025Exhibit Fbd T 05-
Jul 9, 2025Exhibit Fbd T 04-
Jul 9, 2025Exhibit Fbd T 03A-
Jul 9, 2025Exhibit Fbd T 03-
Jul 9, 2025Exhibit Fbd T 02-
Jul 9, 2025Exhibit Fbd T 01-
Jul 9, 2025Exhibit Fbd 16-
Jul 9, 2025Exhibit Fbd 15-
Jul 9, 2025Exhibit Fbd 14-
Jul 9, 2025Exhibit Fbd 13-
Jul 9, 2025Exhibit Fbd 12 Confidential-
Jul 9, 2025Exhibit Fbd 11A-
Jul 9, 2025Exhibit Fbd 09-
Jul 9, 2025Exhibit Fbd 08-
Jul 9, 2025Exhibit Fbd 07-
Jul 9, 2025Exhibit Fbd 06-
Jul 9, 2025EP254 Moderna Reference To Statement Of Defence And Counterclaim For Revocation-
Jul 9, 2025Annex 7 To Exhibit Fbd T 4-
Jul 9, 2025Annex 6 To Exhibit Fbd T 4-
Jul 9, 2025Annex 5 To Exhibit Fbd T 4-
Jul 9, 2025Annex 4 To Exhibit Fbd T 4-
Jul 9, 2025Annex 3 To Exhibit Fbd T 4-
Jul 9, 2025Annex 2 To Exhibit Fbd T 4-
Jul 9, 2025Annex 1 To Exhibit Fbd T 4-
Jul 9, 2025Acknowledgement Of Lodging-
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Request Security Pursuant To R158 No 32591 2025-
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Confidentiality Request-
Jul 9, 202507 08 Upc1 EP254 Reference To Statement Of Defence For Other Defendants(307430487.1)-
Jul 9, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025-
Jun 19, 2025Response To Request For Review-
Jun 12, 2025Outcome Of The Order-
Jun 12, 2025Opportunity To Comment
Jun 11, 2025Acknowledgement Of Lodging-
Jun 6, 2025Exhibit Fbd 5-
Jun 6, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 27016 2025-
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order-
Jun 4, 2025Headnote And Keywords-
Jun 2, 2025Response To Request For Rectification-
May 28, 2025Opportunity To Comment-
May 27, 2025Receipt-
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025-
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome-
May 7, 2025Exhibit G118 Notice European Tender-
May 7, 2025Exhibit G117 Certificate Amalgamation-
May 7, 2025Exhibit G116 Opt Out Confirmation-
May 7, 2025Exhibit G115 Opt Out-
May 7, 2025Comment On Preliminary Objection-
May 7, 2025Comment On Preliminary Objection-
May 6, 2025Notification Of Service-
May 6, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Norway As-
May 5, 2025Acknowledgement Of Access To Case-
May 1, 2025Notification Of Service-
May 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Switzerland Gmbh-
Apr 25, 2025Preliminary Objection-
Apr 25, 2025Notification Of Service-
Apr 25, 2025Exhibit Fbd 4 Moderna Pl-
Apr 25, 2025Exhibit Fbd 3 Dutch Patent Register-
Apr 25, 2025Exhibit Fbd 2 National Registers-
Apr 25, 2025Act 10280 Upc Cfi 191 Confirmation Of Service-
Apr 25, 202525 04 24 EP254 Preliminary Objection Moderna VS Genevant Signed-
Apr 23, 2025Preliminary Objection-
Apr 22, 2025Preliminary Objection Moderna Uk Moderna VS Genevant (EP254) Signed-
Apr 22, 2025Notification Of Service-
Apr 22, 2025Exhibit Fbd 3 Dutch Patent Register-
Apr 22, 2025Exhibit Fbd 2 National Registers-
Apr 22, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Inc.-
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order-
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Response To Letter Brinkhof D.D17 April-
Apr 17, 2025Receipt-
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc-
Apr 17, 2025Outcome Of The Order-
Apr 17, 2025Headnote And Keywords-
Apr 17, 2025Exhibit G114 Letter Re Representation Mll Of Moderna Inc Modernatx Inc-
Apr 15, 2025Receipt-
Apr 15, 2025Notification Of Service-
Apr 15, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Sweden Ab-
Apr 15, 202525 04 15 EP254 Response Re Deadline Extension-
Apr 14, 2025Receipt-
Apr 14, 2025R 9 Aplication Reply To R 9 Request-
Apr 10, 2025Template Order-
Apr 10, 2025Opportunity To Comment-
Apr 9, 2025Receipt-
Apr 9, 2025Opportunity To Comment-
Apr 9, 2025Exhibit Fbd 1-
Apr 9, 202525 04 09 EP254 Request For Deadline Extension Moderna VS Genevant Arbutus Cfi 191 2025 Act 10280 2025-
Apr 1, 2025Notification Of Service-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Netherlands B.V.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Italy S.R.L.-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Germany Gmbh-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna France Sasu-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Denmark Aps-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Uk Limited-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Spain Sl-
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Belgium S.R.L.-
Mar 31, 2025Acknowledgement Of Access To Case-
Mar 28, 2025Acknowledgement Of Access To Case-
Mar 24, 2025Acknowledgement Of Access To Case-
Mar 17, 2025Panel Appointment-
Mar 13, 2025Letter For Service-
Mar 11, 2025Document From Epo-
Mar 6, 2025Receipt-
Mar 6, 2025Panel Appointment-
Mar 6, 2025Formal Checks Notification Of Positive Outcome-
Mar 6, 2025Epo Request For Case Pending-
Mar 5, 2025Statement Of Claim EP254 Signed-
Mar 5, 2025Statement Of Claim EP254Da-
Mar 5, 2025Raw Data Uv-
Mar 5, 2025Raw Data Lc Cad Sample C3-
Mar 5, 2025Raw Data Lc Cad Sample C2-
Mar 5, 2025Raw Data Lc Cad Sample C1-
Mar 5, 2025Raw Data Dls-
Mar 5, 2025Exhibit M.04 United States Pharmacopeia-
Mar 5, 2025Exhibit M.03 Semple-
Mar 5, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture-
Mar 5, 2025Exhibit M.01 Samaridou-
Mar 5, 2025Exhibit G113 Moderna Inc Annual Report Selection-
Mar 5, 2025Exhibit G112 Moderna Annual Report P. 119-
Mar 5, 2025Exhibit G111 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit G110 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit G109 Moderna Rovi Press Release-
Mar 5, 2025Exhibit G108 Moderna Rovi Press Release-
Mar 5, 2025Exhibit G107 Lonza Press Release-
Mar 5, 2025Exhibit G106 Moderna Press Release Lonza Nl-
Mar 5, 2025Exhibit G105 Moderna Ch Service Agreement Tr-
Mar 5, 2025Exhibit G104 Moderna Lonza Press Release-
Mar 5, 2025Exhibit G103 Moderna Portugal Trade Register-
Mar 5, 2025Exhibit G102 Moderna Norway Trade Register-
Mar 5, 2025Exhibit G101 Moderna Sweden Trade Register-
Mar 5, 2025Exhibit G100 Moderna Denmark Trade Register-
Mar 5, 2025Exhibit G099 Moderna Belgium Trade Register-
Mar 5, 2025Exhibit G098 Moderna Italy Trade Register-
Mar 5, 2025Exhibit G097 Moderna France Trade Register-
Mar 5, 2025Exhibit G096 Moderna Germany Trade Register-
Mar 5, 2025Exhibit G095 Moderna Uk Annual Report-
Mar 5, 2025Exhibit G094 Moderna Uk Trade Register-
Mar 5, 2025Exhibit G093 Moderna Poland Trade Register-
Mar 5, 2025Exhibit G092 Moderna Netherlands Madrid-
Mar 5, 2025Exhibit G091 Moderna Es Trade Register-
Mar 5, 2025Exhibit G090 Mresvia Lauer Taxe Germany-
Mar 5, 2025Exhibit G089 Spikevax Lauer Taxe Germany-
Mar 5, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl-
Mar 5, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl-
Mar 5, 2025Exhibit G086 Moderna Nl Hungary Contract-
Mar 5, 2025Exhibit G085 Moderna Nl Hungary Contract Hun-
Mar 5, 2025Exhibit G084 Moderna Nl Annual Report-
Mar 5, 2025Exhibit G083 Moderna Nl Trade Register-
Mar 5, 2025Exhibit G082 Ec Draft Framework Contract-
Mar 5, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 5, 2025Exhibit G080 Moderna Press Release Tender-
Mar 5, 2025Exhibit G079 Ec Press Release Tender-
Mar 5, 2025Exhibit G078 Ex Pa Ec Moderna Ch-
Mar 5, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61-
Mar 5, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60-
Mar 5, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53-
Mar 5, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44-
Mar 5, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35-
Mar 5, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26-
Mar 5, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17-
Mar 5, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8-
Mar 5, 2025Exhibit G076 Moderna Switzerland Trade Register-
Mar 5, 2025Exhibit G075 Modernacovid19Global Website-
Mar 5, 2025Exhibit G074 Modernatx Website-
Mar 5, 2025Exhibit G073 Domain Registrations Moderna-
Mar 5, 2025Exhibit G072 Modernatx Trade Register Excerpt-
Mar 5, 2025Exhibit G071 Moderna Inc Press Release-
Mar 5, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1-
Mar 5, 2025Exhibit G069 Moderna Inc Trade Register Excerpt-
Mar 5, 2025Exhibit G068 Coriolis Report-
Mar 5, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection-
Mar 5, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92-
Mar 5, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 5, 2025Exhibit G064 Ema Assesment Report Mresvia-
Mar 5, 2025Exhibit G063 Moderna Press Release 23 August-
Mar 5, 2025Exhibit G062 Mresvia Smpc-
Mar 5, 2025Exhibit G061 Mitchell Report Table Of Content-
Mar 5, 2025Exhibit G060 Coriolis Report Table Of Content-
Mar 5, 2025Exhibit G059 WO2022197624A1-
Mar 5, 2025Exhibit G058 WO2021222304A1-
Mar 5, 2025Exhibit G057 WO2021159130A2-
Mar 5, 2025Exhibit G056 Richner-
Mar 5, 2025Exhibit G055 Bahl-
Mar 5, 2025Exhibit G054 Espeseth-
Mar 5, 2025Exhibit G053 John-
Mar 5, 2025Exhibit G052 Peer Review Corbett Nature-
Mar 5, 2025Exhibit G051 Hassett-
Mar 5, 2025Exhibit G050 Ema Assessment Report Spikevax-
Mar 5, 2025Exhibit G049 Epo Ar1 To Ar13-
Mar 5, 2025Exhibit G048 Ar13 Redlined-
Mar 5, 2025Exhibit G047 Mr Redlined-
Mar 5, 2025Exhibit G046 Mitchell Report-
Mar 5, 2025Exhibit G045 Petitioners Hearing Slides Slide 27-
Mar 5, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73-
Mar 5, 2025Exhibit G043 D44 Declaration Heyes-
Mar 5, 2025Exhibit G042 D43 Declaration Heyes-
Mar 5, 2025Exhibit G041 Modernas Goa Of 22 November-
Mar 5, 2025Exhibit G040 Arbutuss Goa Of 25 November-
Mar 5, 2025Exhibit G039 Main Request-
Mar 5, 2025Exhibit G038 US2006 0240554 (D25)-
Mar 5, 2025Exhibit G037 Auxiliary Request 13-
Mar 5, 2025Exhibit G036 Od Decision-
Mar 5, 2025Exhibit G035 T 0505 20-
Mar 5, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October-
Mar 5, 2025Exhibit G033 Od Decision-
Mar 5, 2025Exhibit G032 US20080020058(Chen)-
Mar 5, 2025Exhibit G031 Amended Claim With Annotations 13 September-
Mar 5, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May-
Mar 5, 2025Exhibit G029 Extended European Search Report 12 October-
Mar 5, 2025Exhibit G028 Amendments Received Before Examination 30 December-
Mar 5, 2025Exhibit G027 Withdrawal Of The Op Out-
Mar 5, 2025Exhibit G026 US20080045228P Priority Document-
Mar 5, 2025Exhibit G025 WO2009127060A1 Original Application-
Mar 5, 2025Exhibit G024 Samaridou-
Mar 5, 2025Exhibit G023 Genevant Press Release-
Mar 5, 2025Exhibit G022 Federal Circuit Opinion (435)-
Mar 5, 2025Exhibit G021 Federal Circuit Opinion (069)-
Mar 5, 2025Exhibit G020 Ipr Final Written Decision (435)-
Mar 5, 2025Exhibit G019 Ipr Final Written Decision (069)-
Mar 5, 2025Exhibit G018 US9364435-
Mar 5, 2025Exhibit G017 US8058069-
Mar 5, 2025Exhibit G016 Moore Harvard Business School-
Mar 5, 2025Exhibit G015 Moderna Nih Preprint-
Mar 5, 2025Exhibit G014 CR OSS Cen News-
Mar 5, 2025Exhibit G013 Regalado Mit Technology-
Mar 5, 2025Exhibit G012 Corbett Nature Review-
Mar 5, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration-
Mar 5, 2025Exhibit G010 Suzuki-
Mar 5, 2025Exhibit G009 Semple-
Mar 5, 2025Exhibit G008 Zimmerman-
Mar 5, 2025Exhibit G007 Spikevax Smpc-
Mar 5, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 5, 2025Exhibit G005 Genevant Sciences Trade Register-
Mar 5, 2025Exhibit G004 Proof Of Payment Court Fees-
Mar 5, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus-
Mar 5, 2025Exhibit G002 Patent Register Excerpts-
Mar 5, 2025Exhibit G001 EP2279254B1-
Mar 5, 2025Exhibit C Qualification Report-
Mar 5, 2025Exhibit B Cv Katharina Edenharter-
Mar 5, 2025Exhibit A Cv Thomas Lassak-
Mar 4, 2025Formal Checks Request For Correction-
Mar 3, 2025Statement Of Claim EP254 Signed-
Mar 3, 2025Raw Data Uv-
Mar 3, 2025Raw Data Lc Cad Sample C3-
Mar 3, 2025Raw Data Lc Cad Sample C2-
Mar 3, 2025Raw Data Lc Cad Sample C1-
Mar 3, 2025Raw Data Dls-
Mar 3, 2025Exhibit M.04 United States Pharmacopeia-
Mar 3, 2025Exhibit M.03 Semple-
Mar 3, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture-
Mar 3, 2025Exhibit M.01 Samaridou-
Mar 3, 2025Exhibit G113 Moderna Inc Annual Report Selection-
Mar 3, 2025Exhibit G112 Moderna Annual Report P. 119-
Mar 3, 2025Exhibit G111 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit G110 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit G109 Moderna Rovi Press Release-
Mar 3, 2025Exhibit G108 Moderna Rovi Press Release-
Mar 3, 2025Exhibit G107 Lonza Press Release-
Mar 3, 2025Exhibit G106 Moderna Press Release Lonza Nl-
Mar 3, 2025Exhibit G105 Moderna Ch Service Agreement Tr-
Mar 3, 2025Exhibit G104 Moderna Lonza Press Release-
Mar 3, 2025Exhibit G103 Moderna Portugal Trade Register-
Mar 3, 2025Exhibit G102 Moderna Norway Trade Register-
Mar 3, 2025Exhibit G101 Moderna Sweden Trade Register-
Mar 3, 2025Exhibit G100 Moderna Denmark Trade Register-
Mar 3, 2025Exhibit G099 Moderna Belgium Trade Register-
Mar 3, 2025Exhibit G098 Moderna Italy Trade Register-
Mar 3, 2025Exhibit G097 Moderna France Trade Register-
Mar 3, 2025Exhibit G096 Moderna Germany Trade Register-
Mar 3, 2025Exhibit G095 Moderna Uk Annual Report-
Mar 3, 2025Exhibit G094 Moderna Uk Trade Register-
Mar 3, 2025Exhibit G093 Moderna Poland Trade Register-
Mar 3, 2025Exhibit G092 Moderna Netherlands Madrid-
Mar 3, 2025Exhibit G091 Moderna Es Trade Register-
Mar 3, 2025Exhibit G090 Mresvia Lauer Taxe Germany-
Mar 3, 2025Exhibit G089 Spikevax Lauer Taxe Germany-
Mar 3, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl-
Mar 3, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl-
Mar 3, 2025Exhibit G086 Moderna Nl Hungary Contract-
Mar 3, 2025Exhibit G085 Moderna Nl Hungary Contract Hun-
Mar 3, 2025Exhibit G084 Moderna Nl Annual Report-
Mar 3, 2025Exhibit G083 Moderna Nl Trade Register-
Mar 3, 2025Exhibit G082 Ec Draft Framework Contract-
Mar 3, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 3, 2025Exhibit G080 Moderna Press Release Tender-
Mar 3, 2025Exhibit G079 Ec Press Release Tender-
Mar 3, 2025Exhibit G078 Ex Pa Ec Moderna Ch-
Mar 3, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61-
Mar 3, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60-
Mar 3, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53-
Mar 3, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44-
Mar 3, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35-
Mar 3, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26-
Mar 3, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17-
Mar 3, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8-
Mar 3, 2025Exhibit G076 Moderna Switzerland Trade Register-
Mar 3, 2025Exhibit G075 Modernacovid19Global Website-
Mar 3, 2025Exhibit G074 Modernatx Website-
Mar 3, 2025Exhibit G073 Domain Registrations Moderna-
Mar 3, 2025Exhibit G072 Modernatx Trade Register Excerpt-
Mar 3, 2025Exhibit G071 Moderna Inc Press Release-
Mar 3, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1-
Mar 3, 2025Exhibit G069 Moderna Inc Trade Register Excerpt-
Mar 3, 2025Exhibit G068 Coriolis Report-
Mar 3, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection-
Mar 3, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92-
Mar 3, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 3, 2025Exhibit G064 Ema Assesment Report Mresvia-
Mar 3, 2025Exhibit G063 Moderna Press Release 23 August-
Mar 3, 2025Exhibit G062 Mresvia Smpc-
Mar 3, 2025Exhibit G061 Mitchell Report Table Of Content-
Mar 3, 2025Exhibit G060 Coriolis Report Table Of Content-
Mar 3, 2025Exhibit G059 WO2022197624A1-
Mar 3, 2025Exhibit G058 WO2021222304A1-
Mar 3, 2025Exhibit G057 WO2021159130A2-
Mar 3, 2025Exhibit G056 Richner-
Mar 3, 2025Exhibit G055 Bahl-
Mar 3, 2025Exhibit G054 Espeseth-
Mar 3, 2025Exhibit G053 John-
Mar 3, 2025Exhibit G052 Peer Review Corbett Nature-
Mar 3, 2025Exhibit G051 Hassett-
Mar 3, 2025Exhibit G050 Ema Assessment Report Spikevax-
Mar 3, 2025Exhibit G049 Epo Ar1 To Ar13-
Mar 3, 2025Exhibit G048 Ar13 Redlined-
Mar 3, 2025Exhibit G047 Mr Redlined-
Mar 3, 2025Exhibit G046 Mitchell Report-
Mar 3, 2025Exhibit G045 Petitioners Hearing Slides Slide 27-
Mar 3, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73-
Mar 3, 2025Exhibit G043 D44 Declaration Heyes-
Mar 3, 2025Exhibit G042 D43 Declaration Heyes-
Mar 3, 2025Exhibit G041 Modernas Goa Of 22 November-
Mar 3, 2025Exhibit G040 Arbutuss Goa Of 25 November-
Mar 3, 2025Exhibit G039 Main Request-
Mar 3, 2025Exhibit G038 US2006 0240554 (D25)-
Mar 3, 2025Exhibit G037 Auxiliary Request 13-
Mar 3, 2025Exhibit G036 Od Decision-
Mar 3, 2025Exhibit G035 T 0505 20-
Mar 3, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October-
Mar 3, 2025Exhibit G033 Od Decision-
Mar 3, 2025Exhibit G032 US20080020058(Chen)-
Mar 3, 2025Exhibit G031 Amended Claim With Annotations 13 September-
Mar 3, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May-
Mar 3, 2025Exhibit G029 Extended European Search Report 12 October-
Mar 3, 2025Exhibit G028 Amendments Received Before Examination 30 December-
Mar 3, 2025Exhibit G027 Withdrawal Of The Op Out-
Mar 3, 2025Exhibit G026 US20080045228P Priority Document-
Mar 3, 2025Exhibit G025 WO2009127060A1 Original Application-
Mar 3, 2025Exhibit G024 Samaridou-
Mar 3, 2025Exhibit G023 Genevant Press Release-
Mar 3, 2025Exhibit G022 Federal Circuit Opinion (435)-
Mar 3, 2025Exhibit G021 Federal Circuit Opinion (069)-
Mar 3, 2025Exhibit G020 Ipr Final Written Decision (435)-
Mar 3, 2025Exhibit G019 Ipr Final Written Decision (069)-
Mar 3, 2025Exhibit G018 US9364435-
Mar 3, 2025Exhibit G017 US8058069-
Mar 3, 2025Exhibit G016 Moore Harvard Business School-
Mar 3, 2025Exhibit G015 Moderna Nih Preprint-
Mar 3, 2025Exhibit G014 CR OSS Cen News-
Mar 3, 2025Exhibit G013 Regalado Mit Technology-
Mar 3, 2025Exhibit G012 Corbett Nature Review-
Mar 3, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration-
Mar 3, 2025Exhibit G010 Suzuki-
Mar 3, 2025Exhibit G009 Semple-
Mar 3, 2025Exhibit G008 Zimmerman-
Mar 3, 2025Exhibit G007 Spikevax Smpc-
Mar 3, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 3, 2025Exhibit G005 Genevant Sciences Trade Register-
Mar 3, 2025Exhibit G004 Proof Of Payment Court Fees-
Mar 3, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus-
Mar 3, 2025Exhibit G002 Patent Register Excerpts-
Mar 3, 2025Exhibit G001 EP2279254B1-
Mar 3, 2025Exhibit C Qualification Report-
Mar 3, 2025Exhibit B Cv Katharina Edenharter-
Mar 3, 2025Exhibit A Cv Thomas Lassak-
Mar 3, 2025EP254Soc Da-
Mar 3, 2025Acknowledgement Of Lodging-

More cases involving EP2279254B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
UPC_CFI_617/2025Jul 9, 2025ModernaArbutus Biopharma
CC_32138/2025Jul 8, 2025ModernaArbutus Biopharma
ACT_10280/2025Mar 3, 2025Arbutus Biopharma, Genevant SciencesModerna

More cases involving Arbutus Biopharma

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_34390/2025Aug 6, 2025Arbutus BiopharmaModerna
ORD_34391/2025Aug 6, 2025Arbutus BiopharmaModerna
App_34202/2025Aug 1, 2025Arbutus Biopharma -

More cases involving Moderna

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_34390/2025Aug 6, 2025Arbutus Biopharma, Genevant SciencesModerna
ORD_34391/2025Aug 6, 2025Arbutus Biopharma, Genevant SciencesModerna
App_33094/2025Jul 17, 2025Moderna -